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iVerification of Stereotactic Radiotherapy
Abstract
Investigations have been made into the use of a computer based simulation
technique (Monte Carlo (MC)) to ionising radiation transport in order to verify
the doses delivered during linear accelerator based stereotactic radiotherapy and
radiosurgery. Due to the complex nature of the micro multi-leaf collimators
(µMLC) used in this these treatments, a bespoke model of the µMLC was
developed and combined with standard component modules to represent the
remainder of the linear accelerator.
Following validation of the above models, investigations were made into the
dosimetry of small fields, defined by the µMLC and measured with a variety
of detectors. Comparisons of relative output, profiles and depth doses were
made against MC simulations, and a series of correction factors determined, to
account for detector geometry and the non water equivalence of materials used
in semiconductor detectors. An assessment was then made to determine the
smallest fields that can be measured with each detector with confidence.
Systems were then developed to independently simulate stereotactic
treatments and compare doses simulated with those calculated by the treatment
planning system (TPS); excellent agreement between TPS calculations and MC
simulations was observed.
The application of MC methods to determine the most appropriate treatment
tactics and calculation algorithms for stereotactic body radiotherapy in the lung
was then investigated with recommendations made on the most appropriate
calculation algorithms and beam arrangements for the technique. The doses
calculated using the type-b or collapsed cone algorithm agreed most closely with
the MC simulation. There was little difference observed between plans using
more than four beams in the treatment delivery. Treatment techniques using
only three beams or less achieved poorer coverage of the tumour with dose,
producing lower doses at the periphery of the tumour near the interface with the
surrounding lung tissue, compared to using a greater number of beams.
Finally, methods of transit dosimetry using Electronic Portal Imaging
Devices were investigated for use in cranial stereotactic radiotherapy. Three
ii
methods were investigated based on a full MC simulation of the radiation
transport through the patient and on to the imager, prediction of the dose based
on a TPS calculation and an approximation of the radiological path length of
the central axis of the beams to derive an expected dose at the imager plane.
The MC method produced the best agreement at the expense of a longer time
to acquire the comparison doses compared to the TPS calculation method. The
equivalent path length method showed good agreement (within 3.5%) between
delivered and predicted doses but at a single point.
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1.1 Radiotherapy
Irradiating diseased cells with ionising radiation in order to achieve cell death
has been used in the management of malignant and non-malignant disease since
the end of the nineteenth century. This was initially achieved using kilovoltage
X-ray sets and by the application of radium on or near the tumour. By the
middle of the twentieth century, the science of radiotherapy had advanced to use
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high energy beams obtained from high activity radiation sources, such as those
found in 60Co based teletherapy machines. These machines enabled treatment
with high-energy radiation, allowing high, uniform doses to be applied to non-
superficial tumours. The advantages of this approach were further developed
with the invention of the medical linear accelerator, used to generate high-energy
photon and electron radiation using radio-frequency waves to accelerate electrons
along a wave-guide. These electrons are then used to generate photons as they
interact within a high-density target to produce a high-energy photon beam or
scattered using a scattering foil to produce an electron beam (more suited for
superficial lesions).
The rationale of radiotherapy is to exploit the radiosensitivity of tumour cells
by irradiating them to a lethal dose whilst irradiating healthy tissue to a dose
that can be safely tolerated. This can be achieved by confining the radiation
to the target volume using highly attenuating collimators, often accompanied
by high density shielding blocks placed beneath the collimators, which further
conform the radiation to the tumour shape, producing an optimally shaped
radiation field for the particular patient and lesion. Multi Leaf Collimators
(MLCs), consisting of thin fingers of a material with high-density and high
average atomic number can be used to obtain the same effect by moving each leaf
to the appropriate position prior to irradiation. The use of a high average atomic
number materials increases the cross section for interactions occurring at these
energies and therefore shields healthy tissue under the MLCs from receiving high
radiation doses. Conforming the radiation field to the tumour has become known
as ‘conformal therapy’ and is now widely used in routine radiotherapy practice
(Khan, 2010).
1.2 Stereotactic Co-ordinate Systems
The use of conformal radiotherapy has developed in order to satisfy the
oncologist’s desire for a uniform high dose distribution in the tumour volume
whilst sparing healthy tissue. However, uncertainties in the positioning of the
patient during diagnostic scanning and subsequent treatment, together with
movement of the tumour relative to the external patient outline, must be
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accounted for when the oncologist draws clinical target volumes. This inevitably
increases the size of the target volume and indeed the volume of healthy tissue
that is irradiated to a significantly high dose. The purpose of Stereotactic
Radiotherapy (SRT) and Stereotactic Radiosurgery (SRS) is to minimise the
uncertainties in patient positioning during scanning and treatment in order to
reduce the amount of healthy tissue irradiated and allow an increase in the
tumour dose delivered in order to achieve a greater therapeutic effect.
Stereotactic techniques have been used in neurosurgery for many years in the
treatment of malignant and non-malignant cranial disease. In the first decade
of the 20th century, Horsley and Clarke (1908) published a paper in which they
described an external device, illustrated in figure 1.1 used to study the cerebellar
function of the monkey. This device was fitted externally to the monkey and used
to define a three dimensional co-ordinate system using the fixation points of the
device as reference positions. With this fixed frame of reference, it was possible
to describe the function of the patient’s brain to a high degree of positional
accuracy.
Figure 1.1: Horsley and Clarke’s original stereotactic apparatus.
The first human application of this device did not take place until 1918,
when Aubrey Mussen, a Canadian physiologist, commissioned the construction
of a human stereotactic frame (Picard et al., 1983). This was similar to that of
the original Horsley-Clarke apparatus and used ear bars fitting into the external
auditory canal, and a clamp fixed to the infraorbital ridge to fix the device to
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the cranium. As with the original device, it was used to produce stereotactic
atlases of the human brain but despite his encouragements to the contrary,
neurosurgeons were unwilling to use it for clinical neurosurgery.
However, some years later (in 1932) the apparatus was copied in Chicago,
both at the North Western University and the University of Chicago where it
was used to study the electrical activity of feline brains and subsequently by other
institutions that extended its application to the production of atlases of human
as well as animal brains. From these studies, it was found that despite the
accuracy of the system being sufficient to localise sub-cortical structures with
a fair degree of accuracy, anatomical differences between subjects introduced
uncertainties that were considered too large for the system to be used in clinical
practice.
At the same time that Horsley and Clarke were developing their stereotactic
frame, an American neurosurgeon, Walter Dandy, was developing the imaging
technique of ventriculography. However, it was not until some thirty years later
in the mid 1940s, that it was used in conjunction with a stereotactic localisation
system to locate lesions in the brain accurately during neurosurgery (Levy et al.,
1998).
Dandy’s paper of 1918 first describes the process of cranial ventriculography
in which he was able to locate the ventricles of the brain by taking radiographs
of the cranium following filling of the ventricles with gas pumped through holes
drilled in the cranium (la Porte, 1993).
Using this technique to locate the ventricles, the external co-ordinate system
could be accurately referenced to structures within the brain. This technique
was pioneered by Spiegel et al. (1947), using a plaster cap, custom made for
each patient, from which a head ring was suspended, which in turn supported an
electrode carrier. Using this system, shown in figure 1.2 they were able to locate
anatomical targets with reference to landmarks within the brain itself.
Inspired by the work of Spiegel and Wycis, Leksell (1949) developed his own
stereotactic instrument utilizing the concept of the arc-quadrant. This device
was fixed to the cranium, to which a movable arc-quadrant was attached. This
arc quadrant could be moved so that the centre of the arc was positioned at
the centre of the cranial target point. Developments to this apparatus resulted
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Figure 1.2: The original Spiegel and Wycis stereotactic instrument.
in the use of a cuboid frame of reference similar to the stereotactic co-ordinate
systems used today. Other neurosurgeons, Talairach and Tournoux (1988) also
developed a stereotactic system in Paris in the 1940s, in which a frame fixed
to the patient’s skull was used to support a double grid system through which
radiographs were taken. From this grid projected onto the film, a co-ordinate
system over the whole brain was defined relative to external markers, and the
position of structures such as the ventricles could be determined if used in
conjunction with a ventriculogram. A further feature of Talairach’s system was
that it was possible to remove the frame and reposition it in exactly the same
position enabling subsequent procedures to be performed using the same frame
of reference. By the beginning of the 1950s, the work of Spiegel and Wycis,
Leksell and Talairach and Tournoux had convinced the neurological world of the
value of stereotactic co-ordinate systems in accurately locating structures within
the human brain.
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Figure 1.3: CT scan of the BrainLAB stereotactic co-ordinate system attached
to the head ring.
The subsequent development of advanced imaging techniques such as
computed tomography (CT), magnetic resonance imaging (MRI) and positron
emission tomography (PET) has increased the accuracy of the stereotactic system
(Thomas et al., 1984) by enabling the reference of almost all visible neurological
structures to the external stereotactic co-ordinate system. In a CT stereotactic
system, a frame is fitted to the patient, which is worn during scanning. This
frame, consisting of a number of diagonal bars, is used to define the external co-
ordinate system independent of the movements of the scanning system. A typical
system consists of a head ring attached to the patient to which a removable frame
is fixed prior to scanning. Once the patient has been scanned, the co-ordinate
defining bars can be seen on the CT slices from which absolute positions of
structures relative to the external frame can be inferred. Figure 1.3 illustrates
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the BrainLAB 1 localisation system attached to a patient head ring as the patient
is about to be scanned. The high density diagonal bars, that can be seen on the
side of the box appear as white dots outside the patient data on the resultant
CT scan. These white dots are further illustrated in 1.4 in which a transverse
CT section of a phantom used in the verification of stereotactic radiotherapy
scanned within the localising frame can be seen. The localiser bars can be seen
as white dots within blue circles.
Figure 1.4: Stereotactic phantom scanned in the BrainLAB localiser box
indicating position of localiser bars.
Further images of the patient, such as MRI, may be fused to the CT image to
enable improved visualization of the patient anatomy, or with PET to indicate
the function of tissues localised using the system. These images, by virtue of the
fusion are transformed into the stereotactic co-ordinate systems and, as such,
the positions of both lesions and healthy tissue can be referenced in terms of the
1BrainLAB Gmbh, Munich, Germany
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stereotactic co-ordinate system, independent of any uncertainties associated with
the system used to acquire the images or to deliver the clinical intervention. This
may take the form of neurosurgical techniques or by the application of ionising
radiation as in the case of stereotactic radiosurgery and radiotherapy.
1.3 Stereotactic Radiotherapy and Radiosurgery
Leksell (1951) proposed the use of radiation beams to replace surgical instruments
in the treatment of neurological disorders using the stereotactic frame that he
had developed. However, it was not until 1967 that the first prototype machine
was built for this purpose, and the middle of the 1970s before the first purpose
built machines were installed in clinical institutions. Leksell’s machine consists
of a number of radioactive sources that are collimated to produce narrow beams
focused on a common isocentre. The dose from these beams when superimposed
at the isocentre is sufficiently high to be lethal to the lesion. This outcome is
achieved by first imaging the patient within a stereotactic frame and then using
the same frame to position the patient such that the lesion lies at the isocentre of
the system. In order to achieve the high degree of accuracy required, to within a
spatial uncertainty of 1mm, an invasive frame is generally used which is attached
to the patient’s cranium using pins held at high pressure. Consequently, it is
necessary to apply the radiation doses in a single treatment session or fraction,
which is known as stereotactic radiosurgery (SRS).
Stereotactic radiotherapy (SRT) is analogous to conventional radiotherapy in
that the treatment is delivered over several fractions (Warrington and Laing,
1994). This is used in preference to conventional radiotherapy techniques
in circumstances where the advantage of the spatial accuracy of stereotactic
techniques are clinically beneficial. Malignant and non-malignant lesions within
the cranium, in which stable target volumes are situated near sensitive organs,
were the first to benefit from such techniques but the technique has been
implemented throughout the body. In these circumstances, it is necessary to
fit the stereotactic frame to the patient on several occasions and, therefore,
it is necessary to use a non invasive fixation device. Although there are no
technical reasons why stereotactic radiotherapy may not be performed on a
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Gamma Knife2 (the commercial name of Leksell’s machine), the majority of
stereotactic radiotherapy treatments are performed using a linear accelerator
based stereotactic system (Colombo et al., 1985).
1.4 The Medical Linear Accelerator
Linear accelerators, such as those shown in figure 1.5, have been used since the
middle of the twentieth century to produce radiation for use in radiotherapy
(Johns and Cunningham, 1969). In these machines, the momentum of electrons
is increased by accelerating them through a wave-guide through which a radio-
frequency signal propagates. The accelerated electrons are then directed towards
a high density target, which as a consequence of bremsstrahlung interactions
produce megavoltage radiation. These photons are then subsequently shaped
Figure 1.5: Varian 600c linear accelerator used at Velindre Cancer Centre.
by the use of collimating devices to deliver the most appropriate field size. In
a typical modern linear accelerator the wave guide and collimator assembly are
2Elekta AB, Stockholm, Sweden
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manufactured to rotate around a fixed point in space known as the machine
isocentre, enabling efficient treatments to be delivered to the patient by ensuring
that the lesion lies at this isocentre.
Collimation of the beam has conventionally been achieved using two pairs of
fixed high density blocks positioned orthogonally to define the radiation field and
limit dose delivery to a rectangle closest in geometry to the desired treatment
volume. To further conform the field to the target volume, irregularly shaped
shielding blocks, similarly made of high density material were often added to
more closely match the area of high radiation dose. These have the advantage
of reducing the volume of healthy tissue irradiated but each patient requires
customised blocks made especially to match their particular anatomy, which has
significant human resource implications due to the time required to make the
blocks.
In order to reduce the workload but gain the advantages of the custom built
shielding blocks, the multi-leaf collimator (MLC) was developed. As shown in
figure 1.6, an MLC consists of a number of fingers or leaves made of high density
materials that are moved under computer control to produce a field shape similar
to that of a custom built block. This has enabled conformal radiotherapy fields
to be offered routinely in many radiotherapy centres (LoSasso et al., 1993).
The invention of the MLC also heralded the implementation of Intensity
Modulated Radiotherapy (IMRT) (Webb, 2003) on a routine basis. In the most
widely used form of IMRT, the leaves of the MLC are moved during treatment
in order to produce a radiation beam with a varying intensity determined by
the movements of the leaves. By careful choice of the intensity profile of each
beam, and the choice of optimal beam angles, healthy tissue can be avoided to a
greater extent than conformal radiotherapy and the dose targeted at the tumour.
A typical dose distribution produced by IMRT is shown in figure 1.7 in which
concavities in the isodose lines can be seen that avoid the sensitive structures
of the spinal cord and parotids. The possibility of delivering a higher dose to a
partial volume of the target is also realised in this plan, which in the past would
have required a two phase irradiation technique or a more complex plan.
With the widespread introduction of conformal radiotherapy and IMRT,
improved imaging techniques have been introduced in order to verify that the
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Figure 1.6: A Varian Millennium 120 Leaf MLC.
patient is correctly positioned. Initially, these were simply radiographic films
placed opposing the treatment fields at the expected exit point of the radiation
field. As these portal images required processing, it was difficult if not impossible
to process the films quickly enough to determine if the patient position was
correct prior to switching on the radiation. Therefore oﬄine imaging techniques
were applied where images taken over one or a number of radiotherapy fractions
were examined retrospectively after treatment to determine a systematic error in
patient position and the patient moved accordingly for the duration of treatment.
This process clearly has the weakness of being unable to identify gross errors prior
to treatment and has manpower implications associated with the requirement to
process, calibrate and analyse the films. Consequently, electronic methods, using
ionisation chamber arrays or fluorescent screens and semiconductor detector
arrays were developed, allowing images to be acquired, processed quickly and
windowed to display superior contrast than that of radiographic film. These
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Electronic Portal Imaging Devices or EPIDs (Antonuk, 2002) have enabled online
imaging to be performed on patients with high positional uncertainty or small
margins for movement inherent in their treatment plan to be routinely achieved.
EPIDs are also routinely used for oﬄine imaging techniques also due to the speed
of image processing, improved image quality, and their lack of a requirement for
any chemical processing.
Figure 1.7: Typical isodoses produced by IMRT. The red lines indicate the boost
isodose of 85Gy, the yellow the prescribed target dose of 78Gy and the blue
isodose line the prophylactic nodal dose of 68Gy. The yellow and green shaded
areas are the organ at risk (OAR) structures of the parotids and spinal cord
respectively
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1.5 Linear Accelerator Based Stereotactic
Radiotherapy and Radiosurgery
In recent years, the medical linear accelerator has been widely used as the
radiation source in stereotactic radiotherapy and radiosurgery (Colombo et al.,
1985). The relatively small capital required to adapt a conventional accelerator
for stereotaxy compared to the purchase cost of a dedicated Gamma Knife system
has made stereotactic radiotherapy a more viable option for many treatment
centres than was previously the case. Additionally, the increased freedom of
movement in the linear accelerator gantry allows treatment for some lesions
inaccessible to the Gamma Knife, which also suffers from the need to replace
its radio-isotope sources every 5 to 10 years. Due to their number (over 200) and
associated radiation hazards of these sources, there is a significant additional
running cost of the machine, not incurred by a linear accelerator.
The evolution of linear accelerator based stereotaxy has largely followed that
of conventional and conformal radiotherapy. Initial systems produced the small
fields necessary for stereotactic treatment using standard conical collimators
(Shrieve et al., 1998) that produced circular fields of varying sizes.
During treatment planning, the appropriate collimator size was chosen
to cover the treatment volume whilst limiting the dose to healthy tissue.
Analogous to custom shielding blocks in conventional radiotherapy, this system
was developed to include custom cast inserts placed inside the collimator to tailor
the radiation to match the shape of the tumour volume. Figure 1.8 illustrates
a typical system installed on a conventional accelerator, with a custom block
inserted into the conical collimator attached to the machine.
Similar to the issues associated with shielding blocks used in conformal
therapy, there is a significant human resource requirement in the manufacture
of customised collimators for each patient. In order to overcome these time
consuming disadvantages, micro multi leaf collimators (µMLCs) have been
developed in order to conform the radiation field to the shape of the target
(Xia et al., 1999; Cosgrove et al., 1999). These are fitted to the end of the
accelerator for a stereotactic treatment session and work in exactly the same
way as conventional MLCs but consist of thinner leaves than those optimised for
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Figure 1.8: Stereotactic collimator fitted to a conventional linear accelerator.
conventional conformal radiotherapy.
Typically, a conventional MLC leaf width projects a width of 1cm or 5mm
at the isocentre whereas those used for stereotactic radiotherapy have widths
of 4mm reducing down to 1.7mm at the isocentre. More recently, MLC leaves
of 5mm aimed at conventional treatment have become commonplace and allow
fields suitable for stereotactic radiotherapy to be produced with no modifications
necessary to the linear accelerator prior to stereotactic treatment.
The principles of IMRT have also been applied to stereotactic radiotherapy
in order to produce more complex isodose distributions. This is of particular
importance as it is common for target volumes to exist close to sensitive
structures within the brain such as the brain stem. An extension to this idea is
dynamic arc treatment in which the gantry is moved during treatment around the
tumour volume whilst the µMLC leaves are also moved to the optimal position to
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irradiate the target and avoid any organs at risk. This may be further enhanced
by modulating the dose rate and / or gantry speed. This technique is commonly
known at Volumetric Modulated Arc Therapy (VMAT)(Cameron, 2005) and may
be used to deliver a more complex dose distribution or to produce a more efficient
IMRT style plan in terms of the number of monitor units used and treatment
delivery time (Bortfeld and Webb, 2009).
1.6 Linear Accelerator Based Stereotaxy at
Velindre Hospital
In 2004, the first patients were treated using stereotactically guided radiotherapy
at Velindre Cancer Centre Cardiff (VCC). The system currently in use consists
of a relocatable mask system, dedicated treatment planning system and µMLC;
all of which are manufactured and supplied by BrainLAB3. A flow chart of the
stereotactic radiotherapy process is shown in figure 1.9.
The mask system consists of a thermoplastic shell moulded for each individual
patient. The patient is immobilised by the mask in a fixed position relative to
a head ring, which is used to support the mask, and as the reference for the
stereotactic co-ordinate system. During scanning, a localising frame is attached
to the head ring as shown in figure 1.3, which is used as the basis on which
the co-ordinate system is defined during treatment planning. Once scanned,
images are transferred to the planning system, co-ordinates are defined and
beam arrangements optimised to produce the required dose distribution. For
treatment, a target-positioning device on which overlays of the projected beam
arrangements are fixed and used to align the radiation beam to the desired
direction, replaces the localising box. Beams are defined using a µMLC with
a mixture of 3mm and 4.5mm wide leaves projected at the isocentre fitted to
a conventional 6MV linear accelerator which is used in treatment delivery. For
stereotactic radiosurgery, an invasive frame can be used in place of the mask
system.
3BrainLAB GmbH, Munich Germany
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1.7 Physical Issues in Practical Stereotaxy
In order to deliver stereotactically guided radiotherapy safely, account must be
taken of the uncertainties of the treatment process. These are associated with
Figure 1.9: Flowchart of scanning, planning and delivery of stereotactic
radiotherapy (SRT) and stereotactic radiosurgery (SRS).
the positioning of the patient during scanning and treatment, geometric accuracy
of the treatment machine, the calculation accuracy of the treatment planning
system dose calculation method and dosimetric uncertainties of data such as
output factors used as the basis for any such dose calculation.
The geometric accuracy of the treatment unit itself, the patient
immobilisation system and the treatment delivery facility have been considered
by a few authors. Warrington and Laing (1994) summarised the quality assurance
techniques applied at their centre at the time dividing the component parts
into the relocatable frame, CT scanning, treatment planning and machine
quality assurance checks made on a monthly basis. Their work concluded that
using the Gill-Thomas-Cosman (GTC) relocatable frame (Gill et al., 1991),
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patient positional accuracy of better than ±1mm could be achieved when
setting up the frame using a phantom. With additional uncertainties associated
with the rotation of the linear accelerator head and patient couch around the
isocentre, and uncertainties due to the accuracy of patient positioning lasers, a
maximum additive geometric uncertainty of ±3mm was observed. Adding these
uncertainties in quadrature indicated that a 2mm set up margin could reasonably
be applied to fractionated stereotactic radiotherapy. The geometric performance
of the accuracy of the GTC frame was further examined by Kumar et al. (2005)
from approximately one hundred and twenty anterior and lateral portal images
of patients undergoing SRT with the GTC frame. For displacements, the total
errors in the cranial/caudal direction were shown to have the largest SDs of
1.2 mm, while systematic and random errors reached SDs of 1.0 and 0.7 mm,
respectively, in this direction. The corresponding data for rotational errors
was 0.78°SD (total error), 0.58°(systematic) and 0.58°(random). The total 3D
displacement was 1.8mm (mean), 0.8mm (SD) with a range of 0.3mm to 3.9mm.
The BrainLAB mask system (as used at Velindre Cancer Centre) was
investigated in 2010 for repeatability of position accuracy throughout the
treatment process (Minniti et al., 2010) by performing serial CT scans of the
patient, before during and after treatment in combination with portal imaging
of the patient during treatment. This returned further improved results than
those reported with the GTC frame with a mean 3D difference of 0.5mm (SD
0.4mm) in patient positioning obtained from CT images of the patient in the
treatment position over periods of up to four weeks post the initial scan. Using
portal images, a similar magnitude of discrepancy between the isocentre position
defined in the planning system and that observed by a subsequent imaging
modality relative to patient anatomy was observed. This result is particularly
impressive as the reference images were required to be generated outside of the
stereotactic planning system, which did not have the capability to export digitally
reconstructed radiographs.
The accuracy of stereotactic body frames was investigated by Wang et al.
(2006a) in a work which summarised the commissioning and quality assurance of
the entire stereotactic system supplied by Radionics4. Their investigation into the
geometric accuracy of the system indicated that objects within a fixed phantom,
4Integra Radionics, Inc.,Burlington, MA 01803 USA
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localised using the body frame, could be localised to an accuracy to a mean
difference of around 0.6mm (standard deviation approx 0.5mm) in all directions.
As with other phantom studies, this result does not include variation in the
position of target structures due to changes in patient anatomy or movement of
the patient with respect to the stereotactic frame which are more likely in areas
outside the cranium.
Wang et al. (2006b) also considered the performance of the stereotactic micro
µMLC used to collimate the fields to those required by the planning system
including measurements of the leakage through the µMLC leaves, which was
found to be similar in magnitude (1.4%) to that seen in conventional MLCs. As
a test of the calculation performance of their system, Monte Carlo simulations
were performed using the EGS-4 (Nelson et al., 1985) Monte Carlo system in
combination with a number of sources describing the radiation incident on the
µMLC. Despite not completely transporting the radiation through the µMLC,
this study found good agreement between simulated and measured results. A
similar study by Cosgrove et al. (1999), for the BrainLAB µMLC indicated
leakage through and between the leaves similar to that reported by Wang et al.
(2006b).
Dosimetric accuracy of cranial stereotactic systems has been considered by
other authors such as Perks et al. (1999) who considered the dosimetric accuracy
of a stereotactic system using the GTC frame to localise a water filled phantom
containing a small ionisation chamber and concluded that a difference of 2%
between doses calculated by the stereotactic planning system and those measured
could be obtained. By its nature, this phantom was homogeneous and therefore
these measurements were made in the most favourable of conditions. However,
due to the composition of the interior of the cranium being also homogeneous, it
is a good indicator of the calculation accuracy possible using a relatively simple
calculation algorithm. These calculation situations may not apply elsewhere in
the body, such as in the head and neck or lung where stereotactic techniques have
been more recently employed. Traberg Hansen et al. (2005) present a comparison
of two dose calculation methods of doses planned in extra-cranial stereotactic
radiotherapy of the lung. Their study showed a difference of 20% in the doses
calculated using the two calculation methods, indicating the problems in dose
calculation in this group of patients. The study also looked at tumours within
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the liver (a far more homogeneous region of the body), and found negligible
differences between the two calculation regimes. These dosimetric difficulties are
also likely to be present in the head and neck region where there are similar
conditions of tissue heterogeneity to the lung.
Even in the case of homogeneous tissue regions, the dose calculation accuracy
of the treatment planning system is dependent on the data input to it. A series
of papers by McKerracher and Thwaites illustrate these difficulties. In their first
paper, (McKerracher and Thwaites, 2007a) the importance of phantom design
was considered. From measurement, they propose that the use of a small plastic
top equal in height to the depth of maximum dose can be applied to a small
radiation field detector without the need to preserve lateral electronic equilibrium
or to measure collimator scatter factors at a depth beyond the range of electron
contamination. Although this finding is in contrast to the work of other authors,
(Dutreix et al., 1997; Netherlands Commission on Radiation Dosimetry, 1998)
their results comparing output factors at the depth of maximum dose (dmax)to
that at 5cm deep show minimal differences of less than 0.2%. Their second paper,
(McKerracher and Thwaites, 2007b) dealt with the dependence of detector type
and focal source on the measurement of collimator and phantom scatter factors.
Using a technique of measuring ‘in air’ profiles to eliminate volume averaging
effects of each detector, several detectors were examined for suitability with the
conclusion that several of them can be used for measurement of factors down to
fields with dimensions of 1cm. They also investigated the effect of source size on
these measurements and showed a large dependence on output factor with the
amount of the opening of the primary collimator ’seen’ by the detector which can
be considered as the equivalent of source size. This is, of course, also dependent
on the model of linear accelerator.
A third paper (McKerracher and Thwaites, 2008) discussed the measurement
of phantom scatter factors using data obtained from a previous work
(McKerracher and Thwaites, 1999a) to show that phantom scatter factors are
independent of the linear accelerator design and collimation system even for small
fields if a correct measurement methodology is used. A fuller description of the
dosimetric issues associated with small fields as used in stereotactic radiotherapy
is considered in Chapter 5.
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In the case of extra cranial stereotaxy, there are further problems associated
with motion of the tumour during treatment, in which case it is common
practice to reduce the amplitude of breathing using abdominal compression and
breath hold techniques. This can have significant dosimetric effects as shown by
Kontrisova et al. (2006) who described how the volumes of healthy lung receiving
18Gy, 15Gy and 12Gy (in a 3x12.5Gy regime) were reduced by at least 20% by
restricting beam on time to occur only when the patient was performing a deep
inspiration breath hold.
1.8 Study Structure, Aims and Objectives
The aim of this study is to investigate the application of Monte Carlo (MC)
methods to stereotactically guided radiotherapy and radiosurgery. The objectives
of the study are :
1. To develop and validate an accurate model of the stereotactic delivery
equipment
2. To apply Monte Carlo methods to the measurement of doses delivered by
small radiation fields
3. To investigate and develop a system of independent calculation methods of
treatment planning system dose calculations for stereotactic applications
4. To use the Monte Carlo model to determine the most appropriate
treatment tactics and calculation algorithms for extra-cranial stereotactic
radiotherapy
5. To investigate and develop a system for the use of electronic portal imaging
devices for transit dosimetry in stereotactic radiotherapy
The first objective of the project requires an accurate model of the BrainLAB
µMLC used in treatment delivery; once this is complete the model will be
validated in areas of low experimental uncertainty and then used in situations
where precise experimental measurements are difficult. Following validation of
the model, the remaining objectives will be completed by the use of the model
within a distributed computing environment.
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1.9 Thesis Outline
The structure of this thesis is as follows
• Chapter 1: Introduction.
• Chapter 2: A review of dosimetric methods and a description of the Monte
Carlo method, superposition calculation algorithms and the problems
associated with small field dosimetry.
• Chapter 3: A description of the distributed computing system used in the
investigations and of the variance reduction techniques employed.
• Chapter 4: A description of the development of the Monte Carlo model
used throughout the investigation and the measurements made to validate
the model in large fields (> 5cm x 5cm) and small field situations.
• Chapter 5: Deals with the application of the above model to small field
dosimetry and the particular case of small fields produced using the
µMLC and the use of such measurements as an input to stereotactic
treatment planning systems and the verification of doses calculated using
such systems.
• Chapter 6: Describes the implementation of the µMLC model on an
individual patient verification system for cranial and extra-cranial work
and discusses the relevance of such techniques to these situations.
• Chapter 7: Investigates the performance of the planning system in
calculating doses in areas of high tissue heterogeneity and therefore
investigates appropriate treatment techniques such as rotational therapy
versus fixed field conformal radiotherapy and the choice of interactive
treatment planning calculation algorithm used.
• Chapter 8: Describes a system or routine patient verification systems
using electronic portal imaging devices using a Monte Carlo model of the
accelerator and imaging device to determine parameters used in generating
expected doses from treatment plans.
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• Chapter 9: Discussion and Conclusions.
• Chapter 10: Presentations and publications where parts of this work have
previously been presented.
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2.1 Introduction
The purpose of radiotherapy is to deliver a lethal dose of radiation to a tumour
whilst sparing healthy tissue. Due to the sensitivity of both tumours and healthy
tissue it is essential that the amount of radiation delivered by the treatment can
be measured to a high degree of accuracy. Similarly, the algorithms used to
calculate doses in radiotherapy treatment planning systems must also have dose
calculation uncertainties lower than the magnitude of clinically significant dose
increments to tissue.
2.2 Experimental Dosimetry
Radiation, consisting of a beam of photons may be described by determining the
number of photons that cross a given area; this is known as the photon fluence.
However, for non mono-energetic beams it is more appropriate to look at the
amount of photon energy crossing a given area. If a time factor is added to
these quantities then the energy (fluence) rate can be determined by calculating
the photon energy passing through the material per unit area per unit time.
Although it is intuitively simple to describe these quantities, their measurement
is almost impossible. Therefore, it is more convenient to describe a radiation
beam in terms of the amount of energy it deposits in a medium per unit mass.
This is known as absorbed dose.
Direct measurement of absorbed dose is only possible using a technique such
as calorimetry. In this method, the temperature rise in a medium such as water
or graphite due to interactions of the radiation within the medium is detected.
Thus, from a knowledge of the mass of the medium the energy deposited per
unit mass, i.e. the absorbed dose, can be determined. However, due to the small
amounts of energy imparted to the medium (a typical therapeutic radiation
fraction of 2 Gray or 2 Jkg−1 would produce a temperature rise of 5x10−4
degrees centigrade in a kilogramme of water), practical calorimeters are only
of use in highly controlled environments such as national standard laboratories.
Therefore, other measurement techniques have been developed to accurately
measure radiation. Those used within this study are discussed below.
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2.2.1 Ionization Chambers
Ionisation chambers are the most commonly used ionising radiation detectors
currently in clinical use. These consist of a gas filled cavity surrounding a
collecting electrode, held at a different potential to a chamber wall, usually
made of graphite or similar material. This is used to contain the cavity within
the medium. Photons traversing the chamber produce electrons in the chamber
wall, which in turn ionise the gas within the cavity. The movement of these
ions, collected by the electrode, produces a current, the magnitude of which is
proportional to the amount of ionisation occurring within the cavity. The Bragg-
Gray theory (Ma and Nahum, 1991) states that the ionisation produced within a
gas-filled cavity (such as this) inside a medium is related to the energy deposited
in the surrounding medium and therefore the absorbed dose.
If the thickness of the chamber wall is greater than the range of the electrons
produced in the medium, then it can be assumed that the charge collected is a
direct result of interactions within the chamber wall. The charge collected can
therefore be related to the dose to the chamber wall and, by the application
of an experimentally derived correction factor the dose to the medium can
be determined. Further correction factors are required to account for the
perturbation in the dose due to the presence of the cavity, the volume of gas
in the cavity as a result of pressure and temperature variations, recombination
of ions within the cavity and the polarity of the electric field applied between
the electrode and chamber wall. A system of cross calibrations between local
field chambers and dosimetry systems held at national laboratories enables an
accurate (<2%) dose to be measured.
2.2.2 Semiconductor and Diamond Detectors
Diode detectors have been used in radiotherapy for some years to measure relative
dose distributions such as radiation field intensity profiles, and for ‘in-vivo’
patient dose measurements. Diodes have the advantage over ionisation chambers
in that their higher effective atomic number, and therefore increased absorption
allow the use of smaller detecting volumes resulting in a greater spatial resolution
than can generally be achieved using ionisation chambers.
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Radiation incident on the depletion layer of a p-n junction produces electron -
hole pairs which separate due to an electric field applied across the diode, giving
rise to a current proportional to the energy deposited within the depletion region.
A typical diode consists of a silicon p-n junction held within packing material for
ease of handling. Although the active collecting volume (of the order of 0.3mm3)
is much smaller than that of an ionisation chamber, the current produced within
the diode is an order of magnitude higher, making the diode very suitable for
routine use due to the much lower energy required to produce an ion pair in
silicon (3.5eV) compared to air (34eV) and the far greater effective density of
silicon over air.
However, diodes have some disadvantages. Their construction generally
requires the use of high atomic number materials in their electrodes and
protective housing giving energy and directional dependencies, which must be
taken into account when using a particular diode for a particular application
(Saini and Zhu, 2007). The energy dependence may introduce errors in
polyenergetic beams, particularly in areas outside of the open field where,
the deposition of energy occurs from scatter in the head of the machine and
from within the patient and phantom. In these positions there are significant
differences in the spectrum of radiation at these positions compared to the open
part of the beam, which may produce spurious readings as a consequence of the
energy dependence of the detector. Gager et al. (1977) described a method to
avoid this effect using filtration, but this technique is not able to completely
remove the phenomenon. Diodes also have a directional dependence (Jursinic,
2009) that must also be accounted for in measurements. The magnitude of this
effect may be as much as 12% but with careful design may be reduced to less than
2% (Jursinic, 2009). Similarly, their small temperature dependence and effects
due to changes in sensitivity due to radiation damage must also be considered.
2.2.3 Film Dosimeters
Increases in the optical density of radio-sensitive film (radiographic film) as a
result of exposure to ionising radiation can be used in radiation dosimetry with
the application of careful data acquisition, scanning using a photo-densitometer
and calibration techniques (Pai et al., 2007). The active element of radiographic
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film, has a significant content of silver (Z = 45). As the interaction cross section
of the photoelectric effect is proportional the between the fourth or fifth power
of the atomic number, standard radiographic film is more sensitive to lower
energy radiation (where the photoelectric effect dominates) than higher energies
where Compton scattering or pair production are the dominant processes.
Consequently, if films are calibrated at megavoltage energies using the open
part of the field, an over-estimate of the dose may be returned in areas of lower
beam energy beyond the beam edges of a radiation field. Furthermore, due to
the density of the film, there are directional dependencies inherent in the system,
especially when the plane of the film is parallel to the direction of the primary
beam. These issues can lead to significant dosimetric errors but film has the
advantage over other dosimetric methods of having a very high spatial resolution,
down to fractions of a millimetre. This is due to the continuous nature of the
film substance and is limited primarily by the resolution of the scanning system
used to analyse the data.
Despite the dosimetric difficulties, film can been used to measure isodose
distribution to an accuracy of 3% of local dose with a high degree of geometric
accuracy. Dosimetry using radiographic film has become less prevalent in recent
years, partially due to energy and directional dependencies but mainly due
to the transfer of many departments to film-less radiography, in which digital
images are captured and used as the basis for diagnosis in place of conventional
film. This has left many departments without the facility to process film
at all, or with excessive costs and difficulty in ensuring film processors are
available and maintained with fresh chemicals, which are a necessity to ensure
adequate calibration of the films. Increasingly, departments that have adopted
film dosimetry have used radiochromic film (Niroomand-Rad et al., 1998) as an
adequate, and in some respects superior alternative.
Radiochromic film is an almost tissue equivalent substance which exhibits a
change in colour proportional to exposure to ionising radiation. Consequently,
it would appear to have the advantage over standard radiographic film of near
energy and positional independence. It also benefits from a high dose range,
( 10−1 Gray to 103 Gray), is relatively insensitive to visible light and requires
no chemical processing. Its status as a film dosimeter of choice would appear,
therefore, to be well founded. Indeed, the film has been used for several
2.2. Experimental Dosimetry 28
applications within radiotherapy, Meigooni et al. (1996) showed a uniform dose
response across the film to within 4% across the film in one direction but
a deviation of up to 15% in the other, due to non uniformity of the light
source in the scanner. He also found a variation in the energy response of
less than 5% in the megavoltage range. This effect is thought to be due to a
combination of the polarisation of the light used to read the films and the polymer
structure of the radiation sensitive parts of the film, which may give the film a
preferred orientation (Niroomand-Rad et al., 1998). However this experiment
was replicated by Zhu et al. (1997) who found no dependence on the direction of
the film but proposed methods of applying correction factors to obtain a linear
response across the film. The American Association of Physicists in Medicine
(AAPM), report on the use of radiochromic film, (Niroomand-Rad et al., 1998)
made recommendations concerning the type of scanner used, recommending that:
• red light should be used as this is the wavelength at which peak absorption
occurs.
• the orientation of the film should be considered carefully to avoid any
polarisation effects such as those described by Meigooni or a double
exposure technique described by Zhu should be employed.
Several authors have reported successful implementation of these principles
in measurement of doses using this type of film. Bjarngard et al. (1990) measured
central axis depth doses of narrow photon beams using the film and found good
agreement between doses measured with the film and those simulated using
Monte Carlo techniques for large fields but found the agreement diminished as
the fields became smaller. Consequently, it was postulated that the difference
may be associated with the beam spectra used in the Monte Carlo simulation.
It is questionable, however whether this disagreement may be associated with
the energy response of the film or set up uncertainties. McLaughlin et al. (1994)
used the film in a study of the absolute and relative dosimetry of the Elekta
Gamma Knife1 and found excellent agreement between the data measured using
the film and that calculated by the treatment planning system.
1Elekta AB, Stockholm, Sweden
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A more modern implementation of this type of film technology, known as
Gafchromic-EBT film has also been the subject of investigations. Fiandra
et al. (2006) found that the new film has a 10x improved sensitivity than
that of previous film stock while maintaining the tissue equivalence and energy
independence of its predecessor. However, it was also found that a correction for
the lateral heterogeneity was still required, but achieved this without the need
for a double exposure by employing a light scattering correction factor to each
film during processing. Using this method they enabled a dosimetric uncertainty
of 3.6% for doses greater than 0.3Gy. Chiu-Tsao et al. (2005) investigated solely
the energy response of EBT and other new generation radiochromic films and
found that for megavoltage energies the film has no energy dependence within
the range of experimental uncertainties.
2.2.4 Gel and Chemical Dosimeters
Energy deposited in a chemical by radiation may produce a chemical change,
which may be observed and related to the quantity of energy deposited in the
medium. Thermoluminescent dosimeters (TLDs) (Khan, 2010) have been used
for many years in routine dosimetry. In this approach, energy stored in the crystal
lattice of a thermoluminescent material can be released (by heating) in the form
of light, which may be detected and related to the amount of incident radiation.
TLDs have the advantage of a relatively high spatial resolution, (depending on
packaging) and a high degree of stability. Uncertainties in TLD measurements
are of the order of 5% but have, with individual labelling or careful calibration
techniques, reduced experimental uncertainties down to 2%.
Fricke gels or fluids are also used, using the phenomenon of radiation-induced
oxidation of the Fe2+ ions in the ferrous sulphate solution to Fe3+ ions. These
Fe3+ may be observed using spectrophotometry of the dosimeter solution, which
detects changes in the absorption of ultraviolet light as a result of the oxidation.
The major disadvantage of Fricke gels is the large amount of radiation (>10Gy)
required to cause a detectable change.
Poly-Acrylamide (PAG) and BANG (Baldock et al., 2010) 2 gels utilise the
radiation-induced polymerisation of the acrylic monomers to determine dose
2BANG stands for Bis (N, N’-methylene-bisacrylamide, a monomer used in the gel),
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distributions. This works as the polymer chains produced by the radiation, form
micro particles by becoming entangled with the gel matrix, which produce a
visible change which can be used to quantify the dose distribution. Additionally,
this influences the mobility of water molecules within the gel, which consequently
changes the nuclear magnetic resonance (NMR) transverse relaxation time (T2)
of the water’s hydrogen nuclei allowing MRI to be used as the dose read out
mechanism.
A recent review (Baldock et al., 2010) listed the advantages of gel dosimeters
over other dosimetric methods. The advantages are primarily associated with the
fact that the gels produce a 3D dose distribution that can be used to determine
the dose delivered by a single or multiple treatment beams, which can be analysed
after the measurement has been made.The gels are almost tissue equivalent, suffer
from little energy dependence and exhibit no directional dependence. These
polymers do, however, suffer from atmospheric oxygen entering them, inhibiting
polymerisation and subsequently adversely affecting the sensitivity of the gel.
A significant development in the use of gels was reported by Fong et al. (2001)
who manufactured a gel containing ascorbic acid and copper sulphate (amongst
other substances) which act together to bind atmospheric oxygen limiting its
inhibiting effects.
The main disadvantage of gel dosimetry, however, is the requirement of
manufacture by the measuring centre, as few, if any, commercial solutions exist
to allow purchase of ready made gels, and the requirement to scan the gels using a
MR scanner, although some success has been achieved using an optical scanner as
the readout mechanism (Baldock et al., 2010). Despite the advantages of energy
and directional independence of a 3D measurement, the use of gel dosimetry
throughout radiotherapy has not been widespread, probably as a consequence of
the difficulties associated with manufacture and data acquisition.
2.2.5 Dosimetry using Electronic Portal Imaging Devices
Electronic Portal Imaging Devices (EPIDs) have been used for some years in
the verification of patient positioning during treatment (Kirby and Glendinning,
acrylamide (another monomer used in the gel), Nitrogen (in which the gel is produced) and
gelatine
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2006). Fundamentally, they consist of a radiation sensitive flat panel to detect
radiation transporting through the patient. The resulting signal or image is
related to the radiation fluence incident on the detector. Initially, these systems
were based on a fluorescent screen and video camera which have been shown to
be suitable for quality assurance dosimetric measurements and patient specific
exit dosimetry (Kirby and Williams, 1995; Symonds-Tayler et al., 1997). These
authors report an agreement to within 3% when comparing measured doses using
the portal imager against those measured using silicon diodes when considering
exit dosimetry. Agreement of flatness measurements used in routine quality
assurance using the EPID against those taken with a farmer ionisation chamber
agreed to within 1.5%.
In recent years these video based EPID devices have been replaced with
liquid filled ionisation chamber based devices and those using amorphous silicon
as the radiation detector. Ionisation chamber based devices have been shown
to have a response to incident dose of approximately
√
Dose, which is almost
independent of field size (Zhu et al., 1995). Variations in pixel-by-pixel sensitivity
were observed by the same author and, due to the liquid filled nature of the device
a gantry angle dependency has also been observed (Chin et al., 2004). Louwe
et al. (2004) also investigated the long term stability of such devices, finding that
by applying a rigorous quality control procedure a high degree of reproducibility
can be achieved.
Amorphous silicon has become the detective basis for the majority of modern
portal imaging devices. Use of this technology has improved image quality of the
device and eliminated the gantry angle response of the detector. However, the
phosphor screen used to generate photons detected by the silicon which creates
the image has been reported (Sabet et al., 2010) to introduce dosimetric errors
into the device due to the non tissue equivalence of the phosphor screen and
scattering of the visible light. Sabet et al. (2010) investigated removing the
phosphor layer to avoid these effects and used layers of copper and solid water
as build up material. Using this method, they showed that agreement between
doses measured using the EPID, and doses measured using conventional devices
could be achieved to within 1%. However, due to the requirement to remove
the phosphor screen, the practical application of this technique is likely to be
limited.
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The GLAaS algorithm (Nicolini et al., 2006) for absolute dosimetry
successfully applies a calibration algorithm based on the depth of patient or
phantom through which the radiation beam propagates, and the field size of
the incident radiation. Although relatively complex, the algorithm shows good
agreement between doses measured using the EPID and expected results. The
position of the retractable arm on Varian EPIDs has also been shown to be an
important effect on the dosimetric performance of the imager (Siebers et al.,
2004). Siebers et al solved this problem by introducing a uniform layer of lead
into the imager to filter much of the back scatter coming from the support arm.
The application of this technique produced an agreement between doses measured
and expected of less than 1% in the open part of the field. Similar results have
been achieved by approximating the geometry of the support arm in Monte Carlo
simulations to obtain information which can be later used for dosimetric purposes
(Cuﬄin et al., 2010).
2.3 Application of Dosimetric Methods to
Stereotactic Radiotherapy and Radiosurgery
The majority of the above dosimetric techniques have been applied to stereotactic
radiation therapy. Ionisation chambers are the basis of all absolute calibration
regimes due to the traceability of the dosimetry chain to primary standards so
that individual treatment machines can deliver doses to an agreed national or
international standard. Even if other dosimeters are used for the calibration
of the machine, this would still require a cross comparison at some point to
an ionisation chamber to achieve comparison to a national standard. Indeed,
due to the large amount of experience of the use of ionisation chambers within
radiotherapy physics, it is unlikely that any department with a stereotactic
radiotherapy or radiosurgery service will not use ionisation chambers for at least
part of their dosimetric commissioning or validation. The calibration chain is
well known and the correction factors applied to make an absolute dosimetric
measurement are well understood as are the weaknesses of such devices.
Primarily, these weaknesses are associated with the physical dimensions of
such devices which tend to be large compared to some of the fields employed
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in stereotactic techniques. Measurements in small fields are problematic due to
the volume averaging effects of a detector, often large in volume compared to the
field size under investigation which may lead to an underestimate of the measured
dose. This effect can be overcome somewhat by the use of micro-ionisation or pin
point chambers for fields generally down to 1.5cm x 1.5cm (Crop et al., 2009) but
these may suffer from noise introduced to the measurement system by the very
low output from such a low active volume. Despite uneven fluences across the
detector, not invalidating Bragg-Gray theory (Ma and Nahum, 1991), and that
stopping powers for small fields have been shown to be the same as for larger
fields (Verhaegen et al., 1998; Sanchez-Doblado et al., 2003), it has been shown
that the use of reference field stopping powers and perturbation factors may
be insufficient in the dosimetry of small fields (Seuntjens and Verhaegen, 2003).
Consequently, several authors have investigated the use of ionisation chambers
within small fields, using either experimental (Stasi et al., 2004) or Monte Carlo
methods (Scott et al., 2008), either arriving at a total correction factor, for the
ionisation chamber in the conditions under investigation, or the derivation of a
series of adjusted correction factors (Crop et al., 2009).
Perhaps, due to the complexity of the corrections necessary for ionisation
chambers, alternatives have been sought. The high degree of spatial resolution,
(near) energy independence and possibly angular independence of a silicon diode
is an attractive choice for dosimetry in such conditions. The Scanditronix
stereotactic field detector (SFD)3, for instance, offers a very small active volume
making it suitable for use in the measurement of beam profiles with high
spatial precision and in output factor measurements (McKerracher and Thwaites,
1999a). Solid state detectors have a dependence on temperature and on energy
due to the photoelectric cross section being much greater for silicon than tissue
equivalent material but correction factors for these may be easily applied and
diodes such as the SFD have been widely used in stereotactic radiotherapy and
radiosurgery.
Diamond detectors (Heydarian et al., 1996) offer similar advantages in terms
of spatial resolution (although not as small as some diode detectors), with energy
and directional independence, although there is a dependency on dose rate. Dose
rate correction factors are more problematic outside the beam edges during profile
3IBA Dosimetry GmbH, Schwarzenbruck, Germany
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measurement and, due to the difficulties associated with manufacture, diamond
detectors are more expensive. They have however been successfully applied to
stereotactic radiation therapy techniques (Pappas et al., 2008; Verhaegen et al.,
1998).
Other more novel semiconductor devices such as MOSFETs may also be used,
which have excellent responses, independent of dose rate, energy and direction
but require frequent calibration (Das et al., 2008). Semiconductor arrays were
considered by Pappas et al. (2008) and Manolopoulos et al. (2009) who found that
their use solved some of the spatial effects associated with ionisation chambers
when measuring relative dose profiles of stereotactic cones.
Film may be used in output factor determination, particularly for small fields
but its use is generally limited to the measurement of relative dose distributions
in the validation of treatment planning systems either on a systemic or patient
by patient basis.
In recent years, there has been a national recommendation within the
UK to perform patient specific in-vivo dosimetry on all patients (Royal
College of Radiologists, 2008) which is likely to include stereotactic techniques.
Conventional techniques such as diodes, which are considerably larger than the
SFD may have problems associated with their positioning at the entrance of a
small field and their uneven perturbation to the intended dose, which is likely
to be made up of one or a small number of fractions. TLDs may suffer from
similar positional uncertainties and also the fact that they do not provide a real
time measurement of the dose, so that any dosimetric error discovered by such
a measurement may only be determined after the treatment has been delivered,
which in the case of stereotactic radiosurgery is too late for any correction to be
made. Transit dosimetry using EPIDs may be of use in that the large planar
detector measuring dose at the exit of the patient does not suffer from positioning
errors or perturb the beam incident on the patient. There are however no reports
of this being utilised in stereotactic radiotherapy and this will be a focus of one
of the investigations considered in this work.
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2.4 Dose Calculation Methods
2.4.1 Point Dose and Accelerator Calibration
Figure 2.1: Standard calibration conditions.
In general, medical linear accelerators are calibrated to produce a known
dose, typically 1cGy, per treatment machine monitor unit at a standard depth
in a water or tissue equivalent phantom at the centre of a standard field size,
typically 10cm x 10cm at the isocentre. Figure 2.1 illustrates these conditions.
Typically, a focus to surface (FSD) of 90cm is used with the ionisation chamber
placed at the isocentre, a depth of 10cm within the phantom is used. Other
possibilities such as FSD of 95cm with the measurement point at 5cm deep within
the phantom, or setting the calibration point to the depth of maximum dose with
the surface of the phantom at 100cm FSD can also be used. At this point the
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dose delivered to the calibration point can be determined by the relation:
Dose = MU × fcal (2.1)
where
• MU is the number of monitor units delivered
• fcal is the calibration factor, defined as the dose per monitor unit, which
is generally set as part of a local departmental protocol to be a figure of
typically 1cGy/MU. The treatment device is calibrated to deliver this dose
during initial calibration of the machine.
At positions away from the calibration point, doses can be determined by the
application of other factors, accounting for reductions or increases in dose as a
result of a change in field size, a change in depth within the phantom or distance
from the radiation source. There are several methods of calculating dose using
factors describing changes in dose as a result of changes in the geometry of the
radiation. It is usual to calculate the number of monitor units required to deliver
a prescribed dose to a point in question using one of the methods described in
the following sections.
2.4.1.1 Percentage Depth Dose Method
MU =
TD × 100
fcal × %DD(rs)100 × Ffac(d, FSD)× Sc(rc)× Sp(rd)× FISL(FSD)
(2.2)
where
• TD, is the prescribed target dose in Gray
• fcal, the calibration factor defining the dose per monitor unit, usually in
this formalism at the depth of maximum dose, for a 10cm x 10cm field in
a phantom placed 100cm from the radiation source.
• %DD(rs), the depth dose normalised to the calibration point for the field
size rs defined at the patient surface
2.4. Dose Calculation Methods 37
• Ffac(d, FSD), the divergence factor to account for changes at depth d in
the inverse square law characteristics of depth doses at differing FSDs
• Sc(rc), the collimator scatter factor for field size rc defined by the
collimators (i.e at the isocentre depth)
• Sp(rd), the phantom scatter factor for the field size rd defined at the
measurement depth
• FISL(FSD), the inverse square law factor to account for changes in
radiation intensity with changes in FSD
This was the most commonly used dose calculation technique adopted when
the majority of radiotherapy treatment plans were delivered at fixed FSD
although the quantities of Sc and Sp were often combined to form a field size
factor.
2.4.1.2 Tissue Maximum Ratio / Tissue Phantom Ratio Methods
As isocentric treatments were widely introduced, the above definition of monitor
unit calculations was replaced by systems using tissue maximum ratios (TMRs)
or Tissue Phantom Ratios (TPRs) in which the depth doses of 2.2 are replaced
by either TMRs or TPRs. These are similar functions describing the variation of
dose as a a function of depth within the patient or phantom. Whereas depth doses
are measured with a fixed source to phantom distance, and therefore contain
information concerning both attenuation and inverse square law effects TMRs
and TPRs are measured with a fixed source to detector distance with the depth
of water or attenuating material between the detector and the source of radiation
varied. Consequently, only a reduction in dose due to attenuation with depth
is contained within the TPR or TMR curve. This is analogous to an isocentric
treatment and therefore produces calculations based on data acquired closer to
the treatment conditions and simplifies the calculation expression. TMR curves
are normalised to the depth of maximum dose whereas TPRs are normalised to
a defined depth such as 5cm or 10cm deep. For the case of TPRs, the expression
describing a calculation of monitor units can be defined as
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MU =
TD × 100
fcal × TPR(rd)× Sc(rc)× Sp(rd)× FISL (2.3)
where
• TD, is the prescribed target dose in Gray
• fcal, the calibration factor defining the dose per monitor unit often at a
depth of 10cm at the isocentre (i.e. the focus to phantom surface distance
is 90cm)
• TPR(rd), the Tissue Phantom Ratio normalised to the calibration point
for the field size rd defined at the calculation depth
• Sc(rc), the collimator scatter factor for field size rc defined by the
collimators (i.e at the isocentre depth)
• Sp(rd), the phantom scatter factor for the field size rd defined at the
measurement depth
• FISL(FSD), the inverse square law factor to account for changes in
radiation intensity if the calculation point is not at the isocentre
Very good agreement between doses calculated using these methods and those
measured can be achieved with careful measurement of the factors for regularly
shaped fields due to the slowly varying nature of each of these factors with field
size. For small fields, however, the quantities such as Sp , Sc and TPR are
difficult to measure as their variation with field size is quite rapid when the
geometric dimensions of the measurement device are similar to that of the field
under investigation. Consequently, even for point calculations in small fields,
there are large uncertainties, which may prevent their implementation clinically.
For two dimensional or three dimensional planning techniques, dose
calculation at several points is required to enable optimum dose distributions
to be delivered. In recent years beam library methods have been superseded by
convolution techniques and, more recently, Monte Carlo techniques have become
a more realistic solution in areas of calculation uncertainty. The evolution of
these methods is described below.
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2.4.2 Beam Library and Clarkson Methods
Figure 2.2: Geometry of measurement positions of beam library planning system.
Beam library planning systems were originally described by Bentley and
Milan (1971) using a calculation algorithm based on the interpolation of
measured data, illustrated in 2.2. In this illustration, a beam produced at
the radiation source O is incident on a water phantom. Depth doses are
measured along AB, normalised to the dose calibration point at intervals of a
few millimetres depending on storage facilities available at the time. In order
to calculate dose off axis, beam profiles describing the variation of the beam
intensity with lateral distance are used. These vary more slowly with depth than
depth doses but may vary rapidly laterally particularly within the penumbral
area of the beam. Consequently these are measured along a relatively small
number of depths such as BC, DE, FG, but with a high concentration of points
in the penumbral region. Each of these profiles is normalised to the central axis
of the beam. The dose at any point in the 2D plane can therefore be evaluated
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using the following equation:




• Dosebeam,d,x,y is the dose delivered at a depth, d and a radial distance, x
from the central axis from a beam.
• Dcal is the dose per monitor unit at the calibration point
• Foutfs is the output factor describing the dose variation at the calibration
point as a result of the change in field size
• MU is the number of monitor units delivered.
• DDfs,d is the depth dose for a field size, fs at a depth, d normalised to the
calibration point
• PRFfs,d,x is the relative intensity a distance x from the central axis at a
depth, d for a field size fs normalised to the central axis at the depth, d
At points where data do not exist due to restrictions in data storage
capabilities, the quantities PRFfs,d,r and DDfs,d can be obtained by linear
interpolation by careful selection of the measurement resolution to avoid any
significant dosimetric errors.
By repeating this technique at all points in the patient data matrix, a dose
distribution can easily be built up. For a plan involving several beam this process
can be completed for all beams and the total dose determined by a superposition





following which isodose lines can be plotted for subsequent plan evaluation.
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2.4.2.1 Limitations of Beam Library Calculations
The calculations discussed above can be easily understood and implemented
using regular field shapes (squares, rectangle and circles) incident on simple
phantoms. In practice, tumours are rarely simple in shape and reside in patients
with heterogeneous tissue and complex surface geometry. Therefore, corrections
are required to the beam library data to ensure an accurate calculation to allow
for dose variation caused by these phenomena. These have been described by
many authors. Clarkson (1941) proposed a method of dose calculation in which
the scattered component of a depth dose may be considered separately from the
primary component. To facilitate this the Tissue Air Ratio (TAR) is defined as
the ratio of dose at a point within the phantom, Dd to the same point in free





where TARd,rd is the tissue air ratio of a field of size rd at a depth d.
Similarly, the concept of Scatter Air Ratio (SAR) may be used to describe
the amount of scattered radiation within a field, defined as the ratio of scattered
dose within a phantom to the dose in free space. This is commonly obtained by
extrapolating TAR measurements to obtain a zero area TAR and subtracting
this value from the TAR of the field size in question, which represents the primary
dose from the TAR of this field, to obtained the scattered component, hence:
SARd,rd = TARd,rd − TARd,0 (2.7)
Using these quantities, the dose may be calculated at points in situations such
as that illustrated in 2.3 of an irregular field centred atO with a collimating block.
By drawing radii from point O, which may or may not be at the central axis, the
field may be divided into elementary sectors, each of which can be characterised
by the radius drawn. Therefore, if the shape is divided into 10 radii, for example,
then the scattered radiation will be equal to 1
10
of the SAR for a field of that
radius centred at O. By looking up the SAR of each of these radii, an average
SAR may be generated, which can be used to generate an average TAR using
the relation:
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Figure 2.3: Beam’s eye view of a typical irregular field.
TAR = TARd,0 + SAR (2.8)
This can then be used in subsequent dose calculations using formalisms similar
to that described in equation 2.3; the accuracy of which can be increased by
increasing the number of radii used in the SAR calculation.
Day (1950) proposed a similar method based around defining the fields into
constituent rectangles with similarly good results in a range of circumstances. For
treating within the human body, corrections for changes in density are required,
especially in areas of large heterogeneity such as in the lung or head and neck.
Corrections to the depth dose or similar quantity used in the dose calculation
method can be applied, such as those proposed by Batho (1964) utilising
ray tracing methods to arrive at average attenuation coefficients subsequently
developed by other authors (Siddon, 1984; Cassell et al., 1981) to arrive at more
general solutions. Further corrections to the raw beam data are required for the
presence of missing tissue compensators (Gray and Smith, 1994), asymmetric
fields (Millin and Smith, 1994) and other beam modifying devices. To extend
the flexibilities of such systems, methods of generating beam profiles and depth
doses have been considered (Chui and Mohan, 1986) but due to the introduction
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of uncertainties with each correction and the large amount of data required to
obtain the data to generate profiles, depth doses and correction factors, these
dose calculation techniques have generally been abandoned in favour of other
techniques described below.
2.4.3 Convolution-Superposition Dose Algorithms
The transfer of energy from a photon beam to a medium takes place in two
stages. The first stage consists of an incident photon interacting with an atom,
resulting in one or more electrons gaining kinetic energy from the photon and
moving through the material. The second stage consists of this energy being
transferred to further particles in the medium and deposited as absorbed dose to
the patient’s tissue, or it may escape the patient altogether. A quantity KERMA
(kinetic energy released in matter) has been assigned to the energy released in








• K is the KERMA






the mass attenuation coefficient for the medium and
• Etr is the average amount of energy transferred to the electrons by these
interactions
In radiotherapy, absorbed dose is the quantity of most interest as this is the
quantity that describes the amount of energy deposited to a phantom or patient
at a point in the medium. As electrons are released in the medium due to the
first stage of the process, they lose their energy as a result of ionisation and
excitation which takes place at various points along the particles’ track and may
irradiate some energy as a result of bremsstrahlung. Consequently KERMA and
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absorbed dose do not necessarily occur at the same place. The International






• D is the absorbed dose
• dEab is the mean energy imparted by the radiation to a mass, dm of matter.
In conditions of charged particle equilibrium in a medium in which there is
no attenuation of the primary beam and there are no radiative losses of energy,






× Etr = dEab
dm
(2.11)
Therefore, it can be seen that there is a direct relationship between photon fluence
and absorbed dose in this unrealistic situation. However, even in a realistic
situation, a similar relationship holds; if charged particle equilibrium exists at
a point and attenuation is considered, it can be shown that absorbed dose is
proportional to KERMA. This relation is in practice almost constant since, in
high energy photon beams, the average energy of the generated electrons and
hence their range does not change appreciably with depth in the medium. This
is illustrated in figure 2.4 in which it can be seen that at any depth beyond
the point where electronic equilibrium is reached, the absorbed dose delivered
exceeds KERMA due to the interactions causing the deposition of dose occurring
further upstream in the beam direction. Building upon this concept of dose
deposition occurring in a two phase process, algorithms convolving the primary
energy incident on the patient or phantom with a ‘kernel’, describing the energy
spread of these secondary particles have been developed. These produce a more
general solution to dose calculation and are able to calculate dose distributions
in as wide a variety of beam modifying devices, tissue inhomogeneity and field
irregularities as currently used in external radiotherapy.
This can be a achieved using a quantity TERMA, which, is similar to
KERMA but describes the total energy released to the matter per unit mass
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Figure 2.4: Representation of the variation of absorbed dose and KERMA with
depth.







where E is the energy at a the point of calculation.
This quantity can be used to determine the dose deposition resulting from
scattered particles transporting energy away from the initial interaction site.
Consider the situation of figure 2.5 in which a photon enters the patient, interacts
at x′ and transports dose to x. For a primary photon fluence of Φ with an energy




Φ(x′)GT (x− x′) d3x′ (2.13)
The energy spread function, GT , includes energy from charged particles
(positrons and electrons) produced from primary, secondary and multiple scatter
photon interactions and as written (GT (x− x′)) relates to the dose deposited
at x due to a unit fluence at x′ including factors converting photon fluence to






multiplied by the beam energy. Therefore, for a mononenergetic beam of energy
E0:






E0HT (x− x′) (2.14)
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Figure 2.5: Representation of the principle of a photon interacting at x′ and
transporting dose to x.
where HT (x− x′) is a point spread function representing the fraction of energy










E0HT (x− x′) d3x′ (2.15)




T (x′)HT (x− x′) d3x′ (2.16)
This, however, is for a monoenergetic beam, but by adding energy components
to the fluence or TERMA and dose spread quantities of equation 2.16, and
integrating over both energy and volume we have a double integral describing
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′, E)H (x− x′) d3x′dE (2.17)
The practical implementation of such a technique, therefore, relies on accurately
describing the primary fluence and spread functions. The primary fluence
can be readily obtained from a knowledge of the primary beam intensity and
functions describing the collimation and beam direction of the incident radiation.
Additionally modulation functions describing the perturbations of the beam as
a consequence of the presence of a wedge, or other beam altering device may
also be included in the calculation. There have been several approaches to the
implementation of spread functions, which can be considered as two main types
1. point kernels, commonly known as collapsed cone or type-b algorithms
2. pencil kernels commonly known as pencil beam or type-a algorithms
Collapsed cone algorithms, as described by Ahnesjo (1989) approximate the
point spread function by dividing the area over which it irradiates secondary
particles into a number of cones covering the full volume of tissue surrounding
each point. The dose components over each cone are then collapsed to the axis of
the cone, as illustrated in figure 2.6. Using this technique, the dose over the whole
volume of the patient can be built up and, due to the nature of the algorithm
revolving around points within the patient, dose can be tracked across boundaries
of materials and doses in the periphery of high density structures surrounded by
low density structures, which may be calculated with a high degree of accuracy.
Pencil beam algorithms (Ahnesjo et al., 1992) have the advantage over point
kernel methods in that the calculation time is much lower. These work by
dividing the beam into a number of pencils as illustrated in 2.7. In this function,
the spread function is modelled by the profile of each pencil and the dose at a
point calculated by summing the doses deposited from each pencil. The dose
from each pencil is scaled according to the relative electron density of the line
along the axis of the pencil obtained from the CT data of the patient to obtain
the radiological depth to the calculation point. Using this method doses from
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Figure 2.6: Diagrammatic representation of collapsed cone algorithm.
irregular fields can be calculated in areas of tissue homogeneity. However, due
to the nature of each pencil having only a bulk density correction being made
to the depth scaling, no account can be made of the build up effects in tissue
inhomogeneities.
Both of these convolution techniques may be used to model primary radiation
and head scatter within the linear accelerator collimator head which may be
considered separately and then subsequently added together.
2.4.4 The Monte Carlo Method
In recent years, there has been a significant rise in the use of Monte Carlo methods
in radiotherapy physics. This is the result of the implementation of advanced
treatment techniques becoming available, such as CT based conformal therapy,
Intensity Modulated Radiotherapy and stereotactically guided radiotherapy; all
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Figure 2.7: Diagrammatic representation of pencil beam algorithm.
of which present situations in which accurate dose calculations using conventional
methods are difficult, together with the reduced cost of high performance
computers. Verhaegen and Seuntjens (2003) have published a review of the topic
describing the evolution of the Monte Carlo technique in radiotherapy from early
studies in the 1940s on atomic weapons to its implementation in radiotherapy
physics, as has Rogers (2006)
Fundamentally these techniques involve tracking individual particles through
the accelerator geometry and patient and by applying a series of random numbers
to probabilities of interactions occurring obtained from an understanding of the
physics, a simulated dose distribution can be built up.
If the geometric model of the treatment delivery device, the composition of
the patient and the physical interactions are represented sufficiently well, and
enough particles are simulated to reduce statistical errors to an acceptable level,
2.4. Dose Calculation Methods 50
Figure 2.8: Diagrammatic representation of a Monte Carlo simulation.
then doses may be modelled accurately in all dosimetric situations to a degree
not possible by analytical techniques. Monte Carlo techniques, therefore, offer
many benefits over conventional methods in terms of calculation performance
but have the disadvantage of long simulation times and a requirement to know
the exact geometry of the treatment delivery machine, which may not always
be readily available. The issues of speed have been somewhat overcome using
the implementation of variance reduction techniques, which are summarised by
Verhaegen and Seuntjens (2003) and discussed briefly in Chapter 3 and by the
use of distributed computing techniques (Downes et al., 2009). All of these
have contributed to the widespread implementation of Monte Carlo techniques
to patient by patient plan verification (Leal et al., 2003), investigations into
the efficacy of existing radiotherapy treatment systems (Spezi et al., 2001) and
implementation of new radiotherapy and dosimetric techniques (Siebers et al.,
2004). Prudent approximations in the physical interactions simulated within
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human tissue at therapeutic energies using systems such as the Voxel Monte
Carlo (VMC) model (Kawrakow et al., 1996) have reduced simulation times
further and made the possibility of interactive treatment planning with Monte
Carlo methods a possibility.
The flexibility of the Monte Carlo method therefore makes it of great interest
in the verification of stereotactically guided radiotherapy, for various applications
such as treatment plan verification, small field dosimetry and portal dosimetry
which will be discussed in the following chapters.
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3.1 The EGSnrc Monte Carlo Code
The EGSnrc Monte Carlo code system was developed out of the EGS4 code
incorporating many of the additions developed by several authors following the
initial release of the software. The history of EGS4 has been described by
Bielajew et al. (1994) and the functions of EGSnrc by Kawrakow (2010).
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The key features of EGSnrc are that it allows photons, positrons and electrons
to be simulated in any element, compound or mixture using the data preparation
package PEGS4, which is used to create data for use by the EGSnrc system
using a series of cross section tables for each element. The geometry of the
space through which the radiation is transported is defined by user written
subroutines which can make use of a series of predefined subroutines to describe
planes, spheres and other simple geometry. Within this geometry, tracked
particles are transported in steps of random length, the length of which is
adjusted near boundaries to ensure accurate modelling of boundary effects.
Interactions including Bremsstrahlung, pair production, Compton scattering and
photoelectric effect are simulated as well as a wide range of other processes such as
positron annihilation, Coulomb scattering etc., enabling accurate dose simulation
for the purposes of radiotherapy physics.
3.2 The BEAMnrc and DOSXYZnrc Monte
Carlo Codes
The BEAMnrc and DOSXYZnrc codes are based on the EGSnrc codes and
provide the user with a set of predefined tools to assemble codes necessary to
simulate linear accelerators and other treatment delivery devices for the case
of BEAMnrc or by using a voxelised geometry a more general model can be
constructed such as that of a patient etc.
Simulation time can be improved using these systems using the built in
options such as Russian Roulette and Bremsstrahlung splitting which are
discussed briefly in this chapter and described in the relevant user manuals
(Rogers et al., 2009) (Kawrakow, 2010)
3.3 Distributed Computing
The Monte Carlo technique relying on a large number of sequential events can
be considered as an ‘embarrassingly parallel’ problem in that the same result can
be obtained by sequentially simulating a million particles on a single computer
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process or simultaneously simulating a single particle on a million processors
and combining the results at the end of all the simulations. In both situations
a unique random number is required as the starting point for each particle’s
transport through the accelerator and patient geometry. The splitting of these
jobs requires no communication between jobs and can therefore rely on either
accessing a shared memory for input data as in the case of a parallel computing
system or in communication between processors over a computer network or
similar as is the case in a distributed computing solution (Andrews, 2000).
3.3.1 Local Condor Grid
Within Velindre Cancer Centre, as with most if not all similar institutions an
array of personal computers (PCs) used for general office work is installed which,
when powered up and not performing any tasks may have redundant processor
cycles available for tasks such as distributed computing.
The Condor system (Thain, 2005), is an open-source software package
designed to distribute computing jobs amongst a dedicated cluster of computers
or amongst idle computers on an existing office or other network. It is therefore
suitable for use as the basis for a distributed network at our centre.
Condor was initially installed on approximately 50 computers, situated
primarily within the Medical Physics Department which gave approximately 80
cores at an average processor speed of 1 - 1.5 GHz. These computers were
generally powered on overnight and therefore gave an almost uninterrupted
resource of 16 hours per day as well as any idle time that may occur during
the standard working day. Therefore outside of normal working hours there
are 1280 hours of computing time available each day. During office hours the
available time is difficult to estimate and depends on the settings used in a
particular installation. These may be set such that submitted jobs may be run
with a similar priority to the machine user’s tasks or to suspend execution as
soon as the user begins any task. In order to interfere as little as possible with
the routine running of the department the latter option was chosen.
Jobs were submitted to the system using the methodology shown in figure
3.1 with ‘Perl’ scripts used to produce a unique input file describing the input
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geometry of the simulation. Each of these input files is identical with the
Figure 3.1: Representation of the local Condor grid at Velindre Cancer Centre.
exception of the random number seeds used to begin each simulation. These
are then submitted as separate jobs by the ‘experimenter’ node to the ‘submit’
node which distributes each job throughout the Condor network, copying the
relevant files to each node, collecting any output from each job and returning
these outputs to the submit node.
In this system, it is up to the user to generate the input files and to ensure
that the correct executables are available and are presented to each executor
node. The correct files are transferred by the use of a batch file that is run as
each job is submitted.
3.3.1.1 Validation
In order to validate the system depth doses, profiles and output factor
measurements were simulated on the system and compared to those simulated
on a single machine for the same number of particles and also for the same
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amount of time to compare the gain in simulation precision as a consequence of
the increased computing power.
Typical results of relative dose and output factors are shown in figure 3.2,
which illustrates the agreement between simulations using the local Condor
grid and the local machine. In all of the simulations examined there were no
differences observed between the running of the simulation using the Condor
grid or on a local machine.
A drawback of such a system however is the requirement of the users to
generate all of the input files themselves. Although potentially straightforward
it was fairly common for errors to be introduced into the system due to the
large number of files required. Consequently it was determined to investigate a
system for doing this more transparently to the user such as the ‘RTGrid’ system
as described below.
3.3.2 The RTGrid; A Radiotherapy Monte Carlo Portal
The RTGrid (Downes et al., 2009) is a layer sitting above a Condor server that
allows the user to present a single input file to the system via a web browser based
interface illustrated in figure 3.3, leaving the RTGrid to manage the submission
of the correct input files to each of the executor nodes. The system therefore,
acts to the user in exactly the same way as a single machine.
Particular tasks can be described by the use of profiles which can be used to
determine the particular Monte Carlo executables to use, based on Monte Carlo
code or the hardware on which the simulation is desired to run. This can include
customised executables as is the case with simulations using the bespoke model
of the BrainLAB µMLC described in the next chapter.
The RTGrid can run using Condor or other high performance computing job
managers and interface to a number of computing operating systems such as
Linux and OSX as well as Windows. During the early stages of this project the
RTGrid portal sitting on top of the Cardiff University Condor network became
available and was used as the basis for the majority of simulations described in
the following chapters.
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The Cardiff University Condor network consists of several thousand PCs
allowing far more jobs to be run in parallel, compared to the local grid. The
use of a web portal also allows access to the grid from anywhere with internet
access, enabling easy submission, control and return of the simulations from
within the hospital environment.
An instance of the RTGrid was also installed on a local server and attached
to the local Condor grid, enabling the benefits of a single point of entry onto
the resource to be realised. Although the number of processes controlled by
the RTGrid is somewhat limited compared to the Cardiff University Condor
pool, the local installation benefits from a much smaller demand on the Condor
network compared to that of the university network and allows the possibility
to run simulations on phantoms derived from patient anatomy, avoiding data
protection issues that may be present even with anonymised data on a more
public network.
3.3.2.1 Validation
The system was validated using the same method described in section 3.3.1.1,
the output of which is shown in figure 3.4 illustrating the outputs of relative and
absolute dosimetric investigations.
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(a) Profiles
(b) Output Factors
Figure 3.2: Comparison of results of simulation running on a local machine and
the local Condor grid.
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Figure 3.3: Web portal of the RTGrid showing the progress of four running jobs,
two to start and four completed.
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(a) Depth Dose Curve
(b) Magnified Depth Dose Curve
Figure 3.4: Comparison of results of simulation running on a local machine and
the local Condor grid. Phantom placed such that the isocentre (depth = 0mm
on the horizontal scale) is positioned at 10cm deep at an FSD of 100cm
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3.3.2.2 Speed and Efficiency
The efficiency of the RTGrid has been discussed by Downes et al. (2009) who
showed that significant efficiencies can be obtained by the use of the system
with simulation times reduced by thirty times or more. Following the principles
described in the paper jobs were divided into approximately 2 hour runs per
processor and divided into an appropriate number to obtain the desired statistical
uncertainty.
A feature of the system utilising standard desktop PCs is that their
specification is likely to vary significantly from machine to machine and therefore
run times on one particular calculation node may be significantly longer than
those of another. The consequence of this, is that the time to assemble all of
the results may be unacceptably long as the last few jobs are awaited by the
server. Consequently the RTGrid has a feature allowing jobs to be reassembled
after a certain percentage has been completed, as chosen by the user. It was
found that setting this figure to 90% returned jobs in an acceptable amount of
time. To achieve this with suitable statistical uncertainties required increasing
the number of particles in the input file by the appropriate proportion. Another
limiting factor of the grid is the storage space available on the server, which with
other users utilising it was often only tens of gigabytes in size. For a typical
patient simulation, such as those described in Chapter 6, a phantom of 100Mb
in size may be produced and therefore a ‘.3ddose’ file (the standard output file
of the DOSXYZnrc) of similar magnitude produced. For a plan containing 5
beams and each beam divided into 100 jobs this relates to a storage requirement
of 50Gb for all of the jobs when returned. This figure can be reduced by ensuring
only relevant parts of the patient are included in the phantom, and by forcing
DOSXYZnrc to produce compressed output files (.pardose files) used in parallel
processing which can reduce the storage space requirements by around 50%.
3.4 Variance Reduction Techniques
Variance reduction methods can be used to increase the precision of Monte
Carlo simulations that can be obtained for a given number of iterations. Within
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EGSnrc and BEAMnrc several methods are available such as photon forcing and
bremsstrahlung splitting.
Bremsstrahlung splitting improves the statistics of photons produced by
bremsstrahlung events within the simulation by splitting each electron a given
number, NMBRSPL times with directions and energies determined by an
appropriate probability distribution, and given a weight equal to 1
NMBRSPL
.
Directional Bremsstrahlung Splitting (DBS) develops this idea by separately
considering photons that are directed at a region of interest, for example a
radiotherapy treatment field and those that are not. As photons are split
NMBRSPL times following a bremsstrahlung event, they are each assigned
a weight of 1
NMBRSPL
. Each split photon is then individually considered, if it
is directed at the region of interest it is tracked with its new weight as in a
conventional simulation. Those directed outside the region of interest have their
survival determined by comparing a random number to a survival threshold
( 1
NMBRSPL
). If the number is greater than this then the particle is eliminated
but if not its weight is multiplied by NMBRSPL and is considered to be a
fat photon. Photons produced from other interactions involving a fat photon, a
Compton scattering event for example, will also be split NMBRSPL times and
transported or eliminated following the survival mechanism, Russian Roulette.
Russian Roulette survival is also required for non-fat photons to undergo a
photoelectric, Compton or pair production event and is additionally applied to all
electrons liberated as a result of a split Compton interaction. Consequently the
number of charged particles within the simulated beam is reduced considerably
as a consequence of the application of this technique increasing the efficiency of
the simulation of photon dose and fluence but may introduce errors if the charged
particle contribution of any simulated doses is of most interest.
3.4.1 Validation
Due to the potential efficiency gains of DBS investigations were made into
the calculation efficiency of performing simulations with this technique. Using
settings of NMBRSPL, splitting radius etc. as recommended by the writers of
the code (Rogers et al., 2009) simulations were run with and without DBS for
a number of profile and depth dose measurements. Typical results are shown in
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figure 3.5. No significant difference was observed between the simulations with
the variance reduction techniques applied and with these techniques removed
other than could be attributed to statistical uncertainty.
The parameters used in this study for all Monte Carlo simulations unless
otherwise stated are listed in table 3.1.
3.5 Discussion and Conclusion
The RTGrid, combined with variance reduction techniques such as directional
bremsstrahlung splitting allow for fast simulations of the doses delivered by
radiotherapy treatment machines with no reduction in simulation accuracy as
a consequence of introducing them into the simulation system.
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(a) Profiles
(b) Relative Output
Figure 3.5: Comparison of results of simulation with and without the variance
technique DBS, in which electrons undergoing a bremsstrahlung event are split a
number of times and then transported with individual energies and directions of
each particle assigned according to a probability distribution. therefore reducing
the proportion of the number of wasted electrons that are transported and
never produce useful photons in the therapeutic beam. The number of incident
particles were adjusted so that similar uncertainties in each case were observed
in the DOSXYZnrc phantom






DBS splitting field radius 20cm
Source to surface distance 100cm
Brem splitting number 1000
Use rejection plane 60.0cm
CM for e-/e+ splitting 2 (flatfilt)
e- / e+ splitting plane no. 13 (Z=11.1856cm)
Z of Russian Roulette plane 11.14cm
Redistribute of split e-/e+ None
Augmented range rejection OFF
Brems cross-section enhancement OFF
Split electrons or photons at CM none





Exclude fat photons from DBS YES
Range Rejection OFF




Boundary crossing algorithm PRESTA-I
Skin depth for BCA 0
Electron-step algorithm PRESTA-II
Spin effects On
Brems angular sampling Simple
Brems cross sections BH
Bound Compton scattering Off
Compton cross sections default
Pair angular sampling Simple
Pair cross sections BH
Photoelectron angular sampling Off
Rayleigh scattering Off
Atomic relaxations Off
Electron impact ionization Off
Photon cross-sections output Off
Table 3.1: Parameters used in the Monte Carlo Simulations of patient plans.
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4.1 Overview
The machine used for stereotactic treatments at Velindre Cancer Centre was
modelled using the BEAMnrc / DOSXYZnrc (Rogers et al., 1995) suite of
software. These are Monte Carlo codes based on the EGSnrc (Kawrakow et al.,
2010) general codes, optimised for use in radiotherapy. The BEAMnrc code is
used to model the geometry of medical linear accelerators, the output of which
is commonly used as a source to its sister code DOSXYZnrc (Walters et al.,
2005), which enables a voxelised geometry to be used to model patient and
other geometry in a manner analogous to the calculation matrices produced by
a computerised treatment planning system. In each case, the EGSnrc code is
used to simulate the transport of particles within the accelerator and patient or
phantom geometry. Many authors have shown good agreement in the modelling
of medical linear accelerators using these codes, for example Mukumoto et al.
(2009) and Spezi et al. (2001). The system was modelled in the following stages:
1. Modelling of the linear accelerator without the µMLC using standard
BEAMnrc component modules
2. Modelling of the µMLC requiring the writing of a bespoke model of the
beam geometry
This approach was chosen so that, in considering the model of the accelerator
without the µMLC, any errors in the model upstream of the µMLC could be
identified prior to the addition of the µMLC components. For reasons described
later in this chapter, the µMLC geometry, being more complex than a standard
MLC used in radiotherapy, was difficult to model using the BEAMnrc code
exactly. Belec et al. (2005), and latterly Kairn et al. (2010), made approximations
of the µMLC design and, in the case of the former used small adjustments to
the standard BEAMnrc geometry to include the µMLC in their simulations. As
an intention of this work was to examine the dosimetry in small fields and other
areas where an inexact geometric model of the µMLC may introduce errors into
the system, it was decided to produce a new component module which modelled
the geometry of the BrainLAB device more exactly. A further advantage of this
approach was the ability to optimise the code to increase simulation speed.
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4.2 Modelling of the Linear Accelerator
The linear accelerator used, a 6MV Varian 600c, is schematically illustrated in
figure 4.1. As is the standard case for a medical linear accelerator the major
components used to produce the clinical radiation field are as follows:
• An electron gun, used to produce electrons
• A waveguide (in this case an inline guide) used to accelerate the electrons
• A target used to generate photons primarily from bremsstrahlung
interactions between the accelerated electrons and the target
• A flattening filter used to generate a beam of uniform intensity
• A primary collimator to limit the dose to the maximum usable field size
• A monitor chamber used to quantify the amount of radiation produced by
the accelerator




In the case of the machine modelled, there was no conventional MLC attached.
As a result of this relatively standard geometry the accelerator could be modelled
using standard BEAMnrc components.
4.2.1 Determination of Source Size and Energy
The methodology used to model the linear accelerator is diagrammatically shown
in figure 4.2. Although not identical to the procedures suggested by Pena et al.
(2007) and Sheikh-Bagheri and Rogers (2002), this approach is similar, relying
on a significant quantity of measurements to determine the energy and width
of the incident electron beam. By analysing the performance of the model for
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Figure 4.1: Schematic diagram of the components of the Varian 600c linear
accelerator. The lower jaws are shown rotated by 90 degrees for clarity.
both large and small fields, it was hoped that an accurate determination of the
incident electron beam width and energy could be obtained. This is particularly
important when considering the dosimetry of small fields, which are sensitive to
changes in these quantities.
A nominal energy of 6MeV and a source width of 1.0mm was chosen as a
starting position. Shallow profiles, measured at the nominal depth of maximum
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Figure 4.2: Flowchart of process used to determine incident energy and source
size of electrons hitting the target used in Monte Carlo simulations of the Varian
600c linear accelerator.
dose (1.5cm) were simulated for a 35cm by 35cm wide field and compared against
those measured in a water tank using a Scanditronix 1 photon field diode (pfd).
This diode is an energy compensated device with an active area of approximately
2.5mm square, mounted on a higher density backing of tungsten epoxy, used as
1IBA Dosimetry GmbH, Schwarzenbruck, Germany
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the energy compensation device (McKerracher and Thwaites, 2006). A 35cm
wide profile was chosen as this comfortably fitted within the water phantom
used for measurements and was wide enough to enable differences in the profile
shape caused by incorrect energies and source widths to be seen.
Monte Carlo simulations were performed using a BEAMnrc input file
describing the configuration of the accelerator without the µMLC as a source
to a DOSXYZnrc simulation using a water phantom. Doses were collected in
2mm x 5mm x 5mm voxels, where the smallest dimension was in the plane of
the central axis along the line of the profile under inspection. Simulations using
200 million particles were run, giving typical average uncertainties of 1% in the
voxels of interest.
Typical profiles are shown in figure 4.3, which illustrates the comparison of
a measured 35cm x 35cm profile and simulated profiles using incident electron
energies of 5.20MeV and 6.0MeV, with a full width half maximum source size of
1.0mm.
Each of the curves was normalised to the central axis and, as can be seen
from the magnified image in figure 4.3(b) there is a large discrepancy between
measured and simulated profiles at the lower energy but good agreement as
the simulated energy is increased to 6.0MeV. This process was repeated for a
range of energies from 5.0MeV to 7.0MeV in 0.1MeV steps which, indicated by
inspection that the closest agreement between measurement and simulation was
at a nominal energy of 6.0MeV.
Further comparisons were performed by comparing measured and simulated
profiles at a greater range of depths, with each data set normalised to a point
1.5cm deep on the central axis, the results of which are illustrated in figure
4.4 illustrating measured and simulated profiles at depths of maximum dose
(1.5cm), 6cm, 14cm, 21cm and 27cm deep. It can be seen that there is good
agreement between measured and simulated profiles at the central axis for all
profiles, illustrating the insensitivity of depth dose data as the comparator for
energy and source size derivation, but there is a deviation between the two at
lower and higher energies than the nominal 6MeV incident electron energy, which,
although more apparent at the depth of maximum is consistent with depth.
Figure 4.4(l) illustrates the average absolute differences between the measured
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(a) full plot
(b) zoomed plot
Figure 4.3: Typical wide shallow profiles for 35cm x 35cm field with varying
incident energies (points Monte Carlo simulations, lines measurement.
and simulated curves over the central 90% of the profiles. From this figure it can
again be seen that the best match between measurement and simulation of the















(a) 5.20MeV 1.0mm source (b) 5.30MeV 1.0mm source (c) 5.40MeV 1.0mm source (d) 5.50MeV 1.0mm source
(e) 5.60MeV 1.0mm source (f) 5.70MeV 1.0mm source (g) 5.80MeV 1.0mm source (h) 5.90MeV 1.0mm source
(i) 6.00MeV 1.0mm source (j) 6.10MeV 1.0mm source (k) 6.20MeV 1.0mm source (l) Mean ABS(%differences) v
Incident Energy (Error bars are 1
standard deviation)
Figure 4.4: Profiles used in the coarse tuning of incident electron energy (Lines measurements, symbols MC simulations).
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An assessment of the source size was made by doing a similar comparison
between measured and simulated profiles. Several authors have stated that the
source is most accurately modelled using a Gaussian shape distribution (Huang
et al., 2005), (Wang and Leszczynski, 2007), which may also be elliptical in nature
(Kim, 2009b), having different widths in dimensions orthogonal to the electron
beam direction. This was assumed to be correct and, consequently, Gaussian
source sizes were investigated independently along both axes of the accelerator.
Beams were initially simulated with a symmetric 0.5mm full width half
maximum (FWHM) source and increased in 0.5mm steps to a FWHM of 3.5mm,
which is at the top end of source sizes reported by Verhaegen and Seuntjens
(2003). The output of these experiments is illustrated in figure 4.5 in which the
energy is fixed at the previously determined value of 6.0MeV and the source size
varied. There is good agreement in the relative output of each source size along
the central axis on each of the profiles.
Despite the relatively ’noisy’ profiles it can be observed that an increasingly
favourable agreement between measurement and simulation as the source size
increases to a FWHM of 1.5mm, which then becomes worse at larger FWHM
values. From the plot of differences shown in 4.5(h), showing the mean absolute
differences between the measured and simulated profiles over the central 90% of
the beam, it can be seen that the appropriate source size is between FWHMs of
1.0mm and 1.5mm.
The experiment was then repeated, increasing the source size in 0.1mm steps
until an optimum agreement was achieved. Results of this are shown in figure
4.6 for profiles measured and simulated in the inline (gantry target direction).
Although as can be seen from figure 4.6(l) the agreement of measured to
simulated profile is fairly insensitive to source width, optimal agreement between
measured and simulated results were obtained with a source width of 1.4mm in
the inline direction. Setting the source size at 1.4mm in the inline direction the
source size in the orthogonal direction was then adjusted and the experiment
repeated, increasing the source width from 1.0mm to 2.0mm in 0.1mm steps. In
this direction, an optimal source width of 1.3mm was derived.
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(a) 6.00MeV 0.5mm source (b) 6.00MeV 1.0mm source
(c) 6.00MeV 1.5mm source (d) 6.00MeV 2.0mm source
(e) 6.00MeV 2.5mm source (f) 6.00MeV 3.0mm source
(g) 6.00MeV 3.5mm source (h) Mean ABS(%differences) v Incident
Energy (Error bars are 1 standard
deviation)















(a) 6.00MeV 1.0mm source (b) 6.00MeV 1.1mm source (c) 6.00MeV 1.2mm source (d) 6.00MeV 1.3mm source
(e) 6.00MeV 1.4mm source (f) 6.00MeV 1.5mm source (g) 6.00MeV 1.6mm source (h) 6.00MeV 1.7mm source
(i) 6.00MeV 1.8mm source (j) 6.00MeV 1.9mm source (k) 6.00MeV 2.0mm source (l) Mean ABS(%differences) v
Incident Energy (Error bars are 1
standard deviation)
Figure 4.6: Profiles used in the fine tuning of incident electron source width in inline direction (Lines measurements,
symbols MC simulations).
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Subsequently, as a significant change in the source size had been made the
same test comparing simulated and measured profiles was performed but the
incident energy was varied from 5.95MeV to 6.05MeV, in 0.01MeV steps until the
best fit between measured and calculated profiles was obtained. These results are
shown in figure 4.7 indicating an optimum energy of 5.99MeV. Although only a
small change had been made to the incident energy, the source width experiment
was repeated in both cross line and inline directions to ensure that changes to the
incident energy had not unduly affected the influence of the source size. As may
be expected, there were no observable changes in the performance of the model
in correctly simulating doses. It was therefore determined that the optimum
parameters had been derived, giving the closest fit to measured and simulated
data. These were an incident energy of 5.99MeV and a source width of 1.4mm















(a) 5.95MeV 1.4mm source (b) 5.96MeV 1.4mm source (c) 5.97MeV 1.4mm source (d) 5.98MeV 1.4mm source
(e) 5.99MeV 1.4mm source (f) 6.00MeV 1.4mm source (g) 6.01MeV 1.4mm source (h) 6.02MeV 1.4mm source
(i) 6.03MeV 1.4mm source (j) 6.04MeV 1.4mm source (k) 6.05MeV 1.4mm source (l) Mean ABS(%differences) v
Incident Energy (Error bars are 1
standard deviation)
Figure 4.7: Profiles used in the coarse tuning of incident electron energy (Lines measurments, symbols MC simulations).
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4.2.2 Validation of Model
In order to further validate the determined source and incident energy
parameters, profiles were measured and simulated for a variety of field sizes
in both directions along the central axis which are illustrated in figure 4.8.
These illustrate profiles of 5cm, 10cm, 15cm and 20cm width square fields
within a water phantom placed at 90cm fsd from the source. Profiles at
the nominal depth of maximum dose (1.5cm), 5cm, 10cm and 20cm deep
were measured using the SFD diode and compared against simulations of the
accelerator under similar conditions. As can be seen, there is excellent agreement,
between the two data sets, similar to that observed when considering wider
profiles for the accelerator without the µMLC attached. This would indicate that
doses delivered by the accelerator can be modelled using standard component
modules for the conventional parts of the accelerator with accuracies well within
the range of experimental uncertainty.
Further validation was achieved by comparing depth doses, measured along
the central axis of the accelerator using a RK chamber in a water phantom placed
at 90cm FSD. Results of measurements versus simulated doses of the accelerator
in this configuration are illustrated in figure 4.9. Again it can be seen that there
is excellent agreement between measurement and simulation for the range of field
sizes considered.
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(a) 5cm x 5cm profile in ’x’ direction (b) 5cm x 5cm profile in ’y’ direction
(c) 10cm x 10cm profile in ’x’ direction (d) 10cm x 10cm profile in ’y’ direction
(e) 15cm x 15cm profile in ’x’ direction (f) 15cm x 15cm profile in ’y’ direction
(g) 20cm x 20cm profile in ’x’ direction (h) 20cm x 20cm profile in ’y’ direction
Figure 4.8: Comparison of varying size profiles at 1.5cm, 5cm, 10cm and 20cm















(a) 5cm x 5cm depth dose (b) 10cm x 10cm depth dose
(c) 15cm x 15cm depth dose (d) 20cm x 20cm depth dose
Figure 4.9: Comparison of depth doses for various field sizes at 90cm FSD normalised at 10cm deep (lines measured,
points simulations).
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Relative output factors were then considered by calculating the relative
output for a number of standard field sizes (5cm x 5cm, 10cm x 10cm, 15cm x
15cm and 20cm x 20cm). These were derived from simulations of the appropriate
field size and compared to measurements made using a standard Farmer chamber
within a water phantom made. All measurements and simulations were made at
10cm deep within a phantom placed at 90cm FSD. Excellent agreement between
measurement and simulated results can be observed with a maximum deviation
















Figure 4.10: Comparison of measured and simulated output factors measured at 10cm deep within a water phantom at
90cm FSD from the beam focus. The line displays the measured values, the circles those obtained by simulation and the
triangles those adjusted for back scatter into the monitor chamber as discussed in 4.2.3.2.
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4.2.3 Absolute Dosimetric Modelling
The above discussion has concentrated on the derivation of source parameters
in order to simulate beams correctly, from which profiles and depth doses were
obtained and used in subsequent analysis. Whereas there is clearly a place for
these relative dose distributions in verification of treatment planning methods
or investigations into new methods, it is also necessary to be able to simulate
absolute doses correctly. For standard fixed fields, the requirement to do this
may be less important as it is possible, with the application of standard tables,
to calculate with some degree of accuracy the output at the centre of a field
and normalise measured and simulated results to this point. However, for more
complex treatments, such as IMRT, or its analogue in radiosurgery ‘Intensity
Modulated Radiosurgery’ (IMRS), or rotational techniques, this may not be
possible due to the extended complexity of these treatment modalities requiring a
more sophisticated calculation. In these situations, Monte Carlo modelling comes
into its own as the majority of parameters affecting the change in absolute output
with changes in beam geometry can be accurately modelled.
However, Liu et al. (2000) have shown that the change in output as a result
of beam geometry occurs as a consequence of the following:
• scattered radiation from the head of the machine
• scatter from within the patient or phantom
• backscattered radiation from the collimator jaws into the monitor chamber
The first two of these effects are inherently modelled during a Monte Carlo
simulation but the latter, due to the difficulties of analysing both the radiation
transporting through the linear accelerator head and scattering back into the
chamber is not explicitly accounted for in a simulation. Liu et al. (1997) have
shown that radiation backscattered into the monitor chamber increased the
absolute output of the accelerator by up to an additional 3% when comparing the
output of a 3cm by 3cm field and a 40cm by 40cm field, when the effects of head
and phantom scatter are eliminated. Although this is still a small effect compared
to other factors, the effect of backscattered radiation into the monitor chamber
must be considered for a correct estimation of the absolute dose delivered.
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4.2.3.1 Initial Calibration
The initial calibration of the machine was performed by running a simulation of
a 10cm x 10cm field using the model described previously with 1× 109 particles
incident on a DOSXYZnrc phantom at 90cm FSD. Nine measurement points of
2.5mm x 2.5mm x 5mm were positioned around the central axis in a 3 x 3 grid
and the dose from each voxel combined using equation 4.1. This describes the
combination of each dose D sampled m times at position ijk with an uncertainty
∆D˜. The lth sample can be written as D˜(l)ijk with uncertainties ∆D˜
(l)
ijk which can
be combined to produce a single quantity of D˜ijk and uncertainty ∆D˜ijk as
described by Kawrakow (2002), in which samples with the lowest uncertainty
have the highest weighting in the combination.
Assuming that the nine voxels under investigation are equivalent a dose per
incident particle of 9.637×10−17Gy was extracted from the dose matrix produced




























The accelerator was initially calibrated to give a dose of 1cGy per monitor
unit at the depth of maximum at the centre of a 10cm by 10cm field using a
phantom placed at 100cm FSD. This equates to a dose of 0.796cGy at 10cm
deep within a water phantom at 90cm FSD from a 10cm by 10cm field (derived
from standard output factor tables and depth doses). The conversion factor from
Monte Carlo dose per incident particle to dose delivered per monitor unit can
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• Fcal is the calibration factor
• Dcal_point is the dose delivered by the accelerator at the calibration point
per monitor unit
• Dmc is the Monte Carlo simulated dose per incident particle at the
calibration point
In this case this relates to:
fcal =
0.796
9.637× 10−17 = 8.2598× 10
15mu−1 (4.4)
4.2.3.2 Back Scattered Radiation Into The Monitor Chamber
Any radiation backscattered into the monitor chamber clearly has an effect on the
output of the machine and will not be modelled by a Monte Carlo simulation as
the code will simply transport radiation through the machine and take no account
of any dose back scattering into the chamber causing the machine to switch
off prematurely. A correction for this in the absolute calibration is therefore
required. This was done using a procedure similar to that described by Liu et al.
(2000).
A two phase technique was adopted, the first stage of which was to simulate an
accelerator consisting of only a target, flattening filter and primary collimator to
generate a phase space file beyond the primary collimator and before the monitor
chamber. The absence of any subsequent components ensured that no particles,
backscattered from the collimators or other parts of the accelerator, were present
in the phase space file, which may have an effect on subsequent analysis. Using
the phase space file generated from the first stage of this experiment as an input,
the machine was modelled in various configurations of collimator position and
the dose scored in the MU1 channel of the monitor chamber, which is used to
terminate beam delivery. Using the latch option of BEAMnrc, it was possible to
determine the origin of each particle in the chamber. Particles were labelled
as being resultant from primary forward radiation, back scattered from the
Y collimators (closest to the radiation focus) or back scattered from the X
collimators.
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The machine was simulated by opening the jaws not under investigation to
their widest position and then simulating the accelerator with the jaws moved
from their widest position to the smallest, while keeping the opposing jaw at
its widest position. From these measurements, it was possible to determine the
amount of back scattered radiation transporting to the chamber as a function of
collimator position.
Results of this are shown in figure 4.11, from which it can be seen that
the effect is largest for the Y collimators (closest to the chamber) compared to
that from the lower X collimators. The maximum proportion of the radiation
depositing dose in the chamber is approximately 0.7% which is significantly lower
than the almost 3% observed by Liu et al. (2000). Their measurements, however,
were performed on a Varian 2100c accelerator in which the flattening filter is
positioned beneath the primary collimator and, therefore, acts as an uncollimated
source of scatter onto the collimators which may account for this. A least squares
linear fit was fitted to this data to produce a curve of back scatter factor as a
function of collimator position for both X and Y collimators; these are shown
on the graphs of figures 4.11(a) and 4.11(b) for subsequent incorporation into
methods for determining the dosimetric output of the accelerator.
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(a) Y Collimators
(b) X Collimators
Figure 4.11: Proportion of radiation back scattered into the chamber as a
function of collimator position for Y and X collimators.
4.3. Modelling the µMLC 89
4.3 Modelling the µMLC
4.3.1 µMLC geometry
Several authors have modelled linear accelerators used in stereotactic
radiotherapy. A model of the cyberknife stereotactic system has been produced
(Deng et al., 2004), as has a dedicated stereotactic linear accelerator (Verhaegen
et al., 1998), based on a standard Varian linear accelerator with its collimator
jaws replaced by stereotactic cones. Both of these authors report good
success in accurately modelling the characteristics of each device compared to
measurements. Similarly, conventional MLCs have been modelled by many
authors using exact models of the MLC geometry (Heath and Seuntjens, 2003),
and approximations (Keall et al., 2001). Belec et al. (2005) reported their
work modelling the BrainLAB M3 µMLC, which used an adaptation to the
DYNVMLC (Heath and Seuntjens, 2003) used to model Varian MLCs to
approximate the more complex geometry of the BrainLAB device.
Unlike conventional MLCs, which generally use a single tongue and groove,
the BrainLAB µMLC consists of a large number of tongues and grooves
introduced into the device to reduce inter-leaf leakage. Although this could
be achieved by a more simple design, its added complexity is required to allow
for the small dimensions of the MLC whilst allowing full inter-digitation of the
leaves. The design of the leaves is illustrated in 4.12. The multiple tongues and
grooves can be seen in figure 4.12(b), which is the main difference between the
BrainLAB device and conventional MLCs. Figure 4.12(a), however, also shows
that the leaf ends are shaped in a linear fashion with three facets rather than a
singularly angled or rounded design more commonly used on other devices.
As a consequence of this complex design, it is not possible to exactly model
the µMLC using existing BEAMnrc component modules. The approximation
of Belec et al. (2005), based on DYNVMLC component module (Heath and
Seuntjens, 2003) allowed the ends of the leaves to be sloped at any angle. A
model of µMLC was then constructed using three layers of this module, and
were thus it was possible to model the leaf ends exactly. The tongues and
grooves of the µMLC could not, however, be modelled exactly and these were
approximated by combining the tongues and grooves into a single structure.
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(a) Cross Section Through Leaf (b) End on view of leaves
(separated for clarity)
Figure 4.12: Representation of Leaf Geometry of the BrainLAB µMLC.
Using this technique, good agreement between simulated and measured doses
was achieved for a number of situations.
Due to the intention in this study to investigate some aspects of small field
dosimetry, there is a concern that approximations of the tongue and groove
design of the leaves may unduly influence the dose delivered at the centre of
particularly small fields. Furthermore, the three layer approach is likely to have
a negative impact on simulation time due to the requirement to track particles
across unnecessary boundaries, which would be removed by a bespoke model of
the µMLC. Consequently, it was decided that a component module would be
written to model the leaf design more faithfully than previously, which would
remove the uncertainties of doses simulated in the penumbra and in the centre
of small fields, with the added advantage of increasing the simulation speed.
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4.3.2 BLMLC (BrainLab MLC) - a bespoke model of the
BrainLAB µMLC
Component modules for the BEAMnrc code are used to describe the physical
components of the linear accelerator such that the EGSnrc code can be used
to simulate interactions therein. Component modules are, therefore, required to
communicate with other parts of the system in predefined ways and provided
sufficient information to enable the simulation to be performed. A new
component module must consist of at least five subroutines to satisfy these
requirements. These are described in the BEAMnrc user manual (Rogers et al.,
2009) and can be briefly be summarised as
• INPUT_$CMNAME a routine to prompt the use for the input variables
for the module from either the command line or input file
• HOWFAR_$CMNAME defines the geometry boundaries
• HOWNEAR_$CMNAME calculates the perpendicular distance to the
nearest boundary
• WHERE_AM_I_$CMNAME determines the region of the particle on
entry into the the component module
• ISUMRY_$CMNAME writes a summary of input parameters for the
component module to the output listing prior to running of the simulation
Additionally, a series of macros is required to define variables and call these
subroutines at the appropriate time. The bespoke component module, therefore,
required writing of a new version of these to input, describe the geometry and
summarise the data pertaining to the µMLC. The resulting code written in
MORTRAN (as is the rest of the BEAMnrc code) is included in Appendix 1
and conceptually described below.
Using the approach used in other BEAMnrc component modules, the leaf
area is divided into several regions describing the major characteristics of each
leaf bank (illustrated in figure 4.13), in which the leaf bank is divided into several
regions describing the particular part of it where a particle may interact. For
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consistency with other component modules such as DYNVMLC (Heath and
Seuntjens, 2003) the variable IR is used which is set to a value described in
table 4.1.
(a) Beams eye view of leaves in
component module
(b) Cross section through leaves
perpendicular to leaves
(c) Cross section through leaves parallel
to leaves
Figure 4.13: Schematic diagrams of µMLC geometry.
Once a particle enters the component module, the region number is
determined by applying simple geometric checks for its exact position in the
leaf bank. For particles in regions of IR greater than 1 (i.e not in the open
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Value of IR Description
1 Open Part of the field
2 Main part of a leaf
3 The lead screw used to transport the leaf
4 The air gap between the start of the component module and leaves
Table 4.1: Table of values of IR used in the BLMLC component module.
part of the field), the voxel within the leaf is determined. The material through
which the particle is transporting is returned to the main BEAMnrc code as is
the distance to the next voxel. This is in order to ensure interactions are tracked
across boundaries correctly, as the step length of each particle is shortened near
boundaries to assume boundary effects are modelled correctly.
For particles interacting within the leaves themselves, the situation is more
complex. As has been discussed earlier, the µMLC consists of relatively complex
geometry incorporating several tongues and grooves which are modelled by
dividing each leaf into a lattice of voxels, which may or may not be filled with
the collimator material as illustrated in 4.14.
Using this technique, by choosing appropriate dimensions of each voxel, any
shape leaf can be described, limited only by the resolution of the voxels used to
build up the leaf geometry, which, if this is within acceptable limits can be used
to model any geometry within any accelerator. Such a component module would
therefore have a high degree of flexibility associated with it and consequently
was the first approach used in modelling the µMLC.
In reality, the leaf geometry differs slightly from that shown in figure 4.14, in
that the width of the radiation penumbra is limited by adding divergent edges
to the leaves such that they are focused at the radiation source. In order to
incorporate this design into the component module, the lattice distances were
defined at the top of the beam geometry and adjusted at distances further from
the radiation source using similar triangles to obtain the voxel boundaries. In
this way, the divergent shape of the leaves could be modelled as is illustrated
in figures 4.15(a) and 4.15(b) showing even and odd leaves mapped onto the
divergent matrix.
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Figure 4.14: Schematic diagram of a single leaf geometry being mapped onto a
lattice as used in the component module.
For debugging and illustrative purposes, a feature was built into the module
to output the co-ordinates of each particle transporting through the component
module to a text file for later plotting. An example of such a plot can be seen in
figure 4.16. For clarity, adjacent leaves are shown in contrasting colours and it
can clearly be seen that the model is correctly simulating the divergent nature
and geometry of the µMLC. Once the model had been completed and debugged,
several simulations were run to validate the model indicating good agreement
between simulated and measured doses. However, the input file consisting of a
number of lattice positions in x and y directions for 26 unique leaves became
overly complex and consequently comprised many hundreds of lines, compared
to a few tens of lines for a conventional MLC component module.
More significantly, however, was the computing overhead taken up by
needlessly reducing each particle’s step size near the boundary of voxels of the
same material. This effect can be seen in 4.16. In this diagram, near the voxel
4.3. Modelling the µMLC 95
(a) Even leaf (b) Odd leaf
Figure 4.15: Illustration of odd and even leaves on a divergent matrix.
boundaries, the particles are bunched up causing almost constant areas of colour
as particle interactions are tracked across the boundaries, whilst in the middle
of the larger voxels, clear areas can be seen where few interactions take place.
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Figure 4.16: Points of interaction within the generic module.
It was therefore considered prudent to explore a more bespoke model of
the MLC in which the input file required would be much smaller and easier to
understand, consisting of a simple position for each leaf, and to return distances
to the main line of the program between a point of interaction and the nearest
real boundary between materials. These correct distances are illustrated in 4.17,
which illustrates the much greater distances (in the case shown) to the leaf
boundaries compared to those of the voxel boundaries.
This method, however, clearly has the disadvantage of losing almost all of
the flexibility of the component module to model other MLC designs but which,
together with some minor optimisation of the code to improve speed returned
a 40% decrease in simulation times, which for the purposes of this study was
considered the optimal option. An output of the debug mode points of interaction
can be seen in 4.18 in which a similar number of points of interaction to that in
4.16 can be seen.
In this case, the appearance is of a uniform distribution of particles within the
model indicating the expected behaviour of the module in giving a more realistic
representation of the points of interaction.
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Figure 4.17: Illustration of distances to closest boundary calculation in BLMLC.
Figure 4.18: Plot of points of interaction in final module.
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4.3.3 BLMLC subroutines and input files
Despite being simplified compared to the previous version of the CM, the
resultant component module still requires input from the user to describe the
geometry of the collimating device. An extract of a typical input file is shown in
4.19. The quantities required to be entered by the user are:
• The distance of the CM from the radiation source
• The thickness of the leaves and start position of the first leaf
• The orientation and number of leaves
• The interleaf air gap
• The choice of leaf end design (rounded or angled)
• Angle or radius of leaf ends
• Leaf positions
• Media, energy cut off and latch parameters for the CM simulation as are
standard for BEAMnrc CMs
The majority of the parameters are self explanatory and are typical of other
MLC CMs such as DYNVLMLC and MLCE. The exception to this is the angular
items required to define the leaf end geometry. These are entered as two angles
describing the shape of the upper and lower sections of each leaf. These are
illustrated in 4.20.
The leaf thicknesses are not required as these are built into the code to
simplify the input values required by the user. This information is listed in
a relatively user friendly manner at the beginning of the component module
code so as to allow easy editing should future users desire to adjust the model
to suit their particular design of the µMLC. This would be the case if it was
purchased to fit on an accelerator with a different configuration with a likely
different distance from the machine focus (The BrainLAB M3 device is custom
built depending on machine design to minimise the widths of penumbrae and to
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Figure 4.19: A typical input file for the BLMLC component module.
maintain consistency of field sizes across different machines). The code requiring
adjustment for these quantities is illustrated in 4.21.
Although this may require 250 lines of editing per µMLC it is a ‘one-off’ task
that, once completed, has the benefit of greatly simplified input files. For similar
reasons, all parameters, such as the distance of the µMLC from the radiation
source, the leaf thickness, inter-leaf air gaps and leaf end design, could have been
included into the CM code itself and the user simply asked to enter the leaf
co-ordinates. However, as some iterations may be required to obtain the correct
inter-leaf air gap and adjustment of the leaf end, parameters may be useful in
validating the model. These were therefore left as a user input.
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Figure 4.20: Description of parameters entered by the user for the BLMLC
component module.
(a) Mortran code for Y co-ordinates (b) Mortran code for Z co-ordinates
Figure 4.21: Code requiring editing for customisation of the µMLC for different
accelerator designs.
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4.3.4 Validation of BLMLC
Clearly, following the writing of the code, validation of the model is necessary
to ensure that simulations performed with it and any conclusions can be relied
upon. Initially, a scaled diagram of the MLC debug output similar to that
of figure 4.18 was printed out and measurements made and compared with
that of the manufacturer supplied information. These were found to be well
within the estimated uncertainty of 0.2mm associated with the printing and
hand measurement process. Results of this analysis are not included due to this
information being the subject of a non-disclosure agreement between Velindre
Cancer Centre and BrainLAB. This was done for all leaves, and in all possible
planes. Additionally, the BEAMnrc documentation includes a report on the
quality assurance of component modules (Walters and Rogers, 1999), which
suggest tests to be performed for quality assurance purposes of new component
modules. On examination of this documentation, relevant tests were done to
determine if the component module was working in the expected manner.
4.3.4.1 ‘p1a’ test
The p1a test, shown in figure 4.22, is designed to test that the structures within
the collimator are attenuating the incident beam correctly. In order to achieve a
significantly large number of particles in the resulting phase space file, the tests
in the manual suggest using a square electron beam as an incident radiation
source and ‘air leaves’ within a ‘lead space’ as the component module. As it
was possible to run an entire linear accelerator simulation using photons in an
acceptable time for this, it was determined to run tests using both lead leaves in
an air space and air leaves in a lead space. Initially, the results were analysed
from a short run (approximately 30 minutes), using the phase space file scored
at the exit of the µMLC, the results of which can be seen in 4.23. Four runs
were performed, the first of which, shown in 4.23(a), is a scatter plot of the
position of each particle in the phase space file for the standard configuration
of tungsten alloy leaves existing in an air space with estimated inter-leaf gaps
of 0.1mm between each leaf. The shapes of regions with a higher concentration
of particles correspond to that of the test shape shown in 4.22, and it can be
seen that the component module is transporting particles through the inter-leaf
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Figure 4.22: Description of p1a test (from BEAMnrc QA document (Walters and
Rogers, 1999)).
gaps in an expected manner. When scaled and measured, the widths of these
gaps corresponded and the widths of the leaves themselves agreed to within the
estimated measurement uncertainty of 0.2mm.
Figure 4.23(b) illustrates a similar case but with the µMLC constructed from
air existing in ‘metallic alloy space’. The effects of the converse of inter-leaf
leakage can be seen along each leaf, and in this case, the effect of the leaf end
geometry can be seen at the abutting edge shown by a region of a decreased
concentration of particles along the central axis orthogonal to the leaf direction.
Figures 4.23(c) and 4.23(d) illustrate similar situations of lead leaves in an
air space and air leaves in a lead space respectively, but with the inter-leaf gaps
set to zero. These show the expected result of no transmission occurring between
the leaves. An additional transmission can be seen along the right hand edge of
figure 4.23(c), which corresponds to the total width of the leaves being reduced
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(a) ’Lead’ leaves in ’air’ space with with
interleaf gaps
(b) ’Air’ leaves in ’lead’ space with
interleaf gaps
(c) ’Lead’ leaves in ’air’ space without
interleafgaps
(d) ’Air’ leaves in ’lead’ space without
interleaf gaps
(e) ’Air’ leaves in ’lead’ space without
interleaf gaps
(f) DOSXYZnrc Simulation of p1a2 shapes
Figure 4.23: Outputs of phase space analysis of p1a test.
due to the removal of the inter-leaf gaps, resulting in radiation leaking through
this newly induced air gap.
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Figure 4.23(e) illustrates the case with the leaf ends set to be straight. As,
in this case, the leaves abut perfectly across the central axis, no additional
transmission through the abutting region, compared to that through the leaves
themselves would be expected, which is indeed the case in the illustration.
These figures indicate that the component module was behaving in the
expected manner for these tests. Due to the difficulty in scaling these
measurements, a scaling test was performed by running the simulation using
this configuration as an input to a DOSXYZnrc simulation. The results of this
are shown in figure 4.23(f). For this experiment, the BEAMnrc simulation was
incident upon a water phantom consisting of 1mm x 1mm x 5mm voxels placed at
98.5cm FSD. The plane shown is a relative dose distribution of doses deposited in
voxels centred around the nominal depth of maximum dose (1.5cm). This image
was then scaled and printed out at 4× actual size and the openings measured by
hand and compared against those expected. All differences between measured
and simulated distances were within the estimated uncertainty of 0.2mm.
4.3.4.2 Inter-leaf Leakage and Leaf Transmission
A simulation of radiation transport between the leaves of the µMLC was used to
determine both the magnitude of the transported radiation and as a check of the
geometric positioning of the leaves. Simulation of radiation transport through a
closed set of leaves has been performed by several authors (Heath and Seuntjens,
2003; Belec et al., 2005) and generally compared against measurements made
using radiographic film (Belec et al., 2005; Cosgrove et al., 1999; Heath and
Seuntjens, 2003). The difficulties associated in the use of radiographic film in
a modern radiotherapy centre without film processing facilities are described in
section 2.2.3. Velindre Cancer Centre, in common with many others no longer
has film processing facilities, so an approach using the Electronic Portal Imaging
Device (EPID) was used. The EPID present on the Varian 600C accelerator is
discussed in greater detail in Chapter 8, but consists of 512 by 384 semiconductor
detectors used to read out the visible light emitted from a radiation sensitive
screen. This has shown to be a reliable tool in dosimetric tests (McCurdy
et al., 2001; Nicolini et al., 2006; Siebers et al., 2004; Cuﬄin et al., 2010) and
was consequently used to investigate the transmission through and between the
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µMLC leaves. The imager has a spatial resolution of 0.784mm and was placed
at 140cm from the source which relates to a spatial resolution of 0.56mm at the
isocentre. To calibrate the imager, the maximum available field size of 9.8cm
by 9.8cm, defined by the machine collimators and µMLC, was used to irradiate
different doses from 0.5cGy to 80cGy (MU calculated using standard tables).
The resultant calibration curve is shown in figure 4.24.
Figure 4.24: Calibration curve used to convert EPID signal to dose for inter-leaf
leakage measurement.
A transmission of 2.5% of the open field dose was measured through the
closed leaf banks during initial acceptance of the device, this figure was then
used to calculate the monitor units required to deliver approximately 50cGy to
the EPID using standard tables. Following irradiation, the calibration curve was
then applied to the measured data to acquire a data set against which subsequent
simulations were compared. To account for any uncertainties in the positioning
of the imaging device, a 9.8cm x 9.8cm field was irradiated. The width of the
profile obtained was then compared to that expected to derive a scaling factor
to determine the exact positioning of the sensitive volume of the imaging device.
This revealed an accuracy of better than 1mm in the position of the device at
140cm.
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Monte Carlo simulations were performed with identical leaf positions to those
used in the irradiation, and a model of the EPID used derived from measurements
obtained from the manufacturer and previously validated (Cuﬄin et al., 2010).
In the Monte Carlo simulations an inter-leaf gap of 0.14mm was initially chosen
as derived by Belec et al. (2005).
A DOSXYZnrc phantom, with the sensitive volume of the imaging device
placed at the position calculated from the scaling measurements calculated above,
was created with voxels identical in size to that of the sensitive region of the
imager. The co-ordinates of the centre of the calibration field were then compared
to that of an identical field simulated. Using these calculated values of the centre
of the fields, the co-ordinates of the phantom were then adjusted so that phantom
and imager co-ordinates were in identical positions. The simulation was then run
and a plot similar to that shown in figure 4.25 produced. Both measurement and
simulations were normalised to the values at the centre of a 9.8cm by 9.8cm open
field with the µMLC leaves retracted.
Following a comparison of measurement and simulation, the width of the
inter-leaf air gap was then adjusted, with the start position of the leaves
moved for each simulation by an appropriate amount to ensure the leaf banks
maintained symmetry about the central axis, the simulation re-run and the
comparison re-performed. This iterative process was repeated several times until
the optimum comparison between measured and simulated results were observed.
An inter-leaf gap of 0.08mm was determined to be the optimum distance. The
optimum case is shown in figure 4.25 from which excellent agreement is shown
between measurements and simulations in terms of a spatial comparison and in
magnitude.
The magnitude of interleaf leakage can be seen to be of the order of 2.4%
which compares closely to that of Cosgrove et al. (1999) who reported 2.8% and
Belec et al. (2005), 2.4%. The average transmission through the leaves of 1.5% (sd
0.4 %) also compares well with the 1.4% reported by Belec et al. (2005). In this
experiment, a lower transmission under the thicker leaves was observed both by
simulation and measurement, which may be due to the experimental procedure
undertaken, using an EPID with a significantly lower spatial resolution than
the gap being investigated. This averaging effect is somewhat cancelled out in
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Figure 4.25: Plot of Interleaf leakage test (points simulations, lines measured).
the comparison by positioning the simulated voxels in exactly the same position
as the pixels of the sensitive volume of the measurement device and, thereby,
simulating exactly the measurement position.
Therefore, it can be concluded that the component module is correctly
modelling the position of the µMLC leaves, the air-gap between them and the
magnitude of the radiation intensity transporting through them.
4.3.4.3 Positional Tests - Lattice
Using the leaf gap calculated in the previous section, a lattice shape consisting
of alternating open and closed leaves as illustrated in figure 4.26(a) was used,
in a simulation to determine if the magnitude and position of dose transporting
through the leaf air gaps was modelled correctly by the CM.
Measurements were made using the portal imager placed at 140cm FSD
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(a) lattice shape used in test - simulations along line AB
(b) plot of lattice test (points simulations, lines measured)
Figure 4.26: Illustration of shape and result of lattice test.
from the radiation focus with a 5cm block of solid water placed on the top
surface of the imager panel. The same calibration was used, as described in the
previous section, to convert the portal image signal into a dose. The relative dose
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measured by the imager was extracted along the line AB and normalised to the
point at the central axis. The model of the EPID was adjusted to increase the
width of the voxels parallel to the leaf direction to 2cm to reduce the experimental
uncertainty at each measurement point. A simulation of 250× 106 particles was
then run and the doses normalised to the point at the central axis.
As can be seen in figure 4.26(b), there is excellent geometric agreement
between calculated and simulated results indicating that the model is correctly
positioning the leaves in the simulation. There are some slight discrepancies
between the data sets, particularly in the openings around +3cm and +4cm but
generally there is good agreement in both position and magnitude between the
doses measured and simulated.
4.3.4.4 Relative Dosimetric Tests
Relative dosimetric tests were performed using measurements performed in a
water tank using a Scanditronix SFD2 stereotactic diode for the profiles shown
in 4.28 and a Scanditronix RK Chamber for the depth doses of figure 4.27(b).
The SFD has a very small active volume of 0.17x10−4cm3, giving good spatial
resolution. The device has the disadvantage of a small output current, requiring
many samples at each measurement point, resulting in larger uncertainties
compared to other larger volume diodes and most ionisation chambers. The RK
chamber was used due to its small volume and, in common with other ionisation
chambers, a low energy dependence. A 9.8cm diameter circle shape illustrated
in figure 4.27(a) was used to define the field with the collimator jaws defining a
10cm square field. The diode and chamber were both first centred by plotting a
profile along the central axes of a 10cm by 10cm field and the detector moved to
the geometric centre of the field as defined by the points at 50% of the central
axis dose. The origin was set by subsequently setting the active region of the
detector device at the surface. The surface of the water was set to 90cm FSD so
that profiles measured at 10cm deep were at the isocentre distance.
In order to eliminate discrepancies between measured and simulated data
as a consequence of uncertainties in detector and collimator positioning, each
profile was moved so that the 50% position of the profile were symmetric about
2IBA Dosimetry, Schwarzenbruck, Germany
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the central axis. This required a maximum movement of 0.3mm for the set of
profiles illustrated in figures 4.28 which illustrate measured and simulated profiles
taken at lines on and off the central axis.
(a) Shape used in test
(b) Central Axis Depth Dose
Figure 4.27: Outputs of relative dosimetry tests using a 98mm diameter circle












Figure 4.28: Relative profiles on and off axis measured and simulated using the 98mm circular field shape.
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Simulations were performed using a BEAMnrc model of the accelerator plus
µMLC as an input to a DOSXYZnrc simulation configured to model a simple
square water phantom with 2mm x 5mm x 5mm voxels at a depth of 10cm where
the profiles were measured. 250×106 particles were simulated for the experiment
with uncertainties around 1.0% in the open part of the fields.
Results of the comparison between measurement and simulation in which
both data sets were normalised to the dose at the isocentre are shown in figure
4.28. As can be seen there is excellent agreement in both position, magnitude
and shape of the profiles even with the profiles measured at 5cm off axis which
is in the penumbra region of the beam.
Simulations of the depth dose measurement, acquired using 10mm x 10mm x
1mm voxels show similarly good agreement with those measured with differences
beyond the build-up region generally less than 0.5% of dmax dose.
4.3.4.5 Absolute Calibration
.
An absolute calibration factor was found by using the same method described
in section 4.2.3.1. In this case the dose simulated and measured was that at
the centre of a 9.8cm by 9.8cm square field defined by the µMLC to derive a
new calibration factor of similar magnitude to that calculated in equation 4.4
(8.513× 1015mu−1).
4.3.4.6 Back Scatter Into The Monitor Chamber
Radiation back scattered into the monitor chamber from the collimator jaws has
been considered in section 4.2.3.2, in which up to 0.7% of radiation transporting
through the ionisation chamber originated from back scatter from the upper
collimators and 0.25% from the lower collimators. It may be assumed that the
amount of radiation back scattered into the monitor chamber from the µMLC,
which is further downstream than the lower collimators would be further reduced
compared to that of the lower collimators. In practice, the collimator jaws will
cover the µMLC leaves in order to restrict transmission through the leaves to a
minimum.
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In order to verify this assumption, an experiment almost identical in nature
to that described in section 4.2.3.2 was repeated for the µMLC. In this case, both
sets of jaws were opened to their widest position and all the leaves on one leaf
bank also moved to their widest position (4.9cm). A series of simulations were
then run using a phase space file, previously created just before the chamber,
as input source to each simulation. For each simulation, the opposing leaf bank
to that held in its widest position were moved progressively across the field and
using the latch feature of BEAMnrc, the amount of radiation backscattered into
the monitor chamber obtained. The results are plotted in figure 4.29(a).
As can be seen, with the jaws fully open at 40cm by 40cm, and the leaves
plotted from the maximum available field size for the µMLC of 10cm x 10cm
square there is a change in the back scatter of 0.11% for the lowest proportion of
dose into the monitor chamber to 0.13% for the most. In practice this is greater
than would be the case in a realistic situation as the jaws would be positioned no
greater than equivalent to a 10cm by 10cm field. The output of the experiment
repeated in this situation is illustrated in figure 4.29(b). It can be seen that
in this case, the radiation back scattered into the monitor chamber is of the
order of 0.03% and can therefore be considered to be of little significance to the
dosimetric modelling of the device.
In a typical clinical configuration, the collimator jaws are positioned to
back up the collimation of the µMLC leaves as much as possible to reduce the
magnitude of radiation propagating through and between the leaves. This makes
modelling of the situation difficult to generalise.
Consequently a typical shape illustrated in figure 4.29(c), in which
approximately half of the open field was shielded by the collimators was modelled
and the back scatter into the monitor chamber found to be 0.032%. Therefore
the effect of back scatter into the monitor chamber was neglected in the dose
calibration of the model.
4.4 Conclusions
Detailed commissioning tests have shown that the use of standard BEAMnrc
components and a bespoke model of the BrainLAB M3 µMLC can be used to
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(a) 40cm by 40cm jaws (b) 10cm by 10cm jaws
(c) Typical Clinical Shape
Figure 4.29: MLC shape used for, and results of back scatter test.
model doses delivered by such equipment to a high degree of accuracy (<0.5%)
if sufficient particles are simulated to reduce the experimental uncertainties to a
similar level.
Chapter 5
Applications of BLMLC I : Small
field dosimetry
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5.1 Small field dosimetry
The dosimetry of small fields is of particular importance in stereotactic radiation
therapy, as fields are generally smaller than those used in conventional therapy.
Small fields are usually defined as fields of less than 4cm in any direction and
may have dimensions as narrow as a few millimetres. They can be problematic
as, due to their size, there may be a lack of lateral electronic equilibrium in the
field, making measurements highly susceptible to variations in the positioning
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and design of the measurement device. Furthermore, volume averaging may
take place if a large detector (relative to the size of the field) is used. These
effects may result in a significant error in the determination of the dose delivered
by such a field. Additionally, in this situation, positional uncertainties may
cause significant variations in the output measured by the device both on the
central axis and off axis where the influence in collimator design is of particular
significance. In order to determine the limitations of our measurement techniques
and develop solutions to some these problems, the dosimetry of small fields
was investigated applying Monte Carlo techniques using the model described
in chapter 4.
5.2 Methods and Materials
Depth doses were measured for an array of field sizes and a series of detectors;
these are listed below and shown in figure 5.1:
• Scanditronix RK chamber (RK)
• Scanditronix Stereotactic field diode (SFD)
• Scanditronix Photon field detector (PFD)
• Scanditronix Electron field detector (EFD)
• Scanditronix-Wellhofer CC13 ionisation chamber (CC13)
• Scanditronix CC01 micro ionisation chamber (CC01)
• Farmer style ionisation chamber (Farmer)
To improve spatial resolution, the RK chamber and SFD detectors were
positioned with their long axes vertically (parallel to the central axis of the beam)
and horizontally (orthogonal to the beam central axis) where appropriate. In the
discussion below these are labelled, RKHZ, RKVRT,SFDHZ and SFDVRT. A
summary of the dimensions of each of the detectors is shown in table 5.1.
A Scanditronix RFA-300 water tank was used as the phantom for these
measurements with the detector moved from the deepest position towards the
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Figure 5.1: Photograph of detectors used in small field investigations. From left
to right, Farmer, CC13, RK, CC01, EFD, PFD, SFD.
surface to prevent uncertainties due to disturbance of the water being introduced.
The number of sampling points (i.e. the number of times the relative dose was
acquired and averaged at the measurement point) for each detector was adjusted
until a smooth depth dose curve was observed. This number was considerably
more for the SFD (50) compared to that of the RK, PFD or EFD devices (10).
Approximately circular fields of diameters (φ) of 100mm down to 6mm were
used for this comparison. The detectors were centred on the radiation field
under investigation prior to the measurement of the depth dose curve and the
origin found by positioning the effective measurement point of the device at the
surface of the phantom. A depth dose of a large (10cm by 10cm) field was then
measured and the position of maximum dose found. All detectors located a depth
of maximum dose to within 1mm of that expected for a 6MV beam (15mm). A
signal obtained from the accelerator dosimetry system was used to account for
variations in machine output during measurement in lieu of a reference detector
which would have produced significant perturbations in beam intensity for the
smaller fields.
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Profiles were measured using the same field sizes and detectors as described
above, along the central axes of each field at a depth of 10cm with the phantom
positioned with its surface at 90cm from the radiation focus. Measurements were
made at 1mm intervals throughout the beam using a similar number of samples
at each point as that used in the acquisition of depth doses described above.
Total scatter factor measurements, defined as the ratio of dose measured at
the centre of a field under investigation to that of a standard field were measured
using the detectors described above in a water tank placed at 90cm FSD from the
radiation focus. For these measurements, the standard field used was a 100mm
φ circle rather than a more standard 100mm square field due to the requirement
to remove the µMLC to perform these measurements, which would introduce
additional positional uncertainties. In addition a standard Farmer chamber was
also used to measure these output factors within a standard water calibration
phantom.
Monte Carlo simulations were performed using an accelerator modelling the
µMLC as a source to a DOSXYZnrc phantom, which was used to collect data
in 3mm by 3mm by 1mm voxels for depth doses and 1mm by 1mm by 3mm for
profile measurements. Output factors were simulated by adding doses collected
in a 2 x 2 grid of 1mm by 1mm x 3mm voxels for the 6mm, 12mm and 18mm
circles and a 4 by 4 grid of 1mm by 1mm by 3mm voxels for all other field sizes.
Doses were combined using equation 4.1.
5.3 Results and Discussion
5.3.1 Relative Dosimetry
5.3.1.1 Profile Measurement
Figures 5.2 and 5.3 show the output of simulations and measurements for the
100mm and 6mm φ fields. As can be seen, there is generally good agreement
between the measurements using each of the detectors in the open part of the
100mm field but the data sets deviate in the penumbra which is illustrated more
clearly in figure 5.4(a). The 6mm φ profiles consist almost entirely of penumbral
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doses. Again, as illustrated more clearly in figure 5.4(b), deviations between
the detectors, calculations and simulations are evident. For both field sizes, it
can be seen that the detectors with the smallest active area are closest to the
Monte Carlo simulations as one might expect. The calculations of the treatment
planning system show a reasonable agreement with the Monte Carlo simulations
for the 100mm circle but a relatively poorer agreement for the 6mm circle. For
the case of the 6mm circle, artefacts of the 1mm x 1mm calculation matrix can
be seen in the shape of the curve
Field widths are defined as the distance between the positions of 50% of the
dose at the isocentre position. These are tabulated in table 5.2 for both field
sizes. For the 6mm field, using the detector with the poorest spatial resolution
(CC13), an apparent field width of 7.7mm and 8.1mm in the x and y directions
was measured and with the finest (SFD) a field width of 5.6mm and 6.0mm has
been returned. For a spherical tumour defined by such collimators, a 6mm wide
field corresponds to a volume of 84.8mm3. If profiles measured with the CC13
detector were used as the basis for dose calculations (as would be the case in
a beam library based planning system), a collimator position of approximately
4mm would be set to apparently encompass the tumour which would irradiate a
volume of 25.1mm3, irradiating only 30% of the target to the prescribed dose.
The high dependency of field size on the measurement device would indicate
that at least a careful selection of detector be made before measuring and
subsequently entering the data into a treatment planning system or that certain
fields should be disallowed for such algorithms. Currently, most commercially
available systems do not rely on such measurements as the fundamental basis for
dose calculation but this experiment would indicate that care should be taken
in the use of such fields. The iPLAN system, whose data has been validated
against measurements with the SFD diode, returns field widths in the X and
Y directions of 4.94mm and 4.81mm, which using an average radius of 4.88mm
relates to a volume of 45.5mm3. Taking the MC profile (average width 5.8mm,
spherical volume 76.2mm3) as most accurate this relates to a 40% reduction in
the volume of tissue irradiated, confirming the choice to disallow treatments of
such small fields using the iPLAN software at Velindre Cancer Centre. Prior to
this study, fields with their smallest dimension less than 25mm were not allowed.
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5.3.1.2 Depth Dose Measurement
Figure 5.5 illustrates measurements and simulations for depth doses acquired
along the central axis of a 100mm φ circle; each curve is normalised to a point
at 10cm deep. As can be seen from the magnified figure of 5.5(b), there is
close agreement between the simulated curve and the depth doses measured by
each of the measurement devices. Some discrepancies can be seen at the surface.
These effects may be explained by physical dimensions of the detector introducing
artefacts as the parts of it closer to the radiation source than the effective point
of measurement clear the surface of the phantom, causing an over estimate of
the dose. The SFDHZ diode which has the smallest dimension upstream of the
effective measurement point has a smaller discontinuity in the curve near the
surface of the phantom and measures the lowest surface dose.
Figure 5.6 illustrates the equivalent case for the 6mm circle field. As with
the case of the larger field depth doses, the curves are normalised to a depth
of 100mm. For this case there are significant differences between the detectors,
particularly near the surface, where at the depth of maximum there is a difference
of approximately 20% between the smallest (SFDHZ) and the largest (CC13)
detectors.
The Monte Carlo simulations, using 2mm x 2mm x 1mm voxels agree very well
with the SFDHZ detector indicating that this detector may be most appropriate
detector for measuring such small fields. The advantage of MC simulation over
conventional measurement is that it is possible to simulate dose deposition in
situations where it is difficult, or indeed impossible, to measure doses accurately.
Although the measurement of a depth dose is a routine procedure in radiotherapy
physics, it may be argued that the Monte Carlo simulation is a significantly
superior technique to that of physical measurement in situations of such small
fields. The difficulty is of course in knowing that the MC model is correct. The
validation described in chapter 4 has shown that the model agrees very well with
measured doses in areas of low experimental uncertainty and can, therefore, be
used with some confidence in such cases. However, for these very small fields
where there is little secure data to validate the model against one may need to
be circumspect. However, it can be seen from figure 5.6(b) that the behaviour of
the detectors is as expected with those with the smallest active volume agreeing
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closest with the MC simulation. There is a small difference (∼ 3%) between
the cc01 and the MC simulation near the depth of maximum dose where the
difference is greatest confirming the choice of the cc01 as the detector of choice
in such fields with the EFD and SFD also agreeing fairly well. The iPLAN depth
dose shows a significant deviation at this field size, confirming the decision to
disallow such fields for clinical use prior to this study.
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(a) ’X’ Direction
(b) ’Y’ Direction
Figure 5.2: 100mm φ circle profiles.
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(a) ’X’ Direction
(b) ’Y’ Direction
Figure 5.3: 6mm φ circle profiles.
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(a) 100mm circle
(b) 6mm circle
Figure 5.4: Penumbral region of 100mm and 6mm circular field profiles in ‘x’
direction.
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(a) Depth Doses for 100mm φ circle using a variety of detectors
(b) Magnified depth dose curves for 100mm φ circle using a variety
of detectors around 100mm depth











(a) Full curve (b) Magnified curve near surface
(c) Magnified curve around 100mm depth
Figure 5.6: 6mm φ circle depth doses. The stepped effect of some of the measured data in 5.6(c) is due to re-sampling of
the data to a 0.1mm step size to match the data of other curves.
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5.3.2 Relative Output Factors
Output factors measured with each of the detectors under investigation were
normalised to the output of the 100mm φ circle, as this was the largest circular
field possible with the µMLC. This could therefore be related back to the
standard calibration field of 10cm by 10cm using a standard Farmer ionisation
chamber. MC simulations were performed by averaging the dose deposited to
a 4 x 4 array of 1mm x 1mm x 1mm voxels distributed about the central axis
of a phantom simulating the measurement conditions. As these voxels covered
a significant amount of the open field and encroached close to the collimators,
a single 1mm x 1mm x 1mm voxel was used for the 18mm circle field size and
smaller. Figure 5.7 illustrates a comparison of outputs simulated for all field sizes
using this method. Good agreement is observed between the simulations at all
sizes. Although this may indicate that the use of the array may be appropriate
for all field sizes a single point was used for the smallest field sizes to avoid any
collimator effects influencing the simulated output factors.
A plot of the relative output factors for each of the detectors and Monte Carlo
simulations is shown in figure 5.8 and tabulated in table 5.3.
Figure 5.7: Comparison of simulated output factors measured at 10cm deep
within a water phantom at 90cm FSD from the beam focus using an array of












Profile cc01 efd pfd rk sfd cc13 MC iPLAN
6mm x-profile 5.44 5.50 5.63 6.50 5.57 7.70 5.77 4.94
6mm y-profile 6.37 6.30 6.03 7.10 6.04 8.10 5.81 4.81
100mm x-profile 98.70 98.62 98.70 98.52 98.70 99.20 98.71 99.02
100mm y-profile 98.70 98.57 98.70 98.78 98.50 99.10 98.71 99.01
Table 5.2: Field widths in x and y directions measured and simulated using a variety of detectors.
Circle φ (mm) pfd sfd cc13 rk cc01 efd rk hz sfd hz Farmer
100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000
91 0.9888 0.9848 0.9880 0.9880 0.9880 0.9868 0.9880 0.9864 0.9868
80 0.9702 0.9609 0.9693 0.9695 0.9702 0.9643 0.9705 0.9657 0.9669
69 0.9492 0.9437 0.9485 0.9488 0.9467 0.9395 0.9485 0.9425 0.9446
60 0.9302 0.9123 0.9284 0.9277 0.9263 0.9188 0.9290 0.9206 0.9237
51 0.9087 0.8880 0.9060 0.9059 0.9014 0.8949 0.9063 0.8976 0.9006
42 0.8852 0.8613 0.8809 0.8815 0.8761 0.8685 0.8814 0.8714 0.8733
36 0.8680 0.8413 0.8623 0.8622 0.8556 0.8495 0.8624 0.8523 0.8509
30 0.8488 0.8198 0.8414 0.8428 0.8339 0.8280 0.8410 0.8324 0.8128
24 0.8270 0.7964 0.8146 0.8171 0.8068 0.8044 0.8116 0.8096 0.7135
18 0.8009 0.7673 0.7713 0.7808 0.7752 0.7751 0.7614 0.7801 0.5355
12 0.7510 0.7113 0.6532 0.6949 0.7032 0.7188 0.6015 0.7262 0.3064
6 0.5568 0.5466 0.3084 0.4063 0.4691 0.5393 0.2592 0.5565 0.0988











Figure 5.8: Comparison of measured and simulated output factors measured at 10cm deep within a water phantom at
90cm FSD from the beam focus using a variety of different detectors.
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There is a spread in the calculated output factors measured and simulated of
around 0.5% for field sizes greater than 42mm. This spread increases rapidly as
the field size is decreased with the greatest variation occurring, unsurprisingly,
at the smallest field size in which uncertainties associated with the detector size
are largest. This is exemplified in the output factor for the 6mm circle which
varies from less than 0.1 for the Farmer detector to greater than 0.5 for the diode
detectors.
The cause of this effect is volume averaging, which occurs when the
dimensions of the detector are greater than those of the radiation field under
investigation. This is clearly the case for a Farmer chamber in a 6mm field and,
compared with a reference 100mm field, the result is a much lower signal and
hence a lower output factor.
5.3.2.1 Volume Averaging Effects
In order to investigate the effects of volume averaging, simulations were
performed for each of the fields using a water phantom having 0.1mm x 0.1mm
x 3mm voxels over the central 2.0cm x 2.0cm of the phantom to derive a high
resolution description of the dose variation across the detector. Using the RTGrid
Portal on the Cardiff University Condor pool as described in chapter 3, it was
possible to obtain average uncertainties over the open part of the field of less
than 0.50% within 12 hours of submitting to the pool for each field. A surface
plot of this simulation for the 6mm circle field is shown in figure 5.9 illustrating
the non-uniform dose distribution across the likely area of the detector at the
central axis.
The doses from each field were then normalised to unity at the isocentre.
For each detector, its extent was determined and the volume under this area was
calculated to derive a volume averaging factor to be applied to each measurement.
A separate simulation using 0.25mm x 0.25mm x 3mm voxels was run for the case
of the Farmer chamber over the central 25mm x 6mm of the phantom. These
factors are listed in table 5.4 and plotted in 5.11.
As can be seen, the factors are very close to unity in the case of larger fields
for all of the detectors but deviate from this as the field size decreases. For the
biggest detector, the Farmer chamber this occurs around the 30mm circle field
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Figure 5.9: Surface plot of 6mm circle field, simulated using 0.1mm x 0.1mm x
0.5mm voxels, 10cm deep within a water phantom placed 90cm from the beam
focus.
size, whereas for the smallest detector (SFDHZ) the factor remains more or less
constant at unity throughout the field sizes examined, as indeed does the factor
applied to the Monte Carlo simulations.
These volume averaging factors were then used to adjust the measured and
simulated output factors according to equation 5.1. These adjusted factors are








• Fscat is the total scatter factor
• Rraw(det, size) is the raw reading for the detector (det) and field size
• fvolave(det, size) is the volume averaging factor for the detector and field
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Figure 5.10: Plot of volume averaging factors for each of the investigated
detectors.
size
• Rraw(det, ref) is the raw reading of the reference field size
• fvolave(det, ref) is the volume averaging factor for the reference field size
using the detector
As can be seen, there is a convergence of some of the data indicating,
unsurprisingly, that the volume averaging effect is the dominant effect in the
deviation of these output factor measurements between detector types, with
the EFD performing the best of the diodes and the CC01, being an ionisation
chamber with the smallest detector volume showing the best agreement against
the Monte Carlo simulations.








































































































































































































































































































































































































































































































Figure 5.11: Comparison of measured and simulated output factors measured at 10cm deep within a water phantom at
90cm FSD from the beam focus using a variety of different detectors with volume averaging factors applied
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5.3.2.2 Detector Material Compensation
As can be seen in figure 5.11, the PFD (photon diode) shows a more significant
deviation from the Monte Carlo derived factors (and those measured by other
detectors), particularly at the smaller field sizes. This detector contains what
the manufacturer calls an ‘integrated energy filter’ (IBA Dosimetry GmbH, 2010;
McKerracher and Thwaites, 2006), which appears to be a tungsten sheet placed
within the diode construction to reduce the number of low energy photons
traversing into the active region of the diode. Figure 5.12 illustrates the results
of an investigation of the spectral components of the radiation transported to the
central 4mm of the 6mm and 100mm φ fields. This was obtained by running the
simulation of the accelerator with the appropriate field sizes using the BEAMnrc
code alone with additional slabs of air and water appended to the accelerator
model to simulate the phantom arrangement used in the simulation of total
scatter factors. Although a fairly coarse series of bins were used, which may
mask some effects such as an expected pair production peak at 511KeV it can
be seen that there is a greater lower energy component in the 100mm circle,
compared to that of the 6mm circle. Due to the differing stopping power ratios
of water and higher Z components of silicon and tungsten, this could account
for the difference in output of devices containing these elements compared to the
Monte Carlo simulations and small ionisation chamber measurements.
Figure 5.12: Spectral components of radiation over central 4mm of 6mm and
100mm φ circular fields.
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In order to investigate potential composition effects, the simulation was
repeated and the array of voxels used in the Monte Carlo derivation of output
factor that had previously been set to a material of water were replaced with
silicon voxels. A comparison of the output factors determined with this technique
is shown in figure 5.13(a) and a plot of the relative outputs defined as the ratio
of simulated dose in silicon to simulated dose in water is shown in 5.13(b). For
the small fields in particular, there is a significant difference between the relative
outputs simulated in water and silicon.
These factors were then applied to the measurements made with the diode
detectors and again compared to those simulated by the Monte Carlo code.
These are illustrated in figure 5.14, from which the further convergence of the
measurement towards the Monte Carlo simulation can be seen.
Following the application of the volume averaging, and (where appropriate)
silicon output factors the data sets shown in table 5.6 and figure 5.15 were
obtained.
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(a) Relative output factors simulated in Water and Silicon
(b) Ratio of Water to Silicon Simulated Outputs
Figure 5.13: Graphical output of simulations using voxels of Water and Silicon






















































































































































































































































































































































































































































































































Figure 5.14: Measured Output factors of diode detectors with volume averaging factors applied and with and without
silicon correction factors applied; ‘adj pfd’ etc. is the factor obtained with the application of the silicon correction factor.




























































































































































































































































































































































































































































































































Figure 5.15: Measured Output factors of all detectors with application of volume averaging factors and with silicon
correction factors applied to diode detectors.
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There is a much closer agreement between all of the detectors and simulations
with the application of both correction factors and for the most part of the curve
most detectors agree within the experimental or simulation uncertainties. The
exception to this is the Farmer chamber which deviates significantly for fields
below 30mm φ despite agreeing well with the Monte Carlo simulation at the
smallest field size. Despite the application of the correction factors, there is
a difference of 20% between the lowest output factor of 0.428 (MC) with the
highest factor of 0.526 measured with the RK chamber.
Table 5.7 tabulates the percentage difference between the factors measured
and those simulated, which are graphically illustrated in figure 5.16. A fairly
typical shape is shown of the differences between the detector measured output
factors and MC simulations of generally less than 1% for the larger fields which
increases rapidly for the smaller fields at around 30mm, depending on the
detector. Compared to the MC simulations, it can be seen that the smaller
ionisation chambers (CC01, CC13, RKHZ and RKVRT) show the best agreement
with the diodes showing poorer comparisons to the MC factors. This is slightly
in disagreement with the results reported by McKerracher and Thwaites (1999b),
who found the SFD to be the most reliable detector when compared against a
pinpoint ionisation chamber, although their chamber was different in design to
the one used in this comparison.
The suitability of each detector for measurement, based on this investigation
is tabulated in table 5.8, which is obtained by allowing the detector for use if
it returns a relative output factor compared to the MC simulations of less than
1%. In the table this is illustrated by X. For detectors returning a difference
slightly more or less than 1% but have differences at fields sizes on either of it
that would allow or disallow their use, these are represented by a bracketed tick
or cross. Differences of greater than 3% are shown with a double cross.
As can be seen none of the detectors are able to measure an output factor
for the 6mm or 12mm φ fields to within 1% of the MC simulation, apart from
the Farmer which exhibits large differences for fields smaller than 24mm, which
would prohibit these field sizes for clinical use. However, the CC01, CC13, RKHZ
and MC deliver factors within 1% of each other for the 18mm φ fields and larger
with volume averaging factors applied. It could therefore be argued that this
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(a) Full Curve
(b) Magnified
Figure 5.16: Percentage difference of output factors measured with each of the
detectors compared to that derived from MC simulations.
would be the limit of the field sizes used locally within the department. This
would require entry of this factor into the planning system and corresponding
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validation for the range of usable field sizes to be extended as a consequence of
this investigation.
5.3.3 Effect of Incident Source Size on Monte Carlo
Simulations
5.3.3.1 Profiles
It has been shown by Wang and Leszczynski (2007) and Kim (2009a) that the
doses simulated by Monte Carlo simulations are dependent on the incident source
size. Chapter 4 has shown the variation in source size introduces a significant
change in the shape of profiles, particularly near the surface of the phantom
where, for large fields, the difference between the relative dose 15cm off axis may
be as much as 10% for doses simulated using an incident source size of 0.5mm
and 0.35mm. For smaller fields used in stereotactic radiotherapy, this effect is
significantly smaller and a dose difference of 2% can be seen at 4cm off axis,
which would be correspond to a field size (8cm) that would be rarely used in
stereotactic techniques.
Figures 5.17 and 5.18 illustrate the simulations of profiles of a 100mm circular
and 6mm circular fields at 100mm depth within a water phantom at 900mm from
the source. As can be seen, there are differences between the data sets in both the
penumbra and the plateau region of the profile which for the 100m circular field
are 3% between the 0.5mm source and 3.5mm source at 35mm from the central
axis. In the penumbra, the difference between the largest and smallest source
sizes is approximately 2mm at the maximum deviation of the corresponding
curves. The 6mm and 100mm circle field widths are tabulated in table 5.9 where
a maximum deviation of 1mm, for the 100mm φ field and 2mm for the 6mm
φ is observed between the smallest and largest incident source sizes in the ‘Y’
(MLC) direction. In the ‘X’ direction, the field widths for the 100mm circle are
indistinguishable, whereas differences in the width of the 6mm diameter fields of
more than 3mm (50% of the nominal field width) were seen. The shapes of the
dose profile curves differ significantly in the penumbral regions. This is shown in
figure 5.17(d), which is a magnification of the profiles illustrated in figure 5.17(b)
for the ‘Y’ direction defined by µMLC. It can be seen that when using a smaller
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(a) ’X’ Direction (b) ’Y’ Direction
(c) ’X’ Direction (d) ’Y’ Direction
Figure 5.17: Simulated profiles of a 100mm φ circular field for a variety of
incident source sizes, simulated at a depth of 100mm and an FSD of 900mm and
normalised to the dose at the central axis. The lower diagrams are expanded
versions of the figure above
incident electron source sharper edges of the fields are observed. The 1.4mm
source, similar to that previously determined as the most appropriate size shows
the closest agreement with the expected field size widths.
5.3.3.2 Depth Doses
The effect of incident source size on depth dose simulations was investigated by
performing simulations of depth doses similar to those described in section 5.3.1.2
but the incident source size was varied as symmetric FWHM widths of 0.5mm,
1.4mm (closest to that found to give best agreement between simulated measured
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(a) ‘X’ Direction (b) ‘Y’ Direction
(c) ‘Y’ Direction (d) ‘Y’ Direction
Figure 5.18: Simulated profiles of a 6mm φ circular field for a variety of
incident source sizes, simulated at a depth of 100mm and an FSD of 900mm
and normalised to the dose at the central axis. Sub figures (c) and (d) are
expanded illustrations of the penumbra on either side of the profile in the ‘Y’
direction.
doses), 2.0mm and 3.5mm. Results of this for a 100mm circle are illustrated in
figure 5.20.
Although the curves are relatively noisy, it can be seen that they are relatively
insensitive to the incident source width with a maximum deviation between the
0.5mm source and 3.5mm source curves of 1.8% comparable to the uncertainties
of the simulations at this point of 1.2% and 0.8%.
Simulations for the 6mm circle show a greater deviation between the sources
which are illustrated in figure 5.21.
Here it can be seen that there is a greater deviation in the curves which at
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Figure 5.19: Simulated output factors using a variety of incident source sizes.
Figure 5.20: Simulated depth doses for a variety of incident source sizes for a
100mm φ circle, simulated at an FSD of 90cm and normalised to 100mm deep.
the depth of maximum dose, shown in figure 5.21(b) there is a difference of 4.1%
between the 0.5mm and 3.5mm source widths, which have a maximum deviation
of 18.5% of local dose at the deepest point in the phantom. Uncertainties at the
depth of maximum were 0.5% and 0.7% for the 0.5mm and 3.5mm source size
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simulations and 0.8% and 0.9% respectively at 350mm deep.
It can therefore be seen that Monte Carlo simulations of depth doses are
strongly dependent on the incident source width for small fields where it is of
more importance than the electron energy.
5.3.3.3 Output Factors
Variations in relative output factor with source size are more significant than
that those observed for profile and depth dose measurements. This is illustrated
in figure 5.19, which shows the relative output factors of circular fields of radius
100mm down to 6mm. For each curve, the simulated doses are normalised to the
100mm circular dose at the reference point for the incident source size. To avoid
penumbral effects dominating the simulations a single voxel of 1mm x 1mm x
1mm was used to collect the doses in each simulation of a 100x106 particles.
As can be seen the factors measured for the larger circles (greater than 30mm)
there is good agreement between the data sets but as the field size is decreased
there is a larger variation in the output factor, with the 3.5mm source producing
a factor of only 27% of the 0.5mm factor, for the 6mm circular fields.
5.4 Conclusions
The main conclusion of this work is that the measurement and Monte Carlo
simulation of small radiation fields can be problematic and should be undertaken
with care. Section 5.3.1.1 has discussed the measurement of profiles using various
detectors and compared them against Monte Carlo simulations. Profiles such as
these are commonly used in the acquisition of raw data for input into a treatment
planning system such as the BrainLAB iPLAN system which is used routinely
within Velindre Cancer Centre for stereotactic planning.
Comparisons between the detectors and simulations indicate a strong
dependence on detector geometry for measurements in the penumbra of
the beam. The 100mm circle profiles show good agreement between the
measurements and simulations over the central part of the beam but the shape
of the penumbra differs in each case. This can be attributed to volume averaging
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effects during measurement, which have the effect of broadening the width of the
penumbra.
For the 6mm circle, where measurements are made up almost entirely
of penumbral effects, there are marked differences between the measurement
devices, with the larger devices deviating most from the Monte Carlo simulations.
Interestingly the profiles obtained from iPLAN show the smallest width and
would (to the planner’s perspective) indicate that only 60% of the actual
irradiated volume would be covered by such a field, causing larger fields to be
used with a greater healthy tissue being irradiated than planned. Consequently,
until this is investigated further and resolved, such small fields will not be used
clinically with this system.
Similar results were obtained with the depth dose measurements and
simulations. For large fields, such as the 100mm circle, excellent agreement
between the detectors was observed apart from near the surface of the phantom
where large differences were seen due to the different geometries of each of the
detectors breaking the surface of the phantom and introducing errors in the
measured curve.
For the smaller fields, such as the 6mm circle, significant deviations were
observed between the detectors, with the smaller detectors (such as the CC01,
and SFD diodes) giving the closest agreement with the Monte Carlo simulations.
This would agree with the proposition that the large differences seen in these
curves are due to the spatial resolution of these detectors. At the depth of
dose maximum, differences of greater than 15% of local dose are observed and
again would indicate that such fields be used with care. iPLAN underestimates
the dose compared to the Monte Carlo simulations and diode measurements by
approximately 8% and has a position of maximum dose closer to the surface than
any of the detectors.
Relative output factor investigations have indicated a wide variation in the
detectors compared to simulations, which can be attributed and accounted for
to some degree by the application of volume averaging and detector material
correction factors. These eliminate many of the differences between the data sets
but again indicate extreme caution should be used when using the particularly
small fields of less than 12mm φ.
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Although requiring further work to tune the model and correction factors, MC
simulations do offer a method for determining the areas of greatest uncertainty
in small field measurement and give increasing confidence in dosimetry for some
fields such as those in the 18mm - 42mm φ circle range, which should be used
with care. MC offers a method for determining individual detector correction
factors for volume and detector material effects.
Further detailed modelling of the detectors (such as using more exact models
of the detector in the simulation phantom) could further enhance these factors,
which together with a very well validated description of the accelerator geometry,
incident electron energy and source size one could provide even more accurate
factors and correct measurements for these effects. One problem to be overcome
to do this would, of course, be the validation of the source size parameters used in
the simulation. Comparison against uncertain measurements to determine these
parameters may lead to a tautology with inappropriate factors being applied.
Therefore, other techniques such as a direct measurement of the source using a
pinhole camera technique as discussed by Lief and Lutz (2000) may be helpful in
determining the source size, keeping this fixed and adjusting the incident electron
energy only, in the validation simulations to arrive at a unique combination of




















































































































































































































































































































































































































































































































































































































































































































































































































































































































FWHM Source Width 6mm x 6mm y 100mm x 100mm y
0.5mm 5.77 5.00 106.47 100.59
1.4mm 5.75 6.01 106.47 100.18
2.0mm 6.75 6.00 106.47 100.00
3.5mm 8.91 6.93 106.46 99.58
Table 5.9: Field widths measured for 6mm and 100mm φ circles in x and y
directions measured with different incident electron source size widths.
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(a) Full Curve
(b) Near Depth of Maximum Dose
(c) Near 275mm deep
Figure 5.21: Simulated depth doses for a variety of incident source sizes for a
6mm φ circular field, simulated at an FSD of 90cm and normalised to 100mm
deep.
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6.1 Treatment planning system
Treatment planning of cranial stereotactic radiotherapy at Velindre Hospital is
performed using the BrainLAB iPLAN treatment planning system (TPS). The
available functionality includes treatment planning with and without stereotactic
localisation, image fusion of magnetic resonance images (MRI) with planning
or diagnostic CT images and dose calculations using a pencil beam algorithm
(Mohan et al., 1986),(Mohan and Chui, 1987).
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It is generally recommended (Potter, 2000) that an independent calculation
of monitor units is performed prior to the delivery of treatment for all forms of
radiotherapy. Due to the issues associated with the dosimetry of small radiation
fields outlined in Chapter 5, it may be difficult to perform this accurately using a
standard approach of percentage depth doses (PDDs) (or tissue phantom ratios
(TPRs)) and output factors. Furthermore, due to the nature of stereotactic
radiotherapy, doses at points other than the prescription or normalisation point,
such as those within or close to the sensitive structures within the irradiated
volume, may be of equal or greater, importance. It has also been discussed in
Chapter 2 that there are situations where the algorithms used within the iPLAN
TPS suffer from large differences between calculated results and measurements
with the lowest uncertainties, such as in regions of high tissue heterogeneity.
Additionally, it is reasonably common for tables of output factors and TPRs to
be obtained with the same detectors and phantoms as those used in the initial
acquisition of the treatment planning data and thus these may not be entirely
independent, even if a different calculation formalism is used.
For plans where a tabular output factor based check system is appropriate,
such as at the centre of relative large fields, point doses off central axis may be
problematic due to the difficulty of applying point corrections at positions where
there are high dose gradients. This is frequently the case with small fields. It
was shown in chapter 5 that the accuracy in this region is very dependent on the
detector used in initial data acquisition.
A full MC simulation of the treatment delivered using the exact patient
geometry and an accurate model can eliminate or minimise these issues and
enable doses to be examined over the whole irradiated volume as well as at the
prescription or normalisation point.
6.2 Methods and Materials
The use of a Monte Carlo system for routine verification of stereotactic
treatments was investigated using the model of the accelerator and µMLC
described in chapter 4 and the RTGrid processing framework described in chapter
3.
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The work-flow of the investigation is shown in figure 6.1
Figure 6.1: Work flow used in the verification of stereotactic plans using Monte
Carlo simulations using the RTGrid distributed computing portal.
6.2.1 Phantoms
The patient specific simulations were performed using DOSXYZnrc phantom
using patient anatomy derived from the original planning CT scans. A
MATLAB1 script was written, specifically for this project, to perform the
necessary steps to generate the phantom; these were :
1. Collation of the CT data sets and sorting into the correct order
2. Removal of the stereotactic localising box from CT scans
1Mathworks software Ltd, Natick, Massachusetts, USA
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3. Re-sampling of CT data to a convenient resolution (typically 256 x 256
pixels per slice, giving a typical resolution of around 1mm x 1mm)
4. Allocation of density and materials to each voxel
5. Conversion of data into format readable by DOSXYZnrc
The collation of the CT scans was done by simply exporting the data to the
computer running the MATLAB software via a DICOM send of the data from
the scanner to a DICOM listener on the host computer or by simply sending raw
DICOM files between the systems. The DICOM server option was investigated as
this offered the opportunity of developing a service running on the host computer
to automatically generate a phantom on delivery of the CT scans at the host
computer, although this has yet to realised in routine practice.
Patients undergoing a stereotactic treatment are scanned with the localising
box applied to enable transformation of the acquired CT co-ordinates into
stereotactic co-ordinates. As this will not be present in any subsequent treatment
the next stage of the process is to remove the localising box from the patient CT
data.
The Hounsfield units (HU) of these images were then converted into densities
according to the calibration curve shown in figure 6.3, from which a linear fit
was obtained over the two parts of the curves shown in equations 6.1:
density = 0.00097661 ∗HU + 0.017966 HU ≤ 1024
density = 0.00047328 ∗HU + 0.55555 HU > 1024 (6.1)
These figures were obtained by scanning a phantom comprising known
densities, shown in figure 6.2, using the protocol used by the CT scanner for
all stereotactic treatments and measuring the average Hounsfield unit over the
volumes of interest and plotting these against the quoted density. The material
of each voxel was then assigned according to a binning process based on the
acquired HU described by table 6.1
The arrays of co-ordinate, density and material information were written to
a file in the .egsphant format used by DOSXYZnrc for such simulations and
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Figure 6.2: CIRS hounsfield unit phantom showing inserts of different densities.
incorporated into a DOSXYZnrc simulation using a BEAMnrc simulation as an
input source.





Table 6.1: Materials used in the generation of phantoms for patient-specific
DOSXYZnrc phantoms.
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(a) Low HU range
(b) High HU range
Figure 6.3: Hounsfield Unit (HU) conversion to density calibration curves.
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(a) Original CT with localiser attached to
patient
(b) CT with localiser removed
(c) Map of materials used in the simulation (1=Air, 2=Lung, 3=Tissue, 4=Bone)
Figure 6.4: Phantoms Used in Monte Carlo simulations of clinical plans.
6.2. Methods and Materials 163
6.2.2 Monte Carlo Simulations
The plan was simulated using the array of computers attached to the RTGrid
described in chapter 3. To eliminate the requirement to transfer phase space files
across the network, a full BEAMnrc simulation of the accelerator was provided
as the source (ISOURCE=9) to the DOSXYZnrc simulation. The parameters
used in the simulation are listed in table 3.1, which are identical to those used
in the validation of the model.
For each treatment plan, a total of 250x106 particles were simulated for
each case. These were divided in direct proportion to the number of monitor
units planned for each beam so that the lowest simulation uncertainties were
associated with the highest weighted beams. As the phantom for each patient
occupied computer disk space of about 50Mb, each beam was divided into 100
jobs so that the size of the total returned phantoms for a five beam plan was
around 25Gb. This was around the limit of storage space available for use.
Typically, each individual job took about 3 hours of processor time. In practice,
with the overhead of setting up the jobs and the requirement to wait until jobs
submitted to the slower computers were completed, the total run time from the
user perspective was approximately 4-5 hours. Once the complete set of runs
for each plan was complete, the simulated doses were combined at each point
with the phantom according to equation 4.1. For a phantom with 1mm x 1mm
x 1mm voxels, the average uncertainty of doses greater than 20% of the dose at
the prescription point was of the order of 1% .
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6.2.3 Analysis
The outputs of the MC simulation were then compared to the doses calculated by
the TPS. Doses were extracted from the TPS using the dose export function of
iPLAN,which facilitated the export of dose points in an ASCII file easily readable
by a script written in MATLAB into a 3 dimensional array. A calculation grid
of 1mm x 1mm x 1mm was used and the doses sampled at 1mm x 1mm x 1mm
for the output to the ASCII file. This export feature uses co-ordinates based on
start and end positions specified by the user and may therefore not correspond
directly with those of the TPS calculation matrix.
Doses from the Monte Carlo simulations were then similarly read into a
3D array and converted to absolute values using the method described in
4.3.4.5. During the phantom generation process the co-ordinates of DOSXYZnrc
phantom were derived from the calculation matrix extracted from iPLAN.
Therefore further re-sampling of the data was not required to perform subsequent
comparisons.
Comparisons between the dose were made using the gamma method described
by Low et al. (1998). This considers the distance to agreement (DTA)
and absolute point differences between two data sets by calculating the
multidimensional distances between the two data sets in terms of dose and
distance scaled as a fraction of the acceptance criteria.
This is graphically illustrated in figure 6.5 illustrating a single measurement
point ~rm at the origin of the representation. The x and y axes represent the
spatial locations ~rc of the calculated distribution relative to the measured point.
The remaining axis, δ, is the difference between the measured [Dm( ~rm)] and
calculated [Dc ~(rc)] doses. The DTA criterion ∆dm, is represented by the shaded
circle in the ~rc − ~rm plane with a radius of ∆dM . Similarly the acceptance dose
criterion is represented by a circle of radius ∆DM in the δ − x plane.
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Figure 6.5: Graphical representation of the gamma concept from Low et al.
(1998). See text for explanation of symbols
~r( ~rm, ~r) = |~r − ~rm| (6.3)
and
δ( ~rm, ~r) = D(~r)−Dm( ~rm) (6.4)
where δ( ~rm, ~r) is the dose difference at the position ~rm.
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A quantity γ, or quality index can then be defined at each point in the
evaluation plane ~rc − ~rm for the measurement point ~rm so that
γ( ~rm) = min{Γ( ~rm, ~rc)}∀{~rc} (6.5)
Therefore, it can be determined that if
γ( ~rm) ≤ 1, calculation passes (6.6)
γ( ~rm) > 1, calculation fails (6.7)
A problem associated with the pencil beam algorithm of the iPLAN
calculation system is that it calculates dose in water, whereas the Monte Carlo
simulation calculates dose to tissue. This has a minor effect in doses within
homogeneous regions of tissue with densities close to unity where the water to
medium stopping power ratio ( Swater
Smedium
) is close to 1.0, whereas for materials such
as air, the stopping power ratio is approximately 1.12 (Siebers et al., 2000).
This is illustrated in figure 6.6 which shows the results of a simulation and
calculation of a beam incident on a cylindrical tissue phantom 150mm in diameter
with a 60mm air cavity at the centre. As can be seen, the dose distribution of
the TPS calculated doses within the air cavity of figure 6.6(b) significantly differ
from those of the MC simulation of figure 6.6(c). Therefore, differences between
the two data sets may be of little clinical significance as the dose discrepancies
may occur within air cavities which are of little interest routinely. However, in a
γ comparison this may lead to inappropriately low calculations of the percentage
of points passing the criteria and plans with doses calculated correctly failing
the analysis such as a criterion of 95% of points passing a 3% / 3mm γ test as
is commonly used. Consequently, following calculation of the γ indices for each
point, those relating to air were eliminated from the overall calculation. These air
cavities are most likely to occur within the phantom between the thermoplastic
shell and the patient surface where dose calculation accuracy is irrelevant. As
the cranial region generally consists of tissue with a density similar to unity, and
few air cavities this is unlikely to result in a loss in sensitivity of the method to
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(a) Concentric phantom (Relative Density) (b) iPLAN pencil beam algorithm (Relative
Dose)
(c) Monte Carlo Simulation (Relative Dose) (d) Monte Carlo Relative Dose - iPLAN
Relative Dose
Figure 6.6: Comparison of calculated and simulated doses using a cylindrical
phantom of unit density with an air cavity at the centre.
unknown calculation errors.
Some authors (Spezi, 2003), have converted the MC dose to dose to water
prior to the comparison of doses calculated by the TPS. However within the
cranium only a small conversion is required due to the anatomical composition
of the tissues being close to unit density and therefore this was not done. .
In this investigation, γ values for each point were calculated with the
measured doses, Dm in the above explanation replaced by simulated doses. For
all points in which the TPS dose was greater than 10% of the prescription dose,
gamma values using various criteria were calculated. The percentage of points
passing these varying DTA and dose criteria (from 5% / 5mm to 1% / 1mm)
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were calculated and tabulated for each patient.
6.3 Results
A total of 10 cranial patients were simulated using the above method. A
typical result is shown in figure 6.7, illustrating the comparison between the
dose calculated by the treatment planning system and that of the MC simulation.
Figures 6.7(a) and 6.7(b) illustrate the output of both systems for this plan of
a tumour within the cranium, with a prescribed dose of 7Gy per fraction. By
inspection, there is good agreement between the data sets with a similar shape to
the dose distribution for each case observed. This is confirmed in the percentage
difference plot in figure 6.7(c), showing the percentage difference between the
two data sets as a percentage of the prescribed dose (7Gy). Within the brain,
there is little difference between the two sets of data. However, in the outer
layers of the patient near beam entrance points there are larger differences, of
the order of 20% within the shell, which due to the difference window of 2% used
in the figure (chosen to exacerbate areas of dose difference in the brain), are not
obviously seen. This may be due to a combination of issues. Firstly, there are
difficulties associated with the measurement of depth dose and other data near
the surface of a patient, which may have introduced errors into the systems and
the predicted overdose of the treatment planning system may be a real issue.
Secondly an inappropriate material may have been used due to the mapping
of Hounsfield units to materials during the DOSXYZnrc phantom generation
stage of the process. In general, the thermoplastic shell in this region has been
assigned as either tissue or bone and may, therefore, result in an unrealistic
dose deposition. Finally, there may be some sampling issues occurring near the
interface of the patient and air, resulting in discrepancies between the data sets.
This behaviour was seen on all patients but as these occurred within the shell
rather than in the patient, this was not considered to be clinically significant and
therefore not investigated further.
At points deeper within the patient some areas of difference can be seen with
areas of ‘enhancement’ which relate to the position of the skull which can be
attributed to a discrepancy introduced by the planning system in calculating
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dose to water and not tissue.
The γ map shown in figure 6.7(d) for a pass / fail criterion of 2% / 2mm is
shown. In general, a γ of less than one is returned apart from in areas within the
shell where the dose to water - dose to medium issue is prevalent as discussed
earlier and some regions within the bone where similar issues exist.
For each patient, the γ was analysed for all points within the phantom with
doses greater than 20% of the prescription point. These are tabulated in table
8.1 in which it can be seen that there is excellent agreement between the data
sets where for pass - fail criteria down to 2% / 2mm more than 95% of the
points achieve a γ of less than or equal to 1. Patients 2 and 10 however return
a significantly lower number of points passing the tightest gamma criterion (1%
/ 1mm) than the other patients, which is evident to a lesser extent at other
gamma criteria. Both of these patients had an inferior tumour near air cavities,
and indicate a poorer performance of the calculation algorithm in heterogeneous






(a) MC Simulation (b) iPLAN TPS calculation
(c) Percentage Difference (d) Gamma Map (2% / 2mm)
Figure 6.7: Typical output of comparison between TPS and MC dose calculations.
6.4. Conclusions 171
Patient 5%/5mm 4%/4mm 3%/3mm 2%/2mm 1%/1mm
1 100.00 99.99 99.96 99.94 99.82
2 99.78 99.11 97.32 95.53 86.59
3 99.95 99.80 99.40 99.00 97.01
4 99.93 99.70 99.10 98.51 95.52
5 99.83 99.34 98.02 96.69 90.08
6 99.93 99.72 99.15 98.58 95.73
7 99.88 99.53 98.59 97.65 92.96
8 99.98 99.94 99.81 99.68 99.03
9 99.75 99.01 97.03 95.06 85.17
10 99.85 99.42 98.25 97.09 91.26
Table 6.2: Percentage of points passing the gamma test with various tolerances
for each of the 10 patients investigated.
6.4 Conclusions
This work has shown that a Monte Carlo verification system can be used to
independently validate cranial stereotactic plans on a routine basis. Using the
RTGrid, results were returned within 4-5 hours of submission to the grid for
subsequent analysis, which is an acceptable time frame for pre treatment checks
of fractionated stereotactic radiotherapy, in which the plan and subsequent checks
are most commonly performed over several days following the initial planning CT
scan and the commencement of treatment. For single fraction treatments using
invasive frames, in which the planning scan, beam optimisation and any necessary
checks are made within a few hours of the treatment this approach may not be
practical. However with our system and a 7 beam plan, 700 jobs are submitted
to the grid and in general run simultaneously and immediately returning a result
in 4 hours. However the RTGrid submit node is able to submit up to 1000 jobs
at a time to the university-wide Condor pool, therefore it would be possible to
split the simulation into smaller jobs with results being returned in 3-4 hours or
less which may be feasible. This may not be sustainable in practice however as
in this configuration there are other users of the RTGrid and the Condor pool
which may block these jobs from running immediately. Should it be deemed that
this system be used on a routine basis it may be necessary to put some thought
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into ensuring the grid’s availability for these tasks. An alternative approach to
overcome the problem of simulation times would be to shorten the lengths, which
will clearly increase the statistical uncertainties of the data returned requiring a
loosening of the γ criteria to indicate acceptable agreement.
However, the good agreement of all patients analysed may indicate that in
the relatively simple dosimetric situation of cranial stereotactic radiotherapy the
need for such an approach may be unwarranted on a routine basis, although this
investigation has confirmed that the data input into the planning system for the
fields used clinically was correct, and that the planning system is functioning
correctly in calculating doses in areas of tissue homogeneity.
The system may well be of use in validating software upgrades, or as the basis
for ongoing routine quality control of the planning system. For situations such as
in the head and neck or lung where much greater areas of tissue inhomogeneity
exist, this system may be readily adapted for routine use or may provide definitive
information during the validation of advanced calculation algorithms, such as
point kernel based approaches and source model based Monte Carlo algorithms
such as VMC (Kawrakow et al., 1996).
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7.1 Introduction
In recent years, the development of radiotherapy technology, such as the
widespread adoption of conformal therapy and IMRT, has increased the number
of treatment modality options available to the clinician. More recently, IMRT
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has been combined with rotational techniques, which despite having been used
for some years, have now been expanded to allow modulation of the dose rate
and gantry speed. This rotation technique, commonly known as Volumetric
Modulated Arc Therapy (VMAT) introduces many more degrees of freedom for
the TPS optimiser to produce a plan meeting the clinical constraints of the
treatment.
The use of VMAT has been embraced by the radiotherapy community, due
to its ability to provide a superior dose distribution in terms of target coverage
and sensitive organ avoidance than those achieved using IMRT (Otto, 2008). It
can also be delivered in a shorter time.
In tandem with these developments, calculation algorithms used within
treatment planning systems have also evolved, so that most TPSs commercially
available utilise a ‘type-b’ algorithm such as the collapsed cone algorithm
described in section 2.4.3, as well as the ‘type-a’ or pencil beam algorithms
described in the same section. Type-b algorithms have greatly improved the
accuracy of dose calculations within treatment planning systems, especially in
treatment sites such as the lung, thorax and head and neck where there are large
areas of tissue heterogeneity which are poorly modelled by type-a or pencil kernel
based algorithms.
The interest in stereotactic radiotherapy applied to early stage lung tumours
has increased greatly since the beginning of the 21st century after several papers
(Norihisa et al., 2008; Banki et al., 2009; Whyte, 2010; Hof et al., 2004; Wulf
et al., 2005), have shown significant improvement in tumour control for this group
of patients, compared to conventional radiotherapy. This has been achieved by
using a stereotactic technique to localise the tumour by the use of an external
frame, or a frame-less technique in which fixed parts of the patient anatomy are
used as an analogue to the frame. 4D CT, or other advanced imaging techniques
are used to accurately locate the tumour during planning, and with the use of
a stereotactic technique to position the patient, the set up uncertainties can
be reduced. This allows the reduction of safety margins and an escalation in
the doses applied to the tumour. The recently established stereotactic body
radiotherapy consortium guidelines (UK SBRT Consortium, 2011) suggest a dose
regime of 3 x 18Gy or 5 x 15Gy, giving a biological effective dose far higher than
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a conventional conformal radiotherapy treatment (Wulf et al., 2005).
The consortium guidelines demand the use of a type-b algorithm to calculate
the dose due to the inhomogeneities present within the tumour. This may include
a Monte Carlo approach such as that of a VMC (Fippel, 1999) type-algorithm.
While the use of a type-b algorithm is clearly a requirement in such cases,
these algorithms are not without their problems. For example early versions of
the OMP type-b algorithm suffered from memory limitations imposed by the
Windows XP 1 operating system, which although displaying the dose at the
user specified grid, actually reduced the resolution of the calculation grid to the
best possible with the available computing resources. Typically at VCC, actual
resolutions of between 4mm x 4mm x 3mm and 6mm x 6mm x 3mm are observed
for tumours within the lung, depending on the size of the patient anatomy.
This lack of dose resolution may not be a problem in the calculation of
monitor units to the isocentre or prescription point within the tumour, as, at this
point, any increased uncertainties are likely to be small. Despite increasing the
uncertainty of dose calculation in the field edges (and therefore, in the selection
of field width) the magnitude of any errors associated with this limitation are
likely to be smaller than the expansion from clinical tumour volume (CTV), to
planning target volume (PTV) used in the planning process.
However, these limitations in dose resolution may be a problem in
investigating the most appropriate treatment tactic for such cases. Even with the
enhanced collapsed cone algorithm (Nucletron, 2010) which enables a finer dose
grid to be realised, the resolution of such calculations cannot be set to better than
a few millimetres (even though the dose may be displayed at a higher resolution).
During the implementation phase of stereotactic body radiotherapy at VCC,
the benefits of a VMAT treatment technique compared to a conformal technique
were questioned. Clearly, the reduced treatment time of VMAT and therefore
the reduced burden on the treatment machine and patient is a clear advantage of
VMAT over a conformal technique. The increased complexity of validation and
increased quality assurance of each patient may though, negate these benefits.
However, due to the build-up effects of tumours within the lung there may be
some benefit in a rotational technique compared to that of conformal therapy
1Microsoft Ltd, Redmond, WA 98052-6399, USA
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using 4 - 8 beams. For the case of a rotational technique one might expect
that the proportion of dose delivered to the periphery of a tumour from a beam
directly incident on that part of the tumour would be less than that of a conformal
technique, where the dose may fall off at the edges of the tumour and reduce the
effectiveness of any treatment.
Due to the resolution issues of type-b algorithms, and the fact that much
of the dose under investigation will be primarily in the build up region of the
radiation field, a MC investigation was undertaken to investigate the benefits
of VMAT or rotational techniques over conformal techniques, and to assess the
performance of the different calculation algorithms in the situation of stereotactic
body radiotherapy (SBRT) to the lung
7.2 Methods
For this investigation a phantom was constructed of three rings shown in figure
7.1.
The purpose of this design was to mimic the situation of a lung tumour,
surrounded by low density lung tissues. The phantom therefore, consisted of
a number of concentric cylinders with an inner cylinder of 40mm diameter
constructed of tissue material, set as ICRU521TISSUE in subsequent MC
simulations, a 120mm diameter, middle cylinder of lung (ICRU521LUNG) and a
250mm diameter outer cylinder of tissue (ICRU521TISSUE). The length of the
‘tumour’ (i.e. in the dimension into and out of the page) was 40mm. In order
to examine doses near the extremities of the inner cylinder, a fine voxel size is
required. If this is repeated throughout the phantom the size of the phantom
would be large in terms of the physical storage space required on the simulating
machine. Therefore, a scheme of irregular voxel dimensions was used. The voxels
of the inner cylinder were 0.1mm x 0.1mm x 40mm, the middle cylinder were
1mm x 1mm x 40mm and the outer cylinder 10mm x 10mm x 40mm.
A phantom for use with DOSXYZnrc was created geometrically, using these
dimensions and used for subsequent simulations. This phantom was then used
to generate ‘images’ of the phantom in DICOM-RT format which could be read
by a treatment planning system. Due to constraints of the planning system
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(a) XY image through isocentre plane
(b) XZ image through isocentre plane (c) YZ image through isocentre plane
Figure 7.1: Illustrations of the concentric phantom used for TPS based
calculations and MC simulations analogous to an SBRT treatment of the lung.
The images are shown in terms of relative density, the white areas are of density
equal to 1.0 with lung equivalent material surrounding the ‘tumour’ in the centre.
requiring equally spaced pixels in each scan the phantom data were re-sampled to
a resolution of 512 x 512 pixels for each slice equating to a resolution of 0.5mm x
0.5mm for all pixels. Due to the desire to compare a type-b algorithm, which was
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not available on the iPLAN TPS, the Nucletron OnCentra Masterplan (OMP)
TPS was used to calculate doses in the phantom using the enhanced pencil
beam (PB) and enhanced collapsed cone (CC) algorithm of version 3.3SP3 of
the software (Nucletron, 2010).
A field size 50mm x 50mm, was used in all cases with the isocentre of each
beam placed at the centre of the tumour. Simulations and calculations were
performed using 2, 3, 4, 8, 16, 32 beams together with a single beam, rotating
360 degrees around the tumour. This was achieved for the MC simulations by
using source 10 of DOSXYZnrc, which allows for arc therapy to be simulated in
a single run by specifying the range of angles and spacings. The parameters used
for each of these are tabulated in table 7.1.







rotation (360) 0 359.00
Table 7.1: Gantry angle parameters used for simulation of conformal and
rotational technique using DOSXYZnrc source 10.
Thus, a full arc around the patient was simulated by dividing it into 360
beams entering the patient from 0 degrees to 359 degrees in 1 degree intervals.
For the two beam plan, the arc was divided into two beams with 180 degree
intervals. All of the beam arrangements began at 0 degrees and, therefore, the
two beam plan consisted of beams at 0 and 180 degrees. Similarly, the three beam
plan had portals entering the phantom at 0, 120 and 240 degrees with similarly
arranged beams for each of the other plans, each beginning at 0 degrees.
The ‘dose cubes’ from the TPS and ‘.3ddose’ files from the MC simulations
were then extracted and analysed to produce dose volume historgrams (DVHs)
of the tumour and beam profiles of the dose delivered by each of the beam
arrangements.
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7.3 Results and Discussion
7.3.1 TPS Calculation Algorithms
The DVHs for all of the beams, using each calculation method and MC simulation
are shown in 7.2. In figure 7.2(a) there is little separation between the curves but
in the magnified image of figure 7.2(b), it can be seen that the curves separate
due to the number of beams and calculation method used.
The most marked deviations can be seen in the curves for the two and three
beam techniques, the DVHs for which, are shown in figure 7.2(c). It can clearly
be seen that the PB algorithm produces a markedly different distribution to that
of either the MC or the CC. The failure of the PB algorithm to model the build
up effects of the radiation passing from a low density material into the lung would
account for this difference between the algorithms. The CC calculation where
the use of point kernels would account for this effect, agrees very well with the
MC, although the MC DVH shows a slightly better coverage of the tumour than
the CC.This may indicate that the situation of doses calculated using the CC
algorithm in areas of tissue heterogeneity may not be as bad as calculated and
could be an area of further investigation.
These effects are further illustrated in the diagrams of figure 7.3 which show
the percentage differences between the doses within the tumour calculated by
each of the methods. For clarity, doses outside the tumour region have been
removed and the range of differences shown in each figure reduced from -5% to
+5%. The red annulus around each tumour are regions where larger differences
are present of the order of 20%.
For the rotational techniques, the thickness of this annulus is of the order of
0.2mm for the CC v MC comparison and 0.6mm for the CC v PB comparison.
Considering the CC and PB were calculated on a 1mm grid, which required re-
sampling to get to the 0.1mm resolution of the MC simulations, it is arguable
whether this result is of any significance. However, the fact that the PB
calculations do exhibit a thicker high difference annulus may add some credence
to the argument that the CC is a more accurate calculation in this situation.
For the 2 beam approach, the difference between the PB and the other two
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techniques is far more significant. Here, the annulus is significantly thicker in
the case of the PB v MC compared to the CC v MC calculation where for the
former case the annulus is up to 20mm thick, compared to up to 6mm thick for
the latter. This would be consistent with the inability of the PB algorithm to
model the build up effects in this situation.
The comparisons of PB v CC are shown in figures 7.3(c) and 7.3(f). In the
former case small differences can be seen between the two data sets with an
annulus of dose difference of 1% - 2% between them for the rotational technique
near the edge of the tumour. For the two beam case of figure 7.3(f), much larger
differences can be seen in the periphery of the tumour.
In the CC v MC comparison there is a dose difference of around 2% between
the CC and MC near the edges, to the left and right of the figure, which although
present to some extent in the PB calculation is of a smaller magnitude, generally
less than 1% but with small areas of 2%. If one assumes the MC calculation as
being the most accurate, it would appear that this discrepancy is introduced by
the use of CC algorithm. However, this requires further investigation. For the
2 beam technique the differences between the two algorithms in the superficial
layers swamp this effect in the comparison of the two algorithms but a similar











(a) Full DVH (b) Magnified DVH in dose range 0.9 to 1.02
(c) DVH of 2 and 3 beam techniques
Figure 7.2: DVH of doses delivered using 2,3,4,8,16,32 and full rotational techniques calculated using a pencil beam (PB)











(a) CC v MC full rotation (b) PB v MC full rotation (c) PB v CC full rotation
(d) CC v MC 2 beam (e) PB v MC 2 beam (f) PB v CC 2 beam
Figure 7.3: Percentage differences to tumour region of phantom for the different calculation methods using a full rotational
technique and a two field (ant-post) technique (0.1mm x 0.1mm matrix). For clarity doses outside the tumour region
have been eliminated and shaded in dark blue.
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The difference in resolution between the MC and TPS datasets being the
source of the discrepancy, or masking some effects were then investigated by
repeating the MC simulations with a 1mm x 1mm x 40mm in the region of the
tumour, with co-ordinates exactly matching that of the calculation matrix of the
TPS. Results of this are shown in figure 7.4. A similar behaviour is seen to the
finer resolution comparisons in that there is an annulus of dose difference at the
superficial layers of the tumour, which is significantly thicker for the PB v MC
case than the CC v MC case for the 2 beam technique but the differences for the
full rotation technique are much smaller. The discrepancies at the edges of the
tumour, apparently introduced by the use of the CC algorithm are also present.
Although there are some differences between the two experiments, the
thickness of the high dose difference annulus in the high resolution phantom
has an average thickness of around 15mm compared to 10mm for the lower
resolution case, this experiment has confirmed the use of the high resolution grid











(a) CC v MC full rotation (b) PB v MC full rotation (c) PB v CC full rotation
(d) CC v MC 2 beam (e) PB v MC 2 beam (f) PB v CC 2 beam
Figure 7.4: Percentage differences to tumour region of phantom for the different calculation methods using a full rotational
technique and a two field (ant-post) technique, (1mm x 1mm MC matrix). For clarity doses outside the tumour region
have been eliminated and shaded in dark blue.
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7.3.2 Treatment Tactics
Figure 7.5 illustrates the DVHs for the two, three, eight and full rotational
techniques calculated using the MC simulations only. The coverage of the tumour
is fairly similar for each of the techniques. However, the two and three beam
situations do deviate somewhat from the situation with more beams as can be
seen in figure 7.5(b), showing a that a higher volume of the tumour receives doses
around 0.92Gy for cases with the higher number of beams than found with the
rotational case.
For plans with four or more beams irradiating the tumour the DVHs returned
are almost indistinguishable. This is shown in the plots of percentage differences
between each of the conformal beams to the rotational case shown in figure 7.6.
In this diagram a positive dose difference indicates an area of higher dose from
the rotational plan and a negative dose the converse. It can be seen that in the
case of the two and three beam plans, there are large differences in the saturated
region of the annulus of up to -6% and +8% for the two beam plan and -2%
to +4% in the case of the three beam plan. The four beam plan shows slight
differences in the superficial area of the tumour but for techniques involving a
greater number of beams beyond this, the distributions are indistinguishable.
These results would indicate that there is a disadvantage in having less than
four beams in a plan, and that the addition of opposing beams helps over come
the dose loss at the periphery of the tumour due to build up effects.
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(a) Dose range 0.9Gy to 1.02Gy
(b) Dose range 0.9Gy to 0.95Gy
Figure 7.5: DVH of doses delivered using 2,3,8 and full rotational techniques











(a) 2 beam v full rotation (b) 3 beam v full rotation (c) 4 beam v full rotation
(d) 8 beam v full rotation (e) 16 beam v full rotation (f) 32 beam v full rotation




This initial investigation has shown the following :
• There are significant differences between the PB and CC calculation
algorithms at the periphery of tumours lying within low density regions.
This difference is more significant for a smaller number of beams.
• For a fully rotational beam there is little difference between the doses
reported by PB and CC. This may be of interest in systems such as OMP
and Elekta Monaco2 (both used at VCC), which may use a PB algorithm
during its optimisation process to benefit from calculation speed objectives.
• Cold spots within tumours such as those investigated may be avoided by
the use of more than four beams or more
2Elekta-CMS Ltd, Crawley, UK
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8.1 Portal Imaging
Portal imaging has been in use in radiotherapy for many years and is utilised to
verify that the patient has been positioned correctly. Initially implemented using
radiographic films placed in an exit plane of the beam distal to the patient, in
more recent years electronic portal imaging devices (EPIDs) have been used to
acquire an electronic image of the exit radiation, which can be compared to a
digitally reconstructed radiograph (DRR) of the beam produced by the treatment
planning system. A schematic diagram of this configuration is shown in figure
8.1.
Figure 8.1: Schematic diagram of an EPID in clinical use.
Figure 8.2: Schematic diagram of an amorphous silicon electronic portal imaging
device.
At Velindre Cancer Centre, all of the linear accelerators in clinical use are
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equipped with megavoltage portal imaging devices based on amorphous silicon
detectors, which are routinely used for the verification of patient position. Figure
8.2 illustrates the main components of the EPID on the Varian 600c linear
accelerator used for cranial stereotactic treatments at Velindre Cancer Centre.
The device consists of a copper plate, which is used to generate electrons from the
incident photons that have transported through the patient, and to absorb any
low energy scatter which may produce blurring on any subsequent image. The
electrons are then incident on a scintillating layer of terbium doped gadolinium
oxysulphide (Gd2O2S : Tb). This layer produces optical photons, which are
then detected by a two-dimensional array of amorphous silicon (a-Si) coupled to
photo-diodes, which are read out using an array of thin film transistors situated
beneath the a-Si layer (Antonuk, 2002).
The detector provides an image af 512 columns x 384 rows of 0.784mm x
0.784mm pixels producing a maximum field size of 400mm x 300mm at the
position of the detector. For a typical EPID position of 1400mm from the
radiation source, this relates to a field size of approximately 280mm x 210mm,
much larger than the fields used within stereotactic radiotherapy or radiosurgery.
The device is supported by a retractable arm which allows the detector
assembly to be positioned within the gantry assembly when not in use and to a
convenient position for the acquisition of verification images when required.
8.2 Portal Dosimetry
The response of the imager to dose is linear, as can be seen from the plot of
EPID signal versus delivered dose shown in figure 8.3. This was obtained by
placing 50mm of solid water equivalent material on the imager and irradiating
the imager to a series of known doses at the exit of the solid water. The dose
at the exit of the solid water was calculated using standard tables with the
application of an inverse square law factor to account for increased distance
between the radiation focus and the detector. This, therefore, assumes full
scatter conditions in a homogeneous medium, which will not be the case in
this circumstance, but any uncertainties associated with this technique will be
constant across all measurements. As a check of the magnitude of the calculation,
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this situation was simulated using a Monte Carlo model of the accelerator and
imager. The difference between the calculated dose and simulated dose was
within the statistical uncertainties of the simulation (0.5%). The points on the
graph indicate the response of the detector to doses achieved from 0.06Gy (the
dose delivered by 1 monitor unit in this configuration) to 10Gy once the flood
and dark field corrections described below have been applied. The solid line is a
least squares fit of the data showing the near perfect linear relationship between
signal and applied dose over a range much wider than that practically used in
stereotactic radiotherapy.
In order to calibrate the portal imager, a dark field and flood field is acquired.
The dark field, taken with no radiation incident on the detector, is acquired in
order to characterise the response of the imager and associated electronics with
no radiation present. The flood field is obtained by irradiating the entire active
area of the detector with an open field and is used to account for changes in
sensitivity of the detector from pixel to pixel. In dosimetric mode, the images
are obtained without these corrections applied which therefore needs to be done
manually. The dose obtained from the imager is therefore obtained using the
following equation:
Doseepid(x, y) =
Epidsignal(x, y)− darkfield(x, y)
floodfield(x, y)
× floodmean × dcorr (8.1)
where
• Doseepid(x, y) is the dose measured by the detector at a point (x, y) on the
imager panel
• Epidsignal(x, y) is the signal measured by the EPID at (x, y)
• darkfield(x, y) is the dark field measured by the detector with no incident
on the detector at (x,y)
• floodfield(x, y) is the flood field measured with the largest possible field
incident on the detector (x,y)
• floodmean is the mean value of the flood field image.
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• dcorr is the epid signal to dose correction factor obtained from a curve
similar to that shown in figure 8.3
Figure 8.3: Plot of EPID signal versus dose.
An ideal detector would be water or tissue equivalent, whereas, in reality, the
sensitive area of the EPID is constructed of a copper plate, a scintillating material
and the a-Si layer used to capture the signal. All of these are of higher density
than water or tissue and may, therefore, be prone to differences in response with
changes in incident energy spectrum as the field size changes, in a similar way to
that discussed in section 5.3.2.2 and in more detail by Chin (2005). Figure 8.4
illustrates this effect for the case of the EPID.
These data were obtained by simulating the situation of a 100mm slab of
water equivalent material placed at 900mm FSD (i.e. the isocentre at the bottom
of the solid water slab) and the EPID placed at a distance of 1400mm from
the radiation source. In order to reduce the size of the phantom used in the
simulations, and therefore enable the job to be run over a number of machines
on the RT-Grid, voxels in the x-z direction, parallel to the slab surface were
defined as a 3.136mm x 3.136mm voxels (equivalent to the dimensions of the
central 4x4 pixels), symmetric around the central axis surrounded by voxels of
200mm width in which the dose was ignored. Dimensions in the y (vertical plane)
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direction were maintained to be identical to the physical situation. Simulations
were performed for the circular fields used in section 5.3.2.2 and an additional
square field to which each of the simulated doses were normalised.
In section 5.3.2.2, the data are plotted against the diameter of the field but
here it is plotted against the equivalent window width field (EwwF ). This is
a concept defined by Nicolini et al. (2006) as a fast and easy approximation to
calculate equivalent squares for irregular fields.
Applied to the case of a M3 µMLC in which the leaves of the µMLC are in





where X is the width of the field in the X (non µMLC) direction and Y is the
mean of all apertures defined by opposing leaves that lie within the open part of
the field.
The red line and points of figure 8.4 illustrate the set of output factors for
the circular fields defined by the µMLC calculated using Monte Carlo simulations
using a screen within the phantom made of Gd2O2S : Tb compared to a screen
constructed of water (green line). There is little difference between the output
factors measured in both situations for fields larger than an EwwF of greater
than 25mm, below which, the two curves show a significant deviation.
Figure 8.4(b) illustrates a plot of the ratio of the output factors using a silicon
and water screen in the simulations. A field size dependent conversion factor Ksw
can be used to convert the doses measured in with the EPID to doses measured
in water. This is defines as:
Ksw =
relative dose towater
relative dose to screen
(8.3)
For fields of an EwwF greater than 25mm this factor can be assumed to 1.00.
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(a) Relative Output Factors
(b) Si - Water Correction Factors
Figure 8.4: Plot of EPID output factors simulated using a screen of actual
composition, and of water against equivalent window width (EwwF) (top figure
(a)). The bottom figure is the correction required to convert a dose measured
with the EPID screen to a dose in water based on these measurements (again
against EwwF).
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8.3 In-vivo dosimetry
In recent years, the document “Towards Safer Radiotherapy” (Royal College of
Radiologists, 2008) has recommended that all patients undergoing radiotherapy
would benefit from in-vivo dosimetry to confirm that the correct dose has been
applied. Clearly, this includes stereotactic radiotherapy and, by implication,
radiosurgery. Methods such as tabular based dose checks, and pre-treatment
individual patient Monte Carlo simulations, such as those described in chapter 6
can independently verify the dose calculation but are unable to detect errors due
to an incorrect transfer of the dosimetric information to the treatment machine
or an incorrect patient set up.
Consequently, in-vivo dosimetric measurement techniques have been
developed and used routinely by many centres. These generally involve a
detector, of limited spatial extent, such as a diode or thermoluminescent detector
placed at the centre of the applied radiation field on the surface of the patient,
and the dose measured compared to that planned at that point. This may be
replaced or combined with a similar detector at the position of radiation exiting
the patient. This approach is problematic in advanced radiotherapy techniques
such as IMRT, in which the uncertainties associated with placing of the detector
on the patient surface, combined with a modulated beam may make it difficult or
impossible to realise a practical resolution of such methods to confirm doses (or
otherwise) to within the desired level of around 5% or better. Other techniques,
such as VMAT, in which modulating beams are rotated around the patient, have
the added complication that there is no single entry or exit point for a beam
and consequently make single point measurements even more problematic, if not
impossible.
In order to solve some of these problems, pseudo in-vivo or exit dosimetric
techniques have been developed by many authors, as reviewed by van Elmpt
et al. (2008), which utilise the EPID as a dosimetric device. As an integral part
of the machine, the EPID can usually be placed orthogonally to the central axis
beyond the patient, where dosimetric information can be obtained and compared
with the dose expected in this plane. However, this may not always be possible
if extensive couch twists are utilised in the treatment plan, which may cause
collisions with the patient or patient support apparatus.
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As has been shown earlier, the response of the EPID is linear and has a small
dependency on field size. Therefore, the dose in the exit plane can easily be
determined with a careful calibration of the EPID. The difficulty is therefore in
the determination of the expected dose in this plane.
8.4 The Application of EPID-based
Exit Dosimetry in Stereotactic Radiotherapy
Rotational and modulated techniques are commonly applied to stereotactic
radiotherapy and therefore suffer from the same issues as described in
the previous section concerning IMRT and VMAT. Additionally, the fields
used within stereotactic techniques are significantly smaller than conventional
radiotherapy and, therefore, issues with the response of the detector in small
fields (as discussed previously) may be prevalent.
Furthermore, there are increased uncertainties due to the positioning of
a relatively large detector relative to the size of the radiation field on the
central axis of the field where a small discrepancy in position may equate to
a large change in dose due to the proximity of the field edge. Additionally,
for these small fields, perturbations in the intensity of the incident beam, as a
consequence of introducing the detector, may be more significant than in larger
fields as the detector may cover a far more significant area of the incident beam.
For treatments delivered over a small number of fractions (as is generally the
case in stereotactic radiotherapy), and more so in radiosurgery this may be of
significant enough magnitude to require a correction to the monitor units to
ensure delivery of the correct dose, even if only used on the first fraction of
a multi-fraction course, if the number of fractions is small. In conventional
radiotherapy consisting of more highly fractionated regimes (typically between
15 and 37 fractions), any perturbations from a detector placed in a much larger
field are likely to be insignificant
Therefore, an EPID based pseudo in-vivo exit dosimetry approach has several
advantages.
1. The EPID is placed beyond the patient and therefore does not perturb the
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incident beam
2. Dosimetric information concerning the entire beam can be obtained rather
than just a point dose as in other methods. As dose is acquired from
the whole radiation beam, any uncertainties such as movement within
a fraction may be observed, and if necessary taken into account during
analysis
3. The data are acquired electronically and can be analysed immediately using
appropriate software and do not, necessarily require subsequent processing
as is the case for TLDs, for example. The potential speed of data analysis
may make the method appropriate for radiosurgery, in which the treatment
may be interrupted part (e.g. 10%) of the way through treatment, the dose
calculated and a decision made to continue treatment quickly
4. An electronic record of the measurement can be kept and stored as a record
of for future analysis
5. The EPID is generally a standard part of a modern linear accelerator and
use of it as a dosimetry device requires no further financial outlay
6. Use of the EPID as a surrogate in-vivo dosimetry measurement involves no
physical contact with the patient
For these reasons, the use of an EPID based approach to in-vivo dosimetry
was explored using a variety of methods to predict the dose at the imager
plane. Three clinical cases, involving patients undergoing cranial stereotactic
radiotherapy at Velindre Hospital were investigated as ‘proofs of principle’ for
each of the methods. All of the patients were prescribed doses of between 28Gy
and 32Gy to be delivered in daily fractions over four days for indications of a
brain metastasis (one patient) and recurrent gliomas (two patients). For the
case of the brain metastasis the patient had previously received whole brain
radiotherapy.
These three patients had been subject to the standard dosimetric checks,
which include a tabular dosimetry check and an electronic check of the
parameters used to treat the patient following each fraction. Furthermore,
these were part of the cohort of patients investigated in chapter 6 using a full
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Monte Carlo simulation. Therefore, it can be verified that the correct doses were
delivered to these patients on all fractions.
Three methods of pseudo in-vivo dose measurement were investigated:
1. Full Monte Carlo transport of dose through the patient
2. TPS based estimation of the dose at the imager plane
3. A single point dose equivalent path length based correction
8.4.1 Full Monte Carlo Simulation
In this method, the transport of radiation from each beam was simulated using
the Monte Carlo model previously developed. This, together with a model of the
portal imager, is used to determine an expected fluence at the imager plane and
compared to that obtained during measurement.
8.4.1.1 Methods
For each patient, the planning CT scan was taken and converted to a
DOSXYZnrc phantom using a method similar to that described in section 6.2.1.
The difference in the method was that during phantom generation the DICOM-
RT plan file of the treatment under investigation was read and the patient data
rotated about the isocentre by the gantry angle described in the treatment plan
so that a flat imaging panel could be easily constructed at the correct angle
relative to the patient. The model of the imaging panel in use on the accelerator
had previously been developed and validated within the department by Chin
et al. (2003), Cuﬄin et al. (2010) and Cuﬄin (2011).
The gantry angle in the subsequent Monte Carlo simulations was changed
to 0 degrees to maintain equivalence with the treatment plan. The generated
phantoms of the first four beams of patient 1 are shown in the top row of figure
8.7.
Simulations were run using a BEAMnrc simulation of the linear accelerator
head as the input source to a DOSXYZnrc simulation using the generated
phantoms including the EPID. The simulation parameters were those shown
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in table 3.1 and the RTGrid used to run the simulations. Due to the size of
the phantoms generated being of the order of 50Mb each, the number of jobs
for each beam was limited to 50. In this case, a six field plan would require
15Gb of storage on the server which would be near the limit of acceptability
on the resources available to us. Using 108 particles, average uncertainties of
approximately 1.5% in the imager plane were obtained. However, despite using
this parallel technique, these took a real simulation time using the RT-Grid of
over 48 hours.
Following simulation, each MC dose map of the imager screen was divided
by a MC simulation of a flood field and multiplied by the mean of the flood
field to ensure that the MC comparison data set was compared with a similarly
processed data set from the imager.
For each fraction of treatment, portal images of each beam were obtained
integrating the image over the entire duration of treatment. These were then
converted to a calibrated dose, according to the procedure described in section
8.2. The two data sets were then compared and a gamma analysis done for each
point in which the MC dose was greater than 20% of the dose at the central axis.
8.4.1.2 Results
Figure 8.5 illustrates the results for the first fraction of the first patient which
are typical of the results obtained. An inspection of the absolute dose intensity
maps of the MC phantom, and the dose maps obtained from the measurements
shows good agreement, which is reflected in the map of percentage differences
shown in the figure 8.5(c) and the gamma map in figure 8.5(d) in which for this
example 93.9% of points pass a gamma criteria of 3% and 3mm. Phantoms, MC
doses, EPID doses and gamma maps for the first fractions of the first four beams
of patient 1 are shown in figure 8.7.
For this beam, gamma maps of criteria ranging from 1% / 1mm to 6% / 6mm
are shown in figure 8.6 which show expected behaviour. At the ‘looser’ end of
gamma criteria (6% / 6mm), 100% of points pass but at the ‘tighter’ end the
figure is 53.5%
The average number of points passing each set of gamma criteria were
8.4. The Application of EPID-based Exit Dosimetry in Stereotactic
Radiotherapy 201
averaged over each fraction and listed for each beam in Table 8.1, together with
the percentage of beams that pass the gamma criteria at the bottom.
(a) MC Dose (Relative Dose %) (b) EPID Dose (Relative Dose %))
(c) % difference (d) Gamma Map (3% / 3mm)
Figure 8.5: Dose maps, % differences and gamma comparison of EPID and MC
calculations for fraction 1, beam 1 of patient 1. In the gamma map, the value of
gamma below the threshold dose of 10% is displayed in dark red for clarity
8.4. The Application of EPID-based Exit Dosimetry in Stereotactic
Radiotherapy 202
(a) 1% / 1mm (b) 2% / 2mm
(c) 3% / 3mm (d) 4% / 4mm
(e) 5% / 5mm (f) 6% / 6mm
Figure 8.6: Gamma maps for various gamma criteria for fraction 1, patient 1
beam 1. In each map, the value of gamma below the threshold dose of 10% is




























Beam 1 Beam 2 Beam 3 Beam 4
Figure 8.7: Phantoms, dose maps and gamma comparison of EPID MC simulations for patient 1. The top row is an
illustration of the phantom used, the second and third rows the dose maps from the EPID and MC simulation respectively
and the bottom row a gamma map of the comparison between the two data sets. In the gamma map, the value of gamma
below the threshold dose of 10% is displayed in dark red for clarity
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Patient 6%/6mm 5%/5mm 4%/4mm 3%/3mm 2%/2mm 1%/1mm
pat1 beam 1 100.00 99.80 99.10 93.65 79.94 54.68
pat1 beam 2 91.04 87.49 81.54 72.33 58.03 45.16
pat1 beam 3 98.32 96.61 92.97 91.20 79.04 63.41
pat1 beam 4 97.27 96.82 93.85 87.12 78.46 50.94
pat1 beam 5 98.56 97.60 94.42 93.46 82.85 61.25
pat2 beam 1 98.56 98.37 97.68 95.75 78.80 53.89
pat2 beam 2 97.45 97.25 96.57 94.67 77.90 53.28
pat2 beam 3 100.00 100.00 99.48 97.52 80.25 54.89
pat2 beam 4 97.95 97.74 97.06 95.15 78.30 53.55
pat2 beam 5 98.71 98.51 97.82 95.89 78.91 53.97
pat3 beam 1 100.00 100.00 100.00 98.28 80.87 55.31
pat3 beam 2 100.00 99.90 99.20 97.25 80.03 54.74
pat3 beam 3 100.00 100.00 99.76 97.79 80.47 55.04
pat3 beam 4 100.00 100.00 99.56 97.60 80.32 54.93
pat3 beam 5 99.06 98.84 98.16 96.22 79.18 54.16
pat3 beam 6 99.76 99.53 98.83 96.88 79.73 54.53
% of beams
with γ>95% 93.75 93.75 75.00 62.50 0.00 0.00
Table 8.1: Percentage of points passing the gamma test with various tolerances
for full MC transport method.
8.4.1.3 Discussion
The gamma comparisons in this study, do not show as good an agreement
between simulated and measured data compared to that observed in the
simulations of doses delivered to the patient described in Chapter 6. In the
analysis performed in chapter 6, all plans had more than 95% of points passing
a gamma criteria of 3% / 3mm compared to 62.5% of beams in this case. This is
not a surprising result, as some of the random errors in a multi-beam situation
may average out which is not the case when considering single beams and this
situation involving a full transport through the patient to the imager is a far
more complex situation compared to that simulated in Chapter 6.
It may, therefore, be appropriate to loosen the gamma criteria used to indicate
a successful validation for each single beam to 95% of points passing a gamma
criteria of 5% and 5mm as used by Cuﬄin et al. (2010) for the case of IMRT
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verification. For the cases examined, only one beam, beam 2 of patient 1 would
fail with these criteria. It can be seen from figure 8.7 that there appears to be
a positional issue of a few millimetres evident, and may, in fact, indicate that
some degree of positional error occurred during treatment delivery, although this
discrepancy was present on all fractions observed. As the data were analysed
some time after the patient had been treated, there was no opportunity to explore
this individual case further. This discrepancy varied from 3mm - 4mm at the
imager plane which relates to 2.1mm to 2.9mm at the isocentre. This is however
within the 5mm margin expansion used to determine the planning target volume.
In stereotactic radiotherapy and radiosurgery, it is common practice for doses
to be prescribed to a position other than the isocentre, commonly the extremities
of the tumour to ensure that the most amount of tumour possible receives at
least the prescription dose. In such cases, it is common for there to be hot
spots within the tumour of 120% or more. A dose discrepancy of 5% in the
imager plane could, therefore, be considered acceptable on the grounds that a
far greater dose inhomogeneity is allowed in these patients than conventional
radiotherapy. Furthermore, the complexity of the simulation is greater than that
of the calculation and therefore subject to greater uncertainties, therefore a 5%
agreement between the data sets is entirely acceptable
However, there is a greater requirement for positional accuracy than in
conventional radiotherapy suggesting that an adjustment of the distance to
agreement (dta) gamma criterion to a tighter value may be appropriate. Table
8.2 tabulates the gamma for various spatial tolerances from 5mm to 2mm for 5%
dose differences; as the dimensions of the voxels of the MC phantom were 2mm,
distance to agreement criterion of less than 2mm is inappropriate.
As can be seen, only two of the beams fail the gamma criteria of 5% /4mm,
3 at 5% /3mm and 4 at 5% /2mm. The distance to agreement figure is, of
course, measured at the imager plane, which in these instances is at 1400mm
which relates to dta figures of 3.6mm, 2.9mm, 2.1mm and 1.4mm for the 5mm,
4mm, 3mm and 2mm tolerances respectively, at the isocentre. Therefore, it can
be seen that a gamma criteria of 5% / 3mm (at the imager plane) would indicate
acceptable agreement between doses measured with the EPID and simulated,
relating to positional uncertainties of around 2mm at the isocentre.
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Patient 5%/5mm 5%/4mm 5%/3mm 5%/2mm
pat1 beam 1 99.80 97.80 97.14 96.47
pat1 beam 2 87.49 87.10 86.97 86.84
pat1 beam 3 96.61 96.32 96.23 96.13
pat1 beam 4 96.82 96.78 96.76 96.75
pat1 beam 5 97.60 96.74 96.45 96.16
pat2 beam 1 98.37 95.92 95.10 94.29
pat2 beam 2 97.25 94.29 93.31 92.32
pat2 beam 3 100.00 99.95 99.93 99.91
pat2 beam 4 97.74 95.28 94.46 93.64
pat2 beam 5 98.51 96.65 96.03 95.40
pat3 beam 1 100.00 98.32 97.76 97.20
pat3 beam 2 99.90 99.17 98.92 98.68
pat3 beam 3 100.00 97.53 96.71 95.89
pat3 beam 4 100.00 99.21 98.95 98.68
pat3 beam 5 98.84 96.58 95.83 95.07
pat3 beam 6 99.53 97.55 96.89 96.23
% of beams
with γ>95% 93.75 87.50 81.25 75.00
Table 8.2: Percentage of points passing the gamma test with varying dta
tolerances for a dose difference criterion of 5% for the MC transport method.
These results, therefore, indicate that this approach may be used as a
successful method of individual patient validation. The disadvantage of this
technique however is the time required to generate the phantoms (two hours)
and for the simulations to run which may be upwards of 48 hours. As this
method would primarily be used as a secondary validation of treatment plan
transfer and patient set up, one may argue that it is somewhat exhaustive to
simulate doses to arrive at uncertainties of less than 1.5% with the subsequent
expectation of poorer gamma results. Further work is required to indicate the
simulation time necessary to ensure that all correctly delivered treatments passed
the gamma criteria chosen.
Additionally, the phantom may be reduced in size by restricting its dimensions
to only a few centimetres outside the beam edges, which would enable the
simulation to be split up into a greater number of jobs to avoid the physical
limitations of the RTGrid server. Again, further investigation would be required
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to arrive at the best compromise between phantom, phantom voxel size and
simulation uncertainty to derive the optimal figures.
8.4.2 TPS EPID calculation
An alternative approach to obviate the speed difficulties of the full Monte Carlo
simulation described in the previous section is to calculate the doses at the
imaging plane using a TPS or similar. It has been shown by Dahlgren et al.
(2006), Cuﬄin (2011) and Cuﬄin et al. (2010) that for IMRT plans optimised
and calculated using the Nucletron1 OnCentra MasterPlan TPS (OMP) a good
agreement between dose predicted by the EPID and TPS can be obtained using
the collapsed cone (Ahnesjo, 1989) algorithm. Larger differences were observed
between the doses calculated on the TPS using the pencil beam algorithm
(Ahnesjo and Trepp, 1991), which is implemented in a similar way as on the
iPLAN system. However, due to the potential benefit in speed, this method
applied to this situation was investigated.
8.4.2.1 Methods
For this investigation, the CT scans suitable for import into the iPLAN TPS were
generated using a similar method of rotating the patient around the isocentre
and adding the EPID at the required position. Due to the TPS’s calculation
algorithm only computing dose to water, a uniform slab of water was used
to represent the imager material. The data acquired by the EPID was then
converted to water equivalent information using the factors described in section
8.2.
Using the ‘phantom mapping’ function of the TPS, the clinical plan was
transferred to this new case and the clinical beam geometry set to the clinical
isocentre. All beam parameters were kept the same as in the treatment plan
with the exception of the gantry angle which was set to 0 degrees to maintain
the appropriate geometry relative to the EPID. A TPS flood field was obtained
from a calculation by the TPS of a 28cm x 21cm field at the isocentre (40cm
1Nucletron BV Ltd
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x 30cm at the imager plane) incident on the imager geometry and the dose






• DoseTPS(x, y) is the corrected dose calculated by the TPS at a point (x, y)
on the imager panel
• TPSdose(x, y) is the uncorrected dose calculated by the TPS at the imager
plane on the EPID at (x, y)
• floodTPS(x, y) is the dose calculated by the TPS at a point (x,y) on the
imager panel from the largest possible field incident on the detector
• floodTPSmean is the mean value of the floodTPS(x, y) field image.
By applying this flood field correction, differences between the TPS calculated
results and those acquired by the EPID due to the averaging out of the beam
‘horns’ by the flood field are removed.
The two data sets were then compared using a gamma analysis for each point
in which the TPS dose was greater than 20% of the dose at the central axis.
8.4.2.2 Results
Figure 8.8 illustrates the dose and gamma maps for patient 1, fraction 1. There
appears to be a fair visual agreement between the relative intensities of the two
data sets but as can be seen from figure 8.8(c) there is a greater absolute dose
discrepancy between the two data sets compared to that found when the full
MC simulation was used. This is reflected in the gamma comparison of figure
8.8(d) which shows significantly worse results than that observed with the full
MC calculation of figure 8.5(d), where the percentage passing the 3% / 3mm
criterion was 93.9% compared to 86.1%, in this instance, for the first fraction.
The full set of gamma comparisons for this beam averaged over all fractions is
shown in figure 8.9 and tabulated for all beams in all plans investigated in table
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(a) TPS (Relative Dose %) (b) EPID (Relative Dose %)
(c) % Difference (d) Gamma (3% /3mm)
Figure 8.8: Dose maps, % differences and gamma comparisons of EPID and TPS
calculations for beam 1, patient 1. In the gamma map, the value of gamma below
the threshold dose of 10% is displayed in dark red for clarity
8.3. Similarly, as for the MC transport investigation, the phantoms, dose maps
and gamma maps for the first four fractions of patient 1 are shown in figure 8.10.
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(a) 1% /1mm (b) 2% /2mm
(c) 3% /3mm (d) 4% /4mm
(e) 5% / 5mm (f) 6% / 6mm
Figure 8.9: Gamma maps for various gamma criteria for beam 1, patient 1.In
each map, the value of gamma below the threshold dose of 10% is displayed in




























Beam 1 Beam 2 Beam 3 Beam 4
Figure 8.10: Phantoms, dose maps and gamma comparison of EPID MC simulations for patient 1.The top row is
an illustration of the phantom used, the second and third rows the dose maps from the EPID and TPS calculation
respectively and the bottom row a gamma map of the comparison between the two data sets
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Patient 6%/5mm 5%/5mm 4%/4mm 3%/3mm 2%/2mm 1%/1mm
pat1 beam 1 95.30 93.10 90.40 85.74 62.10 56.60
pat1 beam 2 92.17 88.90 80.12 73.32 57.97 38.30
pat1 beam 3 98.02 95.76 92.98 88.18 63.87 58.22
pat1 beam 4 98.84 96.56 93.76 88.92 64.41 58.70
pat1 beam 5 99.69 97.39 94.56 89.68 64.96 59.21
pat2 beam 1 97.37 95.12 92.36 87.60 63.45 57.83
pat2 beam 2 98.78 96.50 93.70 88.87 64.37 58.67
pat2 beam 3 99.33 97.04 94.22 89.36 64.73 58.99
pat2 beam 4 97.11 94.87 92.12 87.36 63.28 57.67
pat2 beam 5 97.08 94.84 92.09 87.34 63.26 57.66
pat3 beam 1 99.97 97.66 94.83 89.94 65.14 59.37
pat3 beam 2 97.55 95.30 92.53 87.76 63.57 57.94
pat3 beam 3 96.81 94.58 91.83 87.09 63.08 57.50
pat3 beam 4 97.88 95.62 92.85 88.06 63.78 58.13
pat3 beam 5 99.77 97.47 94.64 89.76 65.01 59.25
pat3 beam 6 99.25 96.96 94.15 89.29 64.67 58.95
% of beams
with γ>95% 93.75 68.75 0.00 0.00 0.00 0.00
Table 8.3: Percentage of points passing the gamma test with various tolerances
for dose. TPS calculation of dose to EPID.
An apparent systematic difference between TPS dose and EPID dose was
investigated by extracting the central voxels from the TPS dose and the EPID
dose. The percentage difference between the average doses in the central 5x5
EPID pixels equivalent to an area of 3.92mm x 3.92mm and the central 4mm x
4mm of the TPS dose were calculated and tabulated in table 8.4.
The differences of table 8.4 were then averaged to produce a correction factor
of 3.67% which was then uniformly applied to the TPS calculated doses. The
gamma analysis was then repeated and tabulated in 8.5. As can be seen excellent
figures are returned by the application of this empirically derived correction
factor.
8.4.2.3 Discussion
There is a relatively poor agreement between measured and calculated results
using this technique. The reason for this is not clear but Cuﬄin et al. (2010)
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Patient fract 1 fract 2 fract 3 fract 4
pat1 beam 1 -3.72% -3.47% -2.37% -4.36%
pat1 beam 2 -4.39% -2.77% -3.94% -4.14%
pat1 beam 3 -3.86% -3.41% -4.13% -3.59%
pat1 beam 4 -2.78% -3.72% -3.95% -3.27%
pat1 beam 5 -4.60% -2.35% -4.53% -3.22%
pat2 beam 1 -3.24% -2.57% -3.46% -4.12%
pat2 beam 2 -2.67% -4.03% -4.46% -3.62%
pat2 beam 3 -4.04% -3.81% -4.17% -3.84%
pat2 beam 4 -3.72% -3.84% -3.95% -4.97%
pat2 beam 5 -4.60% -4.46% -4.56% -4.37%
pat3 beam 1 -3.16% -3.77% -3.21% -4.27%
pat3 beam 2 -3.02% 3.66% -2.96% -4.61%
pat3 beam 3 -3.05% -3.41% -3.88% -3.71%
pat3 beam 4 -4.82% -3.75% -3.13% -3.90%
pat3 beam 5 -4.87% -2.53% -3.03% -3.15%
pat3 beam 6 -3.57% -3.87% -2.59% -2.54%
Table 8.4: Percentage differences between doses calculated at the centre of the
EPID and by the TPS and those measured with the EPID.
showed with their investigation that the pencil beam algorithm of OMP was the
source of similar discrepancies. The imaging panel is within the build up region
of the detector and, as such, a systematic difference of a few percent could be
considered a better agreement than would be expected in this situation as the
build up effect is not modelled in a pencil beam or type-a algorithm.
An improvement in the agreement between TPS dose and EPID dose could be
explored by the use of a more complex algorithm within the TPS. Unfortunately,
however, the iPLAN TPS does not have a type b or collapsed cone type algorithm
and VCC have not currently purchased the iPLAN Voxel Monte Carlo (VMC)
option, which could be used to explore this discrepancy further. The fact that the
full MC simulations agree with the EPID measurements and the doses calculated
within the patient in chapter 6 agree between the TPS and MC would also
tend to point to the fact that this discrepancy is due to the weaknesses in the
calculation algorithm of the TPS. Other treatment planning systems available
within the department do not contain models of the µMLC, which is solely used
for stereotactic radiotherapy. Therefore, it was not possible to change the TPS
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Patient 6%/5mm 5%/5mm 4%/4mm 3%/3mm 2%/2mm 1%/1mm
pat1 beam 1 100.00 100.00 100.00 100.00 85.54 58.51
pat1 beam 2 96.8 95.70 94.90 93.82 77.01 49.51
pat1 beam 3 100.00 100.00 100.00 100.00 85.93 58.77
pat1 beam 4 100.00 100.00 100.00 100.00 86.31 59.03
pat1 beam 5 100.00 100.00 100.00 100.00 86.30 59.03
pat2 beam 1 100.00 100.00 100.00 100.00 87.04 59.53
pat2 beam 2 100.00 99.82 99.82 99.82 85.39 58.40
pat2 beam 3 100.00 100.00 100.00 100.00 85.56 58.52
pat2 beam 4 100.00 100.00 100.00 100.00 87.63 59.94
pat2 beam 5 100.00 100.00 100.00 100.00 88.75 60.70
pat3 beam 1 100.00 100.00 100.00 100.00 86.68 59.28
pat3 beam 2 100.00 100.00 100.00 100.00 86.58 59.22
pat3 beam 3 100.00 99.54 99.54 99.54 85.15 58.24
pat3 beam 4 100.00 95.65 95.65 95.65 81.82 55.96
pat3 beam 5 100.00 95.79 95.79 95.79 81.94 56.04
pat3 beam 6 100.00 93.87 93.70 93.47 79.95 54.69
% of beams
with γ>95% 100.00 93.75 87.50 87.50 0.00 0.00
Table 8.5: Percentage of points passing the gamma test with various tolerances
for dose. TPS EPID calculations with correction factor applied.
to further confirm this conclusion.
The use of a correction factor to adjust the TPS dose may be of some promise
in resolving this discrepancy and, when applied, only two beams fail to have 95%
of points passing the 3% / 3mm gamma comparison. Figure 8.10 also shows that
the beam with an apparent positioning error has also been identified, which is
reflected in the visual examination of the gamma map and in the reported average
gamma figures tabulated.
A plot of varying distance to agreement figures in the gamma comparison at
a discrepancy of 5% (prior to the correction factor being applied) is shown in
table 8.6. Unlike the MC comparisons only 19% of beams pass the 5% / 3mm
criteria. This would suggest that the empirically derived correction factor and
the adjusted gamma criteria would need to be applied to achieve good agreement
between the data sets.
This method is also considerably faster than the MC method in that a
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Patient 5%/5mm 5%/4mm 5%/3mm 5%/2mm
pat1 beam 1 93.10 90.63 89.81 88.99
pat1 beam 2 88.90 86.50 85.70 84.90
pat1 beam 3 95.76 92.73 91.72 90.70
pat1 beam 4 96.56 95.54 95.21 94.87
pat1 beam 5 97.39 94.24 93.19 92.14
pat2 beam 1 95.12 91.27 89.99 88.71
pat2 beam 2 96.50 96.40 96.37 96.34
pat2 beam 3 97.04 92.02 90.35 88.67
pat2 beam 4 94.87 90.05 88.44 86.84
pat2 beam 5 94.84 90.65 89.26 87.86
pat3 beam 1 97.66 94.89 93.96 93.04
pat3 beam 2 95.30 94.80 94.64 94.47
pat3 beam 3 94.58 89.66 88.01 86.37
pat3 beam 4 95.62 94.46 94.08 93.69
pat3 beam 5 97.47 94.80 93.91 93.02
pat3 beam 6 96.96 96.88 96.86 96.83
% of beams
with γ>95% 68.75 18.75 18.75 12.50
Table 8.6: Percentage of points passing the gamma test with varying dta
tolerances for a dose difference criterion of 5% for the TPS calculation method.
comparison dose map can be produced within a few hours of the plan being
completed with only the scans containing the EPID needing generation. The
calculation time of the iPLAN system prior to dose export is instantaneous.
8.4.3 Path length approximation
For an in-vivo measurement, the intention is to confirm the validity of the overall
dose delivered rather than the fluence across the beam. Another approach to
solve the problems associated with the previous methods is to predict the doses
based on a simple measurement obtained from the patient scans to obtain an
expected dose, at a single point, and compare that to the dose measured by the
EPID during treatment.
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8.4.3.1 Theory
For the majority of cranial stereotactic radiotherapy and radiosurgery cases,
EPID dosimetry at the centre of the field, can be greatly simplified due to the
fact that
• The patient composition is fairly homogeneous in this region
• The thickness of sites treated being within the cranium is relatively
constant at around 150 - 250mm
• The range of field sizes is fairly small and is limited by the µMLC to be less
than 100mm and is limited locally (due to dosimetric issues) to be greater
than an equivalent circle of 25mm diameter
• All fields are generally positioned around the isocentre and therefore ‘off
axis’ and ‘back scatter’ factors, arising as a consequence of the effects of
the support arm changing position relative to the fields do not need to be
taken into account
Consequently, if there is no couch rotation involved, the imager may be placed
in almost the same position on a daily basis allowing a set of dosimetric factors
to be measured in this situation, closely analogous to the treatment situation.
To derive dosimetric quantities in this situation, a dose calculation formalism
analogous to a TPR (Khan, 2010), based approach is applied. In standard
conditions, the dose at the isocentre of a phantom can be calculated by
rearranging equation 2.3 to give:
Dose = MU × fcal × TPR(fs, depth)× Sc(cs)× Sp(fs)× fISL (8.5)
where
• Dose is the dose at the isocentre
• fcal is the dose delivered per monitor unit under standard conditions
• TPR is the tissue phantom ratio for a field size fs at depth
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• Sc is the collimator scatter factor for a collimator setting cs
• Sp is the phantom scatter factor for a field size of fs
• fISL is the inverse square law factor for points at non isocentric distances.
All of these quantities can be approximated by measurements made with the
EPID. In order to do this, the machine and EPID were set up according to figure
8.11(a) with layers of a water equivalent material, WTe (McEwen and DuSautoy,
2003), placed on the treatment couch with the isocentre placed in the centre of
the slab.
In a conventional dose calculation, a machine calibration factor would be
calculated at the isocentre, at a depth within the phantom, such as point B
in figure 8.11(b) with a significant amount of phantom material beyond the
measurement point to provide sufficient back scatter. However, in this situation,
the exit dose at point C is of more interest than that at the centre of the phantom.
A calibration curve, similar to that in figure 8.3, was derived, by positioning
the isocentre of the machine at point C, and irradiating a 100mm slab of solid
water with a 100mm x 100mm square field defined by the µMLC and standard
collimators. A series of known doses, found by adjusting the number of MU
according to standard tables, were then used to irradiate the block, with these
doses measured by the EPID. A relationship between calculated dose and EPID
signal could then be derived with the effects of missing back scatter at point C
being taken into account by this calibration procedure, to give an EPID signal
to dose conversion factor fepiddose .
Analogues of TPRs were then measured by keeping the isocentre at point C
on the stack of solid water and delivering a fixed number of monitor units whilst
varying the thickness of solid water, the length of line AB in figure 8.11(b), with
the doses again acquired using the EPID. These are shown in figure 8.12 such that
a relationship between EPID dose and phantom thickness can be determined.
The expected dose at the EPID from a beam of EwwF field size, from MU
monitor units passing through a patient of radiological depth drad can therefore
be determined by:
8.4. The Application of EPID-based Exit Dosimetry in Stereotactic
Radiotherapy 218
(a) Position of WTe
(b) Points within WTe)
Figure 8.11: Experimental set up for acquisition of data for path length method.
Doseepid = fepiddose × TPRepid(EwwF, drad)× fEwwF × ISL(dgeom) (8.6)
where
• Doseepid is the epid dose expected at the imager plane
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• fepiddose is the epid signal to dose conversion factor
• TPRepid is the Tissue Phantom Ratio measured with the EPID for a field
size of equivalent window width EwwF and a radiological depth drad
• fEwwF is the field size factor
• ISL is the inverse square law factor based on the geometric distance dgeom
between the isocentre and the position of the exit plane in the clinical
situation.
The field size factor ffieldsize is analogous to a total scatter factor Scp, which
holds true for calculations at the isocentre but is not the case in this situation.
However, the screen field size factors, illustrated in figure 8.4(a) are used in this
situation and simulated with this beam arrangement. Therefore, these effects are
taken into account. As the support arm is held in the same place for both the
acquisition of data and during measurement the effects of differing amounts of
back scatter into the sensitive volume of the EPID as a function of the position
of the support arm can also be neglected.
8.4.3.2 Methods
For each beam, from each fraction, the expected doses were calculated using
equation 8.6 and compared with that measured using the EPID. The radiological
and geometric depths were obtained by ray tracing the central axis through the
MC phantoms generated for the MC transport investigation discussed previously.
8.4.3.3 Results
The results of the calculations for each beam and each fraction are tabulated in
table 8.7. There appears to be a random variation between the dose expected
and that measured at the EPID, possibly as a result of the approximation of the
collimator and phantom scatter factors to a single factor based on the EwwF
and uncertainties in the calculation of geometric depth and other factors used in
the calculation
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Figure 8.12: TPR equivalent measured with EPID (linear and natural logarithm
scales for relative dose).
8.4.3.4 Discussion
This method shows relatively good agreement at a single point at the imager
plane. The greatest discrepancy between measured and calculated doses is 3.61%,
which is of a similar magnitude to the accuracy achieved using other methods
such as in-vivo diodes and TLDs. The time taken to calculate these doses was
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Patient fract 1 fract 2 fract 3 fract 4
pat1 beam 1 2.15% 2.44% 1.86% 2.15%
pat1 beam 2 -2.73% -2.22% -2.53% -2.53%
pat1 beam 3 -1.74% -1.36% -1.20% -1.43%
pat1 beam 4 -0.44% -0.30% -0.85% -0.56%
pat1 beam 5 2.33% 2.98% 0.54% 1.91%
pat2 beam 1 -0.76% -2.21% -2.13% -1.14%
pat2 beam 2 -0.61% -0.30% -0.25% -1.30%
pat2 beam 3 -0.24% -1.25% -0.03% -1.25%
pat2 beam 4 -1.10% 0.52% -1.02% 0.85%
pat2 beam 5 -1.06% -1.72% -1.24% 0.66%
pat3 beam 1 -2.11% -3.30% -0.03% -1.28%
pat3 beam 2 2.51% 2.38% 2.26% 3.61%
pat3 beam 3 -0.55% -0.26% -0.83% 1.30%
pat3 beam 4 -1.45% 0.65% -2.01% -0.92%
pat3 beam 5 1.24% 0.92% 2.48% 1.55%
pat3 beam 6 0.35% 0.72% 0.77% 1.60%
Table 8.7: Percentage differences between predicted and measured values using
path length approximation model - no back scatter correction and assumes Scp
is unchanged at exit plane.
small once the MC phantoms had been generated and of the order of less than
two minutes per plan. However, were this to be used as the sole method of
in-vivo dosimetry, a method of radiological depth calculation would need to be
developed to enable fast calculation. This information may be fairly readily
obtained by placing calculation points on the patient anatomy using the TPS,
or by developing software to automatically calculate the radiological depth from
the CT planning scans, but this has yet to be investigated and developed.
8.4.4 Discussion
All three methods investigated have shown that they are capable of providing
assurance that the delivered doses are within acceptable limits or identifying
those outside tolerance which require further investigation. A summary of their
performance is shown in table 8.8.
The full Monte Carlo transport approach, although the most accurate
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technique is, unsurprisingly, the most time consuming and resource intensive. It
may be argued that the time required to simulate the exact clinical situation is
not warranted as the level of validation required is of a much lower precision than
that offered by the technique. It does, however, offer a completely independent
dose calculation of doses at the imager plane and may be of value in particularly
complex cases or in the introduction of new technique into a department. As a full
transport of incident radiation through the patient is involved from a complete
model of the accelerator head, a high degree of confidence can be placed in the
accuracy of the system for difficult cases, such as those involving heterogeneous
tissue e.g. for stereotactic techniques in the lung and other sites. Using an
appropriate set of gamma criteria, the approach can identify delivery errors to
within realistic tolerances.
The TPS technique has the advantage of a fast calculation of the predicted
doses but requires an empirically derived correction factor to get the measured
doses to within expected limits. In many respects, the application of such a factor
is counter intuitive to the concept of in vivo dosimetry as the application of a
factor derived from the inability of the TPS to calculate doses correctly in this
situation may cancel out any other discrepancies in dose calculation introduced
by the TPS. The MC technique has shown, for these three patients at least, that
the miscalculation is associated with the weaknesses in the calculation algorithm
in calculating doses in a relatively complex situation involving large amounts of
inhomogeneity. Although this technique may be usable for a type-a algorithm
with a correction factor applied, there appears to be little advantage in adopting
this system over the path length approximation until these dosimetric errors are
investigated further and a a solution without the need for an empirical correction
factor found. The use of a type-b or VMC type calculation may overcome these
difficulties, and for tumour sites outside the cranium, where still further areas of
inhomogeneity exist, the method needs further investigation.
The path length approximation technique provides the advantage of a fast
calculation and good agreement between the doses measured with the EPID
and those predicted by the technique. Despite suffering from the disadvantage
of offering only a single point calculation, for fixed, small unmodulated fields it
may be argued that this is the most appropriate technique for cranial stereotactic
radiotherapy and radiosurgery.
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With the increasing interest in extra-cranial stereotactic radiotherapy an
interesting piece of further work would be to extend this investigation into areas
of high tissue inhomogeneity such as those found in the lung to determine if the
same behaviour and agreement between predicted doses and those measured at
the imager plane are observed.
MC Transport TPS calculation Path length
Accuracy Excellent (<3%) Fair (<5%) Good (<4%)
Preparation Speed 2 hours 2 hours 10 Minutes
Calculation Time 48 hours 2 Minutes Instant
Independence Excellent Fair Good
Information Excellent (Full beam) Excellent (Full beam) Fair (Point dose)
Table 8.8: Comparison of EPID dose prediction methods.
..
8.5 Conclusions
This work has shown that the three methods investigated can be used, with
varying degrees of accuracy to validate the delivered doses to a patient for cranial
stereotactic radiotherapy. A gamma comparison criteria of 95% points passing
5% / 3mm for the MC transport would appear to be an appropriate measure for
determining the accuracy of dose delivery in this situation.The TPS calculation is
less successful, probably as a consequence of the calculation algorithm, which may
be solved by the use of more advanced calculation algorithms or the acceptance
of less rigorous gamma criteria. For the cases considered 93.8% of beams passed
a gamma criteria of 6% / 6mm. The path length approximation confirmed doses
were correct on the central axis to within 3.6% and could be used as a check of
correct dose delivery to within a similar tolerance.
Monte Carlo methods have enabled a solution to be derived using a full MC
transport of radiation through the patient and also in the derivation of ‘water to
screen’ correction factors.
Chapter 9
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9.1 Conclusions
The work has concentrated on the application of Monte Carlo dose calculation
methods in stereotactic radiotherapy, primarily within the cranium, but with
some investigations into the application of MC methods in extra-cranial
stereotaxy in inhomogeneous media, such as that found in the lung.
In Chapter 4, a model of the accelerator and the BrainLAB µMLC was
developed and shown to have very good agreement between experimental
measurements and simulations. As with the rest of this study, the use of
high performance computing techniques using Condor and the RTGrid allowed
detailed tuning of the model to arrive at parameters which could be used with
confidence in subsequent parts of the work. A model of the µMLC was developed
which modelled the exact geometry of the device, enabling rapid (compared
to some approximations of other authors) and accurate simulations of doses
delivered by the device. The development of this component module was the
largest aspect of the work and it would be interesting to compare with the results
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of Kairn et al. (2010) who showed excellent agreement between measurement and
simulation using existing component modules.
The exact geometry within the BLMLC component module did however
provide confidence that the effects of collimator design on the output from
small fields would be modelled exactly, which was the basis for the study in
Chapter 5. In this chapter the performance of several detectors was examined
in the measurement of relative and absolute doses and compared to those
simulated using BLMLC and a model of the accelerator. Correction factors for
volume averaging and detector composition were derived which could be applied
profitably within the clinic. More importantly however, these studies have helped
define the circumstances, in terms of field size, in which the measurements
made by the detectors could be used with confidence. Locally at VCC this has
confirmed our current practice of field size limitations (perhaps even suggesting
that we have been too cautious in setting field size limits), and provides a secure
platform to implement smaller fields if required.
Further clinical implications of the model were discussed in Chapter 6 in
which a system for routine verification of plans calculated using the BrainLAB
iPLAN system was developed. Excellent agreement was achieved between the
doses calculated by the TPS and using the MC system, giving confidence in the
validity of the dosimetric performance of the TPS. Dose calculations in volumes
with a high degree of tissue homogeneity are not troublesome and with the
exception of field size limitations should not unduly cause problems for a pencil
beam or type-a calculation algorithm. It could be argued therefore, that such a
system is unwarranted for such treatments but there are likely to be occasions
where treatments are required in areas of high tissue heterogeneity (such as found
just inferiorly to the brain) where the MC method can add to the validation of
the TPS calculation. Similarly, when small fields are used, the system may be of
use as is the case when new beam data or calculation algorithms are introduced
into the department where this system can provide a completely independent
calculation for comparison.
In Chapter 7 the situation of extra cranial stereotactic treatments in the lung
or other heterogeneous media was examined. Using the MC simulations enabled
a fine dose grid to be calculated and comparisons made against the dose produced
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by a TPS. From this work it was shown that at least a type-b algorithm should
be used in calculation of doses to the lung, although the requirement for this may
reduce as the number of beams is increased. It was shown that beyond three
beams there is little advantage in the use of additional beams to overcome the
surface effects of such treatments but that the image and calculation resolution
may be significant in properly modelling such situations.
Chapter 8 dealt with the subject of dosimetry using Electronic Portal
Imaging Devices (EPIDs). Three methods were compared ranging from a
full MC simulation to a simple path length correction. All of the methods
investigated showed some promise as a routine system. However, whereas the
MC solution had limitations associated with the time required to set up and
run the simulations, and the path length approximation has a weakness of only
considering a single point, the TPS calculation relies on an empirically derived
correction factor, based on previous data to enable a satisfactory result. The work
has shown however that EPID based transit dosimetry can be used in the routine
verification of treatment delivery of stereotactic radiotherapy and radiosurgery.
The application of MC methods was able to realise one method and facilitate
the other two, by producing water to imager, and field size correction factors.
9.2 Further Work
There are several areas investigated in this study, which open up possibilities for
further work. A comparison of the models of the µMLC produced in this study
with those of Belec et al. (2005) and Kairn et al. (2010) would be an interesting
study and the limitations of the approximations made in the less exact models
compared with that of BLMLC.
For the small field investigation a more exact model of the diodes would
be an interesting study to determine, in more detail the effects of the material
manufacture on dose measurement in various conditions. This may enable the
output data to converge further on the MC simulations.
Both the plan verification and the EPID based dosimetry sections, have clear
uses in extra cranial stereotactic radiotherapy. In these situations of greater
uncertainty in the TPS dose calculation the MC approach may be used to
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independently validate the TPS calculated dose prior to treatment. On treatment
the extension of the EPID based work may provide a valuable addition to the
tools available to verify that doses have been delivered correctly. However, due
to the complexity of the clinical situation, certainly it would be expected that
the path length approximation method and the TPS calculation method would
require further investigation to determine their feasibility. The MC method
should be applicable in this situation. As has been shown by Cuﬄin et al. (2010) a
type-b algorithm is necessary for good agreements of the TPS or similar methods
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Appendix - Source Code of BLMLC subroutines and macros








"   Revision 1.4 last edited  2001/06/29 21:43:27
"   Last changed by bwalters and currently locked by 
"     started from BLMLC_cm.mortran  (SID 1.8 last edited 00/12/11)"
%C80
" ***********************************************************************"
"                           BLMLC_cm.mortran                           "
" ***********************************************************************"
"                                                                        "
"                               SUMMARY                                  "
"                               =======                                  "
"    A Component module to be used in conjunction with OMEGA/BEAM        "
"    for Monte Carlo simulations of photon and electron beams (used in   "
"    radiotherapy)transported through a BrainLAB M3 Multileaf   " 
"    Collimator system. This CM takes into account the multiple          "
"    tongue and groove geometry and offers a choice of divergent or      "
"    rounded leaf ends.      "
"    It also accounts for the leaf driving screw hole, tips and support  "
"    railings explicitly.  "
"    
"  M3s vary depending on the accelerator to which they are attached    "
"    To simplify this, distances are hard wired into the code rather     "
"    than have a very complicated input file.  "
"  "
" Information from BrainLAB on the above will be required          "
"       This CM was originally written by                                "
"                                                                        "
"             Ajay Kapur, Stanford University                            "
"             Charlie Ma, Stanford University                            "
"             Room A0-42                                                 " 
"             Division of Radiation Physics                              "
"             Department of Radiation Oncology                           "
"             Stanford University                                        "
"             300 Pasteur Drive                                          "
"             Stanford, CA 94305                                         "
"             Tel: (650) 498-6378                                        "
"             FAX: (650) 498-4015                                        "
"             Email: kapur@reyes.stanford.edu                            "
"                                                                        "
"      extensively reworked by                                  "
"                Blake Walters, NRC Ottawa                               "
"               bwalters@irs.phy.nrc.ca 
"
" More extensive reworking to account for BrainLAB M3  "
"
"                                 "
"     "
"         -------------------------------------------------------        "
-1-
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"         Velindre Cancer Centre                          "   
"         Files needed:                                                  "
"         1. BLMLC_cm.mortran                                            "
"         2. BLMLC_cm.macros                                             
"                                          "




"                             *****************               ""toc:
"                             *               *               ""toc:
"                             *   BLMLC     *               ""toc:
"                             *               *               ""toc:







"                          GENERAL DESCRIPTION
"                          *******************
"
"   This set of routines is used in conjunction with BEAM.MORTRAN to 
"   simulate one component module of a clinical linear accelerator:
"
"   This component module can be added to the simulation by including these
"   routines in the MORTRAN file BEAM_CM.MORTRAN and including the MORTRAN 
"   replacement macros associated with this component module in the file
"   BEAM_COMMON.MORTRAN.  The order of the component modules in either of
"   these files is unimportant.  To explicitly include this component module 
"   the simulation it must be included in the $CM_LIST replacement statement.  
"   The component modules in this list are stacked sequentially for the 
"   simulation, one on top of the other, and must not overlap.
"
"   1>. This module can be used as single or double focus multileaf
"       collimators.
"   2>. Used as x or y direction parallel to the leaf. 
"   3>. it can have max 100 leaf pair which are equal width, symmetrical 
"       arranged with y axis or x axis. For more than 26 leaf pairs some work will be required
"   4>. Each leaf has two separate parts which can be moved in the leaf
"       direction independently.
"   5>. Rules to obey:
"           i.  You must enter your MLC dimensions in the YREG and ZREG sections
"
" Similar in approach to DYNVMLC but added lots of special cases for the M3
" You MUST edit the ZREG and YREG for your MLC
;
"I>
"I> Geometry of BLMLC:
"I> **********************
"I>                                 top view
"I>                                         
"I>            ------------------------------------------------
"I>                                |           
"I>            ------------------------------------------------
-2-
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"I>                           |           | 
"I>           -----------------           ---------------------
"I>                      |        opening     | 
"I>           ---------------     (IR=1)      -----------------
"I>                         |                 |
"I>           ------leaves--------      -----------------------
"I>                 (IR=2)      |     |
"I>           --------------------------------------------------
"I>                                  |
"I>           --------------------------------------------------
"I>   
; 
"I>       cross-section through leaves taken perpendicular to leaves 
"I>
"I>                               * ZFOCUS(1)
"I>                           .   .   .   
"I>                       .    . .|. .    .     
"I> - - - - - - -     .     .   . | .   .     .
"I> airgap(IR=3)  .      .     .  |  .     .      .     
"I>     -------- ------ ------ ---|--- ------ ------ ---------
"I>   leaf     / leaf / leaf /leaf|leaf\ leaf  \ leaf \  leaf 
"I>   1    /    2  /     3  /  4  | 5   \  6     \  7    \  8 
"I>    /        /          /      |      \          \        \ 
"I>    -------- ---------- -------|------- ---------- --------- -
"I>                            Z-axis        
;
"I>            cross-section through leaf taken || to leaf
"I>             I)  FOR FOCUSED DIVERGENT LEAF ENDS :
"I>
"I>                               * ZFOCUS(2) 
"I>  - - - - - - - - - - - -    . | . 
"I>  airgap(IR=4)              .  |  .
"I>     ----------------------    |    ------------------------
"I>                          /    |    \       
"I>        Leaf B  (-ve)    /     |     \    Leaf A (+ve)      
"I>                        /      |      \     
"I>    -------------------        |        ----------------------
"I>                            Z-axis                                      
"I>              II)  FOR ROUNDED LEAF ENDS :
"I>
"I>                               * 
"I>  - - - - - - - - - - - -      |  
"I>  airgap(IR=4)                 |   
"I>     -------------             |              --------------
"I>      --------\     \          |            /
"I>    hole IR=3 | A   |          |           |<------Leafradius     
"I>     ---------/     /          |            \    B
"I>     -------------             |              --------------
"I>                            Z-axis
;
"I>   IR is the region number within the CM.  There are three local regions
"I>   shown above.
"I>
"I>
"I>            ------------------------------------------------------
"I>            |             Region            | Description         |
-3-
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"I>            |-------------------------------|---------------------|
"I>            |  absolute       | local       |                     |
"I>            |-----------------|-------------|                     |
"I>            |                 |             |                     |
"I>            |IRSTART_MLC      | IR_MLC      |  as shown in above  |
"I>            |  +IR_MLC-1      |             |    (1 to 4)         |
"I>            |                 |             |                     |
"I>            |                 |             |                     |





"                      INPUT_$BLMLC
"                      ISUMRY_$BLMLC
"                      HOWFAR_$BLMLC
"                      WHERE_AM_I_$BLMLC
"
"       Called from BEAM's subroutines:
"                      INPUT
"                      ISUMRY
"                      HOWFAR
"
"       Subroutines called:  




"                             RESTRICTIONS ON USE/KNOWN BUGS





"                               INPUT FROM UNIT 5 






"*************************  ERROR CONDITIONS  ****************************
"*************************************************************************
"
"                              SIMULATION PARAMETERS









%E "Start of subroutine HOWFAR_$BLMLC (Rev 1.4)"
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"************************************************************************
"********************Component Module BLMLC *****************************
"************************************************************************
"
"                          Subroutine HOWFAR_$BLMLC
"                          ***********************
"
" HOWFAR routine for stacked planar media. 
"
" Determine if current region number is within component module BLMLC,
" evaluate DIST, distance to region boundary along current trajectory. 
" USTEP must not exceed DIST.
"
"   There are N_$BLMLC local regions + an air gap (if present):
"
"  local              absolute                                   description
"-------------- --------------------------------------------- ---------------
"IR_$BLMLC IR_start_CM(ICM_$BLMLC)+IR_$BLMLC-1 exclude front air gap
"-------------- --------------------------------------------- ---------------
"   Geometrical co-ordinates, as set in INPUT_$BLMLC are:
"
"   ZFRONT_$BLMLC     front of CM (upstream surface, air region)
"   ZMIN_$BLMLC       front of cone 
"   ZBACK_$BLMLC      back of cone







"V>{p1} the value to compare with ustep
"V> if {p1}+1.0e-5 < ustep shift it, otherwise no shift
;
REPLACE {$GEO_SHIFT_1_(#)} WITH {
  ;IF({P1}~=0.00 ) [
    IF({P1}+1.0E-5< USTEP) [{P1}={P1}+1.0E-5;]  
   ]










   COUNT,  
   IRL,        "T>local region number (absolute), required by HOWNEAR macro
   I, J,        "T>loop control
   REGION_$BLMLC,     "T>region number within CM (relative)
   NEWREGION_$BLMLC,     "T>region number within CM (relative)
   NX,NY,NZ,        "T> Subindices for region
-5-
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   OUTOFCMFLAG,     "T> Flag to denote particle out of CM
   OUTOFMLCFLAG,    "T> Flag to denote particle out of MLC 
   LEAFIS,          "T> Leaf number
   LHS,RHS,     "T> Macro variables to find + and - closest boundary index 
   ZLHS,ZRHS,
   YLHS,YRHS,LEAF_CHWITH,LEAF_DE, "for leaf boundary indicees
   IDIR,        "T> direction sign, used in call to where_am_i
   XREG_MIN, XREG_MAX,
   YREG_MIN, YREG_MAX,
   ZREG_MIN, ZREG_MAX, "Indicees of end boundary regions"
   YREG_STRT,
   LEAF_TOP, LEAF_MIDDLE, LEAF_BOTTOM;
DOUBLE PRECISION
   DIST,      "T>Distance to z boundary along current particle trajectory   
   UVL(2),    "T>temporary variable
   TRYY1,TRYY2,
   XoN,XoP,    "T> Negative and Positive leaf centers (rounded leaf)
   Zo,         "T> z position of rounded leaf tip
   XP,XN,YP,YN,ZP,ZN,    "T>+ and - distances in x,y, z directions
   XDIST,YDIST,ZDIST,    "T> x,y, Z distances to nearest boundaries 
   DIST1,DIST2,DIST3,    "T> Variables to control particle propagation
   STEP2,                "T>  "
   TLHS,TRHS,            "T> temporary macro variables like lhs,rhs
   DISCRIMINANT,         "T> Variable for rounded leaf
   TEMP,TEMP1, TEMP2, TEMP3, TEMP4, TEMP5, HOLE,
   STEP_UNIT,
   XYL(2),     "T> rearranged x and y coordinates
   XYFL(2),
   Z_LEAF_BOTTOM,
   Z_LEAF_TOP,
   XL, XR,
   ZFL;
" prepare the local variables "
"============================="
IRL = IR(NP); "local region number (absolute)"                     
IR_$BLMLC = IRL - IRSTART_$BLMLC + 1;   "rel. local region number" 
IF(ORIENT_$BLMLC=1) [












"Initialise NX,NY,NZ to try and avoid segmentation fault"
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NY=0;
NZ=0;













" Determine if current region number is within component module ,if so
" evaluate DIST, distance to region boundary along current trajectory. 
" USTEP must not exceed DIST.
"
" the following block double check:
"=================================
"      1. the particle is out of the CM or regions in z direction
"      2.                        the regions in xy directions
"     if so reset the ir #, and print out the warning message.
"comment: this block is not time consumming, can be kept in the final version
"=======
"
"  now do the air gap check if existed.
"=====================================
"
IF(N_GAP_$BLMLC=1 & IR_$BLMLC=4 ) ["Check the air gap first"
IF(W(NP)>0.0) ["Particle going forward" 
DIST = (ZMIN_$BLMLC - Z(NP))/W(NP); "distance to front of CM"
IF(DIST <= 0.0) [ 
USTEP=0.0;
$BLMLC_FIND(IR_$BLMLC, 0.0);








] "double check if a particle is out of the AIR GAP"
]
ELSEIF(W(NP)<0.0) [ "particle going backward"
DIST = (ZFRONT_$BLMLC - Z(NP))/W(NP); "distance to front of CM"
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ELSEIF(IR_$BLMLC=1 | IR_$BLMLC=2 | IR_$BLMLC=3) [  
IF(W(NP) > 0.0) ["particle going forward"







IF(DIST <=0.0) [   
USTEP=1.E-16;"ensures call to AUSGAB on leaving CM"
CALL WHERE_AM_I(ICM_$BLMLC,1);
RETURN;
] "double check if a particle is out of the CM"
]
ELSEIF(W(NP) < 0.0) [ "particle going backward"   







IF(DIST <= 0.0) [
USTEP=0.0;













]  " for w(np)=0.0 case"
]  
" end of z direction check
"=========================
$BLMLC_FIND(REGION_$BLMLC,0.0);
IF(REGION_$BLMLC=4) [ "Particle is in the air gap "
REGION_$BLMLC=IRSTART_$BLMLC-1+REGION_$BLMLC;
IF(W(NP) > 0.0)[


















] "end of particle going forward"
ELSEIF(W(NP) < 0.0) ["particle going backward"









] " end of going backward"
ELSE[
RETURN;
]   " W=0.0 CASE "
]" end of region 4"
IF(OUTOFMLCFLAG=1) [  
STEP2=STEP_UNIT;
TEMP1=(SURPARA1_$BLMLC(1,YREG_MIN)*(ZFL-ZFOCUS_$BLMLC(1))-XYFL(1));  




 TEMP1 = -1000.00 
]
TEMP2=(SURPARA1_$BLMLC(TOT_LEAF_$BLMLC,YREG_MAX)*









IF( TEMP1>=0 ) [
TEMP=MIN(TEMP,TEMP1);
]










C:\Documents and Settings\to121060\My Documents\My Dropbox\Phd\Thesis\images\Appndx\BLMLC_cmthes.mortran 25 March 2011 09:32
] 






CALL MINDISTANCE_$BLMLC(DIST1,LEAFIS,NX,NY,NZ,ZFL,XYFL,UVL);  
"$BLMLC_MINDISTANCE(DIST1);"















ELSEIF( (STEP_UNIT>DIST1) & (DIST1>=0)) [
REGION_$BLMLC=REGION_$BLMLC+IRSTART_$BLMLC-1;
LOOP[
DIST1=DIST1+1.0E-5; "we have to shift it regardless to avoid "







IF( OUTOFCMFLAG=1 ) [
EXIT;
]
ELSEIF( (NEWREGION_$BLMLC~=REGION_$BLMLC) | OUTOFMLCFLAG=1 )[     
USTEP = MIN(USTEP,DIST1); 











"trying to delete a close bracket her to get round error - 22/12/06"
"if it gets here, then it exited either because OUTOFCMFLAG=1"
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IF( OUTOFCMFLAG=0 ) [
$BLMLC_FIND(NEWREGION_$BLMLC,DIST1);
"still have to check if we have left the CM in case STEP_UNIT"


















]; "End of IF loop for step_unit>dist1
;
"   end of HOWFAR_$BLMLC





END; "End of subroutine HOWFAR_$BLMLC"
%E "Start of WHERE_AM_I_$BLMLC (Rev 1.4)"
"************************************************************************
"
"                          Subroutine WHERE_AM_I_$BLMLC
"                          ***************************
"
" WHERE_AM_I routine for a stacked right cylinder slabs.  
"
" WHERE_AM_I_$BLMLC determines the new region number when a particle  
" traverses a component module boundary.  The scheme is as follows:
"
"      Whenever a particle is to be transported to a component module 
"      boundary in HOWFAR, the subroutine WHERE_AM_I is called.  The
"      current component module and particle direction (backwards or
"      forwards) are transferred to WHERE_AM_I in the CALL statement.
"      WHERE_AM_I determines which component module the particle is
"      about to enter and calls the WHERE_AM_I_$BLMLC subroutine for
"      that component module, transferring the particle direction. 
"      The region number that the particle is about to enter is 
"      determined in WHERE_AM_I_$BLMLC from the knowledge of which
"      surface the particle is entering through (front if IDIR=1,
"      back if IDIR=-1) and the (X,Y) coordinates of the particle.











"T>TYPE DECLARATIONS FOR WHERE_AM_I_$BLMLC 
"T>**************************************
"T>
INTEGER NX,NY,NZ,   "T>Indices of subregions 
        I,J, 
        OUTOFCMFLAG, "Flags to denote out of CM and 
        OUTOFMLCFLAG, " MLC respectively
        LEAFIS,       " Leaf number
        IDIR,   "T>direction of particle, +1=forward, -1=backward
XREG_MIN, XREG_MAX,
YREG_MIN, YREG_MAX,YREG_STRT,
ZREG_MIN, ZREG_MAX; "Indicees of end boundary regions"
DOUBLE PRECISION   XYL(2), XYFL(2), ZFL, UVL(2), XoN, XoP, Zo, TEMP1, TEMP2,
                   TEMP3, TEMP4, HOLE, Z_LEAF_BOTTOM,Z_LEAF_TOP;























 "particle entering this CM through front face (upstream)"
   IF(N_GAP_$BLMLC = 0) [ "no air gap this CM"
















   ]         " end of the no air gap case"
   ELSE [ "this CM has an air gap at the front"
      IRNEW = IREND_$BLMLC;
        ]
]
ELSE [ "particle entering CM through back face (downstream)"
   $BLMLC_FIND(IR_$BLMLC, USTEP);
   IF(IR_$BLMLC=1)
     [IRNEW=IRSTART_$BLMLC; RETURN;]






END; "End of subroutine WHERE_AM_I_$BLMLC"
%E "Start of subroutine INPUT_$BLMLC (Rev 1.4)"
"************************************************************************* 
"                           Subroutine INPUT_$BLMLC
"                                                  
"*************************************************************************
"*************************************************************************
"  A CM input subroutine for a series of 2 or more slabs.
"
"  It must fill all parameters in COMMON/CMs/ associated with this CM.
"
"  Routine prints error messages on unit 6 for
"      format error on input
"      end of file hit
"      error in logic of input file
"
"  The format of the input is presented in the section INPUT FROM UNIT 5  







"  **************************************************************** "
"              TYPE DECLARATIONS FOR INPUT_$BLMLC 
"  **************************************************************** "
DOUBLE PRECISION  NEG_$BLMLC,     "T>Leaf B tip
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                  POS_$BLMLC,     "T>Leaf A Tip
                  TEMP1,
                  TEMP2;
INTEGER I,J,K,L,        "T>DO loop indices
        IRA,            "T>Absolute region number
        MED_FLAG,       "T>flag used by media-sort macro $MED_INPUT
        MED_INDEX,   "T>medium index, set after medium sort by $MED_INPUT
NUM_$BLMLC, "T>number of adjacent leaves with same opening coordinates
LEAFTYPE,     "T>temporary input variable for LEAFTYPE
MIN_INDEX,   "T>index of leaf with min. opening coordinate
MAX_INDEX,  "T>index of leaf with max. opening coordinate
XREG_MIN, XREG_MAX,
YREG_MIN, YREG_MAX,YREG_STRT,
ZREG_MIN, ZREG_MAX; "Indicees of end boundary regions"
" **************************************************************** "
"                 STEP I : INITIALIZE PARAMETERS
"                          =====================
 ICM_$BLMLC = ICM;
" **************************************************************** "














OUTPUT;(/' Next component is a BRAINLAB M3 type MLC'/' Title: ',$);
MINPUT ($BLMLC) TITLE_$BLMLC;(60A1);
          "MINPUT is a replacement macro with EOF and
          "ERR branching to :EOF_{P1}: and :ERR_{P1}:
OUTPUT TITLE_$BLMLC;(' ',60A1); 
            "OUTPUT is a replacement macro which writes to"
            "unit 5.  Used here for echo of user input"
"WRITE(IOUTLIST,'(60A1)') TITLE_$BLMLC; 
            "Unit 7 is temporary file of user input
OUTPUT;(/' Do you wish to plot some co ordinates out for debugging?',$);
MINPUT ($BLMLC) PLT_$BLMLC;(I3);





"II. CHOOSE THE BLMLC ORIENTATION "
"============================== "
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OUTPUT; (' Input leaf orientation (0=parallel to y, 1=parallel to x) and '/
         ' no. of groups of leaves with equal width on one line'/' :',$);
MINPUT ($BLMLC) ORIENT_$BLMLC, NGROUP_$BLMLC; (2I5);
OUTPUT ORIENT_$BLMLC,NGROUP_$BLMLC; (2I5/);
IF(ORIENT_$BLMLC~=1) [
      ORIENT_$BLMLC=0;
      OUTPUT;(/' Orientation defaults to 0.'/);
 ];
IF(NGROUP_$BLMLC<=0) [
      NGROUP_$BLMLC=1;
      OUTPUT;(/' No. of groups defaults to 1.'/);
 ];
WRITE(IOUTLIST,'(2I5)')ORIENT_$BLMLC,NGROUP_$BLMLC;
"III. DESIGNATE REGION NUMBERS "
"============================= "
N_$BLMLC = 3; 
           "Number of regions in this CM (excluding front air gap)
ICM_$BLMLC = ICM;      "CM index for this component module 
IRSTART_$BLMLC = IR_start_CM(ICM_$BLMLC); 
                      "Index of first region in this CM, 
                      "set by previous CM or in MAIN if ICM=1
IERR_GEOM(ICM_$BLMLC) = 0; "Geometry-checking flag, 0 if no error detected
"IV. GET DISTANCE FROM THE REFERENCE PLANE, z=0 "
"============================================== "
;





   IF(ICM_$BLMLC=1) [
      Z_min_CM(ICM_$BLMLC)=ZMIN_$BLMLC;
      OUTPUT ICM_$BLMLC, Z_min_CM(ICM_$BLMLC);
       (//' ***WARNING IN CM ',I4,' ($BLMLC):'/
           ' Z_min_CM(1)  > distance to front of MLC '/
           ' Z_min_CM(1) reset to ',F8.5,' cm'//);
      WRITE(IOUTLIST,
         ' (//'' ***WARNING IN CM '',I4,'' ($BLMLC):''/
          '' Z_min_CM(1)  > distance to front of collimator''/
          '' Z_min_CM(1) reset to '',F8.5,'' cm''//)')
          ICM_$BLMLC, Z_min_CM(ICM_$BLMLC);
     ]
    ELSE[
      OUTPUT ICM_$BLMLC;
       (//' ***** WARNING WARNING WARNING *****'/ 
          ' ***ERROR IN CM ',I4,' ($BLMLC):'/
          ' Overlaps with previous CM'/
          ' Error will be propagated'//);
      WRITE(IOUTLIST,
         ' (//'' ***WARNING IN CM '',I4,'' ($BLMLC):''/
          '' Overlaps with previous CM''//)')
          ICM_$BLMLC; 
      IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
     ]
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"              STEP TWO : GET BLMLC GEOMETRY INFORMATION 
"                         ============================
" ************************************************************** "
" I. THICKNESS OF LEAVES "
" ======================= "
;
OUTPUT; (' MLC Leaf thickness (cm):',$);
MINPUT ($BLMLC) ZTHICK_$BLMLC; (F15.0);
OUTPUT ZTHICK_$BLMLC;(F15.5, ' cm'/);
WRITE(IOUTLIST,'(F15.5)') ZTHICK_$BLMLC;
" Validate the user-input thickness "
IF(ZTHICK_$BLMLC<0.0) [
    OUTPUT ICM_$BLMLC;(//' ***ERROR IN CM ',I4,' ($BLMLC):'/
                          ' ZTHICK < 0.0'//);
    IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
 ];
ZMAX_$BLMLC = ZMIN_$BLMLC + ZTHICK_$BLMLC;
;
" Instead of the input for geometric parameters" 
"to be supplied in the input card"
" geometry will be hard wired in for now."
" If this routine is successful this should be" 
" removed and the user encouraged to enter geometry"
" via input card - Tony Millin Sept 06"
"   "











































































































































































































































































































































































































































































OUTPUT; (' set tot leaf to 26',$)
" III. START POSITION OF LEAVES"
" ============================="
;
OUTPUT; ('About to start entering leaf positions etc',$)
OUTPUT ZMIN_$BLMLC; (/' Input the starting X (ORIENT_$BLMLC=0) or '/
         ' Y (ORIENT_$BLMLC=1) position at z = ',F15.0, ' cm : ', $);
MINPUT ($BLMLC) START_$BLMLC; (F15.0);
OUTPUT START_$BLMLC; (F12.5);
WRITE(IOUTLIST,'(F15.8)') START_$BLMLC;
" Checking the validity of user-input"
IF(ABS(START_$BLMLC)-RMAX_CM(ICM_$BLMLC)>1.E-5) [
  OUTPUT ICM_$BLMLC;
   (//'***ERROR IN CM ',I4,' ($BLMLC)'/
   ' START POSITION EXCEEDS CM BOUNDARY'//);
   IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
 ];
"IV. INTER-LEAF AIR GAP "
"====================== "
OUTPUT; (/'Input the inter-leaf air gap(>=0.0) : ',$); 
  "leaf gap defined at ZMIN"
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      LEAFGAP_$BLMLC=0;
      OUTPUT ICM_$BLMLC;
         (//'***ERROR IN CM ',I4,' ($BLMLC)'/
         ' Inter-leaf air gap is negative - reset to 0   '//);
         IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
      ];
"V. TYPE OF LEAF ENDS - ROUNDED VS FLAT DIVERGENT "
"================================================ "
"THIS NEEDS REWRITING TO ACCOUNT FOR THREE REGIONS OF BRAINLAB MLC!"
"DO LATER .................................... 26/11/06"
"=================================================================="
OUTPUT; (/'Input the type of leaf end desired : only opt 1 supported ',/,
          '   0 --- Rounded leaf end or ',/
          '   1 --- Focused leaf end  ');
OUTPUT; ('Input your choice : ', $);
MINPUT ($BLMLC) ENDTYPE_$BLMLC; (I5);
WRITE(IOUTLIST, '(I5)') ENDTYPE_$BLMLC;
OUTPUT ENDTYPE_$BLMLC; (I5/);
"Leave rounded end code in for now as it may be needed - can't see why though"
IF(ENDTYPE_$BLMLC=1) [
OUTPUT; ('Input the angle of the upper part of leaves (rads) :',$);
MINPUT ($BLMLC) THETA_TOP_$BLMLC; (F15.0);
OUTPUT THETA_TOP_$BLMLC;(F12.5/);
OUTPUT; ('Input the angle of the lower part of leaves (rads) :',$);





ELSE  [ "Defaults to rounded ends "
   OUTPUT (ZTHICK_$BLMLC/2); 
          (' Input the radius >= ', F12.5, ' cm ', /
          ' of the leaf ends : ',$);
   MINPUT ($BLMLC) LEAFRADIUS_$BLMLC; (F15.0);
   OUTPUT LEAFRADIUS_$BLMLC; (F15.0/);
   WRITE(IOUTLIST,'(F15.8)') LEAFRADIUS_$BLMLC; 
   IF((LEAFRADIUS_$BLMLC < (0.5*ZTHICK_$BLMLC)) | 
      (LEAFRADIUS_$BLMLC < 0.0)) [
" This is done to ensure that the leaf end is rounded all the"
" way from zmin_$BLMLC to zmax_$BLMLC. "
" Otherwise the curvature will fall short."
     LEAFRADIUS_$BLMLC=0.5*ZTHICK_$BLMLC;
     OUTPUT ICM_$BLMLC,LEAFRADIUS_$BLMLC;
      (//' ***ERROR IN CM ',I4,' ($BLMLC)'/
      ' LEAFRADIUS_$BLMLC is less than minimum acceptable'/
      ' RESET TO ', F15.5, ' cm for now'//);
     IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
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    ]
    IF(HOLEPOS_FULL_$BLMLC>=LEAFRADIUS_$BLMLC) [
      HOLEPOS_FULL_$BLMLC=LEAFRADIUS_$BLMLC-0.1;
      OUTPUT ICM_$BLMLC,LEAFRADIUS_$BLMLC;
      (//'***ERROR IN CM ',I4,' ($BLMLC)'/
      ' Hole position in FULL leaves is greater than leaf'/
      ' radius. Reset to ',F12.5,' cm for now'//);
      IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
    ]
    IF(HOLEPOS_ISO_$BLMLC>=LEAFRADIUS_$BLMLC) [
      HOLEPOS_ISO_$BLMLC=LEAFRADIUS_$BLMLC-0.1;
      OUTPUT ICM_$BLMLC,LEAFRADIUS_$BLMLC;
      (//'***ERROR IN CM ',I4,' ($BLMLC)'/
      ' Hole position in ISOCENTER leaves is greater than leaf'/
      ' radius. Reset to ',F12.5,' cm for now'//);
      IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
    ]
    IF(HOLEPOS_TAR_$BLMLC>=LEAFRADIUS_$BLMLC) [
      HOLEPOS_TAR_$BLMLC=LEAFRADIUS_$BLMLC-0.1;
      OUTPUT ICM_$BLMLC,LEAFRADIUS_$BLMLC;
      (//'***ERROR IN CM ',I4,' ($BLMLC)'/
      ' Hole position in TARGET leaves is greater than leaf'/
      ' radius. Reset to ',F12.5,' cm for now'//);
      IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
    ]
 ]; " End of checking the leaf end ;
ZFOCUS_$BLMLC(2)=0.0; "temporary set to avoid crash in summary
"VI. FOCUS FOR DIVERGENT LEAF SIDES "
"==================================== "
OUTPUT; (' Input the Z focus point of the leaf sides: ',$);




   ZFOCUS_$BLMLC(1)=ZMIN_$BLMLC-1.E-4;
   OUTPUT ICM_$BLMLC,ZFOCUS_$BLMLC(1); 
      (//' ***ERROR IN CM ',I4,' ($BLMLC)'/
       ' ZFOCUS(1) cannot be equal to ZMIN_$BLMLC'/
       ' ZFOCUS(1) reset to ',F15.5,' cm for now'//);
   IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
 ]
ELSEIF(ZFOCUS_$BLMLC(1)>ZMIN_$BLMLC & ZFOCUS_$BLMLC(1)<ZMAX_$BLMLC) [
   ZFOCUS_$BLMLC(1)=ZMAX_$BLMLC;
   OUTPUT ICM_$BLMLC,ZFOCUS_$BLMLC(1);
      (//' ***ERROR IN CM ',I4,' ($BLMLC)'/
       ' ZFOCUS(1) is between ZMIN_$BLMLC and ZMAX_$BLMLC'/
       ' This will cause leaf sides to overlap'/
       ' ZFOCUS(1) reset to ',F15.5,' cm for now'//);
   IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
 ];
"VII. CALCULATE THE Z-AXIS COORDINATES OF DIFFERENT SUB-REGIONS "
"============================================================= "
"this is done on a leaf-by-leaf basis      done already see above"
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"VIII. CALC PARAMETERS IN DIRECTION PERPENDICULAR TO LEAF ORIENTATION"
"=================================================================="
" as above




































































































































































































































"LEAF 23 - 17-06
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" DO  I=1,26[
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"IX. INPUT THE COORDINATES NEG_$BLMLC AND POS_$BLMLC " 
"===================================================== "




OUTPUT; (' Input for MLC A and B leaf tips '/);
IF(ORIENT_$BLMLC=1)[
    IF(ENDTYPE_$BLMLC=1)[
      OUTPUT;(' Input min. X, max. X of top of opening in leaves,');
    ]
    ELSE[
      OUTPUT;(' Input min. X, max. X of rounded leaf ends,');
    ] 
]
ELSE[
    IF(ENDTYPE_$BLMLC=1)[
      OUTPUT;(' Input min. Y, max. Y of top of opening in leaves,');
    ]
    ELSE[
      OUTPUT;(' Input min. Y, max. Y of rounded leaf ends,');
    ]
]
OUTPUT;(' # of adjacent leaves with these coordinates:');
I=1;
LOOP[
  OUTPUT I;('   For leaf',I4,' :',$)
  MINPUT ($BLMLC) NEG_$BLMLC, POS_$BLMLC, NUM_$BLMLC; (2F15.0,I5);
  IF(NUM_$BLMLC<=0) NUM_$BLMLC=1;
  OUTPUT NEG_$BLMLC, POS_$BLMLC, NUM_$BLMLC; (2F12.5,I5);
  WRITE(IOUTLIST,'(2F15.5,I5)')NEG_$BLMLC, POS_$BLMLC,NUM_$BLMLC;
  IF(NEG_$BLMLC > POS_$BLMLC)[
     NEG_$BLMLC = POS_$BLMLC;
     OUTPUT ICM_$BLMLC,I,I+NUM_$BLMLC-1,NEG_$BLMLC;
      (//' ***ERROR IN CM ',I4,' ($BLMLC)'/
   ' Min. and max. opening coordinates in leaves ',I4,' - ',I4,' overlap'/
   ' Both coordinates set to ',F15.5,' cm for now'//);
     IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
                               ]
  IF(ABS(NEG_$BLMLC)>RMAX_CM(ICM_$BLMLC)|
     ABS(POS_$BLMLC)>RMAX_CM(ICM_$BLMLC)) [
     OUTPUT ICM_$BLMLC,I,I+NUM_$BLMLC-1;
      (//' ***ERROR IN CM ',I4,' ($BLMLC)'/
      ' Tip of leaves ',I4,' - ',I4,' are outside CM '//);
     IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
                                            ];
  DO J=I,I+NUM_$BLMLC-1["define opening for all leaves in group"
    IF(J>TOT_LEAF_$BLMLC) EXIT;
    LEAFB_$BLMLC(J)=NEG_$BLMLC;
    LEAFA_$BLMLC(J)=POS_$BLMLC;
  ]
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  I=J;
]WHILE(I<=TOT_LEAF_$BLMLC);"End of Coordinate inputs for || direction "  
IF(ENDTYPE_$BLMLC=1)[
"Not sure why this is here as zfocus_$blmlc"
" will not be used may cause problems"
DO I=1, TOT_LEAF_$BLMLC [
SURPARA2_B_$BLMLC(I)=LEAFB_$BLMLC(I)/(ZMIN_$BLMLC-ZFOCUS_$BLMLC(2) );
SURPARA2_A_$BLMLC(I)=LEAFA_$BLMLC(I)/(ZMIN_$BLMLC-ZFOCUS_$BLMLC(2) );
                         ];
                    ];








"XII. GET ECUT, PCUT, DOSE SCORING ZONE AND MATERIAL IN EACH REGION 
"==================================================================
IRA = IRSTART_$BLMLC-1;
DO IR_$BLMLC = 1,N_$BLMLC ["loop through regions to get information"
   IRA = IRA+1;
   IF(IR_$BLMLC=1) [
       OUTPUT IR_$BLMLC;
        (/' Region',I4,' (MLC opening):'/
          ' ECUT, PCUT (MeV), DOSE ZONE (0=NO DOSE SCORED), IREGION_TO_BIT'/
          ' :',$);
   ] 
   ELSEIF(IR_$BLMLC=2) [
       OUTPUT IR_$BLMLC;
        (/' Region',I4,' (MLC leaves):'/
' ECUT, PCUT (MeV), DOSE ZONE (0=NO DOSE SCORED), IREGION_TO_BIT, IGNOREGAPS'/
         ' :',$);
   ]
   ELSE[
       OUTPUT IR_$BLMLC;
        (/' Region',I4,' (driving screw holes):'/
         ' ECUT, PCUT (MeV), DOSE ZONE (0=NO DOSE SCORED), IREGION_TO_BIT'/
         ' :',$);
   ]
   IF(IR_$BLMLC~=2)[
      MINPUT ($BLMLC) ECUT(IRA),PCUT(IRA),DOSE_ZONE(IRA),IREGION_TO_BIT(IRA); 
      (2F15.0,2I5);
      OUTPUT ECUT(IRA),PCUT(IRA),DOSE_ZONE(IRA),IREGION_TO_BIT(IRA);
             (2F15.5,2I5);
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      WRITE(IOUTLIST,'(2F15.5,2I5)')
             ECUT(IRA),PCUT(IRA),DOSE_ZONE(IRA),IREGION_TO_BIT(IRA);
   ]
   ELSE[
      MINPUT ($BLMLC) ECUT(IRA),PCUT(IRA),DOSE_ZONE(IRA),
                        IREGION_TO_BIT(IRA),IGNOREGAPS_$BLMLC; (2F15.0,3I5);
      OUTPUT ECUT(IRA),PCUT(IRA),DOSE_ZONE(IRA),IREGION_TO_BIT(IRA),
             IGNOREGAPS_$BLMLC; (2F15.5,3I5);
      WRITE(IOUTLIST,'(2F15.5,3I5)')
    ECUT(IRA),PCUT(IRA),DOSE_ZONE(IRA),IREGION_TO_BIT(IRA),IGNOREGAPS_$BLMLC;
   ]
   IF(ECUT(IRA) < ECUTIN) [ECUT(IRA)=ECUTIN;];
   IF(PCUT(IRA) < PCUTIN) [PCUT(IRA)=PCUTIN;];
   OUTPUT IR_$BLMLC; (' material of region ',I3,' ',$);
     $MED_INPUT($BLMLC); " inputs character array MED_IN from unit 5, loops" 
  "through array MEDIA(24,I) to check if medium was previously input."  
  "If so, sets MED_INDEX to index of previous medium.  If not," 
  "increments NMED and sets MED_INDEX to NMED."  
   MED(IRA) = MED_INDEX; " medium of the planar slab"
 ] "end of loop over IR_$BLMLC"
;
IF(IGNOREGAPS_$BLMLC=1 & IREJCT_GLOBAL>0)[
   IF(ORIENT_$BLMLC=1)["leaves parallel to X"
       OUTPUT;(/' *******Range rejection in $BLMLC will ignore all'/
               ' air gaps if the particle is in the leaves and has'/
               ' X < min. X of leaf openings (not including leaf ends)'/
               ' or X > max. X of leaf openings (not including ends)'/);
   ]
   ELSE["leaves parallel to Y"
       OUTPUT;(/' *******Range rejection in $BLMLC will ignore all'/
               ' air gaps if the particle is in the leaves and has'/
               ' Y < min. Y of leaf openings (not including leaf ends)'/
               ' or Y > max. Y of leaf openings (not including ends)'/);
   ]
   DO I=1,TOT_LEAF_$BLMLC["loop through leaves to find index of those with"
                           "max. +ve opening and min. -ve opening"
       IF(I=1)[
           MIN_INDEX=I;200 FORMAT(' ',I1,A3,A1,10(F7.2,','));
           MAX_INDEX=I;
       ]
       ELSE[
           IF(LEAFB_$BLMLC(I)<LEAFB_$BLMLC(I-1))MIN_INDEX=I;
           IF(LEAFA_$BLMLC(I)>LEAFA_$BLMLC(I-1))MAX_INDEX=I;
       ]
   ]
   IF(ENDTYPE_$BLMLC=1)["straight, focused ends"
"       MIN_PLANE_$BLMLC=MIN(LEAFB_$BLMLC(MIN_INDEX),"
"                        SURPARA2_B_$BLMLC(MIN_INDEX)*"
"                       (ZMIN_$BLMLC+ZTHICK_$BLMLC-ZFOCUS_$BLMLC(2)));"
"       MAX_PLANE_$BLMLC=MAX(LEAFB_$BLMLC(MAX_INDEX),"
"                         SURPARA2_B_$BLMLC(MAX_INDEX)*"
"                         (ZMIN_$BLMLC+ZTHICK_$BLMLC-ZFOCUS_$BLMLC(2)));"
MIN_PLANE_$BLMLC=MIN(LEAFB_$BLMLC(MIN_INDEX),
                        SURPARA2_B_$BLMLC(MIN_INDEX)*
                       (ZMIN_$BLMLC+ZTHICK_$BLMLC));
       MAX_PLANE_$BLMLC=MAX(LEAFB_$BLMLC(MAX_INDEX),
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                         SURPARA2_B_$BLMLC(MAX_INDEX)*
                         (ZMIN_$BLMLC+ZTHICK_$BLMLC));
   ]
   ELSE["rounded leaf ends"
       MIN_PLANE_$BLMLC=LEAFB_$BLMLC(MIN_INDEX)-LEAFRADIUS_$BLMLC+
                         SQRT(LEAFRADIUS_$BLMLC**2-(ZTHICK_$BLMLC/2.)**2);
       MAX_PLANE_$BLMLC=LEAFA_$BLMLC(MIN_INDEX)+LEAFRADIUS_$BLMLC-
                         SQRT(LEAFRADIUS_$BLMLC**2-(ZTHICK_$BLMLC/2.)**2);
   ]
   write(*,*)' min,max ',MIN_PLANE_$BLMLC,MAX_PLANE_$BLMLC;
]
ELSE["set to default"
   IGNOREGAPS_$BLMLC=0;
]
"
"XIII. SET UP AIR GAP TO PREVIOUS CM IF PRESENT
"  =========================================
"
"  The air gap has the highest region number in the CM, even though its
"  the top of the component module.  This is to allow the assignment of
"  region numbers on input of the parameters of each local region 
"  (mainly to assign the medium number of the region).  
"  The air gap is then assigned after all of the
"  CM parameters have been input.
"
"note that if this is the first CM (ICM_$mlc=1) then the gap thickness
"Z_gap_THICK(ICM_$BLMLC) = 0, which is used as a flag for no air gap
Z_gap_THICK(ICM_$BLMLC) = ZMIN_$BLMLC - Z_min_CM(ICM_$BLMLC);
IF (Z_gap_THICK(ICM_$BLMLC) < = 0.0) [
   Z_gap_THICK(ICM_$BLMLC) = 0.;
   N_GAP_$BLMLC = 0; "no air gap for this CM"
  ]
ELSE [ 
   N_GAP_$BLMLC = 1; "this CM has an air gap"
   IRA = IRSTART_$BLMLC+N_$BLMLC; "absolute region number of air gap"
   MED(IRA) = AIR_INDEX; "medium is air"
 ];
"
"XIV. SET UP REGION NUMBERS
"===========================
"




IREND_$BLMLC = (IRSTART_$BLMLC -1) + N_$BLMLC+N_GAP_$BLMLC;
NREG = NREG+N_$BLMLC+N_GAP_$BLMLC; 
                            "Total no of regions in full geometry up 
                            "to and including this CM
IF (NREG <= $MXREG) [ 
   IR_start_CM(ICM_$BLMLC+1) = IREND_$BLMLC+1; 
  ]    "have not exceeded maximum region number
       "Index of first region in next CM:"
ELSE [
   OUTPUT ICM_$BLMLC,NREG,$MXREG;
   (//' ***ERROR IN CM ',I4,' ($BLMLC):'/
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   T2,I4,' regions requested, only ',I4,' available'//);
   IERR_GEOM(ICM_$BLMLC)=IERR_GEOM(ICM_$BLMLC)+1;
 ];
"
"XV.  ESTABLISH CM BOUNDARY
"============================
"
RMAX_CM_FLAG(ICM_$BLMLC) = 2; "put a square boundary about CM
"
"XVI. ESTABLISH DOSE SCORING ZONES AND BIT SETTING FOR EACH REGION
"===================================================================
"
IRA = IRSTART_$BLMLC-1; "absolute region number"
DO IR_$BLMLC=1,N_$BLMLC ["loop over local region number"
   IRA = IRA+1;
   "dose-scoring zones"
   NDOSE_ZONE = MAX(DOSE_ZONE(IRA),NDOSE_ZONE); "Number of dose zones"
   MAX_BIT = MAX(IREGION_TO_BIT(IRA),MAX_BIT); " current maximum"
   "charged particle range rejection parameters"
   ESAVE(IRA)=ESAVE_GLOBAL; "Particles with total energies below ESAVE are"
                            "considered for range rejection"
   ECUTRR(IRA)=ECUT(IRA); "Minimum energy on exit from region GXD"
   E_min_out(ICM_$BLMLC)=ECUT(IRA); "Minimum energy on exit from CM"
  ] "end of loop over IR_$BLMLC
"XVII. ESTABLISH SUB-REGION IR VALUES
"===================================
DO L=1,TOT_LEAF_$BLMLC [ 
      DO I=1,5 [ "NX"
           DO J =1,7 [ "NY"
                DO K = 1,15 [ "NZ"
                  SUBINDEX_$BLMLC(L,I,J,K)=1; "
                  ];
            ];
         ];
      ];
;
"Now define regions containing leaf medium"
DO L=1,TOT_LEAF_$BLMLC[" Do For All Leaves"
















































































































































]   
];
"Now set driving screw hole to air - Not right at moment change later"
   DO J=3,3 [
      SUBINDEX_$BLMLC(L,2,J,6)=2;
      SUBINDEX_$BLMLC(L,5,J,6)=2;
     ]
]
  "   =======================
"






  (//' *** ERROR *** unexpected end of file reading input for CM',I3);
STOP;
:ERROR_$BLMLC:
;OUTPUT ICM;(//' *** ERROR *** format error on input for CM',I3);
STOP;
END;  "End of INPUT_$BLMLC"
%E "Start of subroutine ISUMRY_$BLMLC (Rev 1.4)"
"***********************************************************************
"
"                          Subroutine ISUMRY_$BLMLC
"                          ***********************
"
" Summarize input, write graphics file for EGS_Windows, and set parameters 












   ICOLOUR, "T>colour of CM for EGS_Windows
"   ID,     already defined gf  T>index of dose scoring zone
   IRA,     "T>absolute region number
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   I,J,     "T>DO loop index
   ISTART,IEND; "T>indices for outputting info"
$REAL  VOL_$BLMLC(3), "T> region volumes
       YY1(9),          "T> YY1 and YY2 index subregion along perpendicular..
       YY2(9),          "T> direction to MLC orientation 
       YY3(9),          "T> specific for target leaf
       YY4(9),          "T>
       YY5(9),          "T> same for full leaf
       YY6(9),          "T> 
       YY7(9),          "T> same for isocenter leaf
       YY8(9),         "T>
       Zo,             "T> THe z-coordinate of the leaf center
       XoP,XoN,        "T> The center of the rounded leaves ends along leaf
       M1,M2,          "T> Variables related to partial(rounded) leaf volume 
       THETASUB,       "T> Angle at leaf end subtended by Z boundaries of reg.
       TOTALVOL,       "T> Total volume of MLC CM
       ZSQUARE,ZCUBE,AREA,    "T> Variables related to partial leaf volumes
       TEMP,TEMP1,TEMP2,TEMP3,"T> Variables related to partial leaf volumes
       HOLD;            "T> to hold a TEMP value
RETURN;
END;
%E "Start of subroutine HOWNEAR_$BLMLC (Rev 1.4)"
"***********************************************************************"
"                                                                       "
"                          Subroutine HOWNEAR_$BLMLC               "
"                          ******************************               "
"                                                                       "
" Calculates min. distance to nearest region boundary                   "
" Used to be HOWNEAR macro, but is now called from that macro.          "
"                                                                       "
"***********************************************************************"
" Rewritten for BLMLC module"
"============================"





$REAL   DIST_sngl; "T> min. distance to nearest region boundary"
DOUBLE PRECISION   XYL1,XYL2, "T> X(NP) and Y(NP)"
                   XoN, XoP, DIST,
                   UVL1,UVL2,
   Z_LEAF_BOTTOM,
   Z_LEAF_TOP,
                   TEMP1,TEMP2,TEMP3,TEMP4,
                   TEMP5,TEMP6,HOLE, "T> temp. distance variables"
                   XL,XR,Lo,Ro,Zo;          "T>temp distance variables"
$INTEGER I,J,K, "T> looping index"
         NZ, "T> index of subregion in Z direction"
         NY, "T> index of subregion perpendicular to leaf opening direction" 
         NX, "T> index of subregion in direction of leaf opening"
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         LEAFIS, "T> leaf no. where particle is located"
 LEAF_TOP, 
 LEAF_MIDDLE,
 LEAF_BOTTOM, "BOTTOM Z INDICES OF REGIONS OF LEAF FOR CALCULATING X REGION"
 LEAF_STRT, "INDEX OF START OF LEAF GROOVE"
 LAST_LEAF,
 LEFT_BORD, RIGHT_BORD,

















IF(IGNOREGAPS_$BLMLC=1 & XYL2 < MIN_PLANE_$BLMLC &
XYL1 > SURPARA1_$BLMLC(1,1)*(Z(NP)-ZFOCUS_$BLMLC(1)) &
XYL1 < SURPARA1_$BLMLC(TOT_LEAF_$BLMLC,8)*(Z(NP)-ZFOCUS_$BLMLC(1)) &
IR_$BLMLC=2)[
"particle within negative leaves, ignore air gaps for range rejection"
"distance to most -ve leaf side...note this is to the tip of the tongue"
TEMP1=SURPARA1_$BLMLC(1,1);
TEMP1=ABS((TEMP1*(Z(NP)-ZFOCUS_$BLMLC(1))-XYL1)/SQRT(1+TEMP1**2));
"distance to most +ve leaf side...note this is to the back of the last"






ELSEIF(IGNOREGAPS_$BLMLC=1 & XYL2 > MAX_PLANE_$BLMLC &
XYL1 > SURPARA1_$BLMLC(1,1)*(Z(NP)-ZFOCUS_$BLMLC(1)) &
XYL1 < SURPARA1_$BLMLC(TOT_LEAF_$BLMLC,8)*(Z(NP)-ZFOCUS_$BLMLC(1)) &
IR_$BLMLC=2)[
"particle within positive leaves, ignore air gaps for range rejection"
"distance to most -ve leaf side...note this is to the tip of the tongue"
TEMP1=SURPARA1_$BLMLC(1,1);
TEMP1=ABS((TEMP1*(Z(NP)-ZFOCUS_$BLMLC(1))-XYL1)/SQRT(1+TEMP1**2));
"distance to most +ve leaf side...note this is to the back of the last"
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]
ELSE["do not ignore air gaps for range rejection"
LEAFIS=0; "Determine which leaf we are in, I is index of leaf number"
"in order to find out if we are in a gap (leafis=0)"




























IF (LEAFIS > 0) [









"So we know NY but are we on the next leaf along?
IF ((NY = 6) & (LEAFIS < 26)) [
IF (LEAFTYPE_$BLMLC(LEAFIS)=1) [
IF ((NZ=3)|(NZ=7)|(NZ=11)) [
IF (XYL1 > (SURPARA1_$BLMLC(LEAFIS+1,1)*(Z(NP)-ZFOCUS_$BLMLC(1)))) [
LEAFIS=LEAFIS+1; 
NY=1; "we can't be further over than ny=1
]
ELSE [


















ELSEIF ((NY =7) & (LEAFIS <26)) [
IF (LEAFTYPE_$BLMLC(LEAFIS)=1) [
IF ((NZ~=5) & (NZ~=9) & (NZ~=13)) [
IF (XYL1 > (SURPARA1_$BLMLC(LEAFIS+1,2)*(Z(NP)-ZFOCUS_$BLMLC(1))))  [
















IF ((NZ~=3) & (NZ~=7) & (NZ~=11)) [


















"BELOW IS END OF ELSE DO NOT IGNORE AIR GAPS FOR RANGE REJECTION"
"]"
" IF (LEAFIS =0) [
" OUTPUT NZ,NY,XYL1; ('NZ :',I3,' NY :',I3,' XYL1 :',F10.7);
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" ]
IF(LEAFIS~=0) [








"By now we know which z region we are in so use this to calculate"
"which X region we are in. Also calculate XL and XR for dist calc"




IF ((XYL2>TEMP1 & XYL2<TEMP2) | (XYL2=TEMP1 & UVL2>=0.0) |





ELSEIF ((XYL2<TEMP1 & XYL2>TEMP3) | (XYL2=TEMP1 & UVL2>=0.0) |










ELSEIF((XYL2>TEMP2 & XYL2<TEMP4) | (XYL2=TEMP2 & UVL2>=0.0) |











ELSEIF ((NZ>LEAF_TOP) & (NZ<=LEAF_MIDDLE)) [" In middle region of leaf"
IF ((XYL2>TEMP1 & XYL2<TEMP2) | (XYL2=TEMP1 & UVL2>=0.0) |





ELSEIF ((XYL2<TEMP1 & XYL2>TEMP3) | (XYL2=TEMP1 & UVL2>=0.0) |
(XYL2=TEMP3 & UVL2>=0.0)) [
NX=3;
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ELSEIF((XYL2>TEMP2 & XYL2<TEMP4) | (XYL2=TEMP2 & UVL2>=0.0) |















IF ((XYL2>TEMP1 & XYL2<TEMP2) | (XYL2=TEMP1 & UVL2>=0.0) |





ELSEIF ((XYL2<TEMP1 & XYL2>TEMP3) | (XYL2=TEMP1 & UVL2>=0.0) |










ELSEIF((XYL2>TEMP2 & XYL2<TEMP4) | (XYL2=TEMP2 & UVL2>=0.0) |
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OUTPUT NZ;(/'PROBLEM DETERMINING X REGION - NZ:',I5);
]
    "Calculates distance to closest boundary in Y and z direction"          
IF(LEAFTYPE_$BLMLC(LEAFIS)=1)[
IF (NY=1|NY=7) [












































































































ELSEIF (NY = 7) [
I1=7;
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"NOW CHECK DISTANCE IN X DIRECTION"
"XL AND XR NOW CALCULATED ABOVE BUT LINES FROM DYNVMLC_CM WILL HAVE TO BE"
"REINSTATED IF ROUNDED LEAVES ARE EVER USED"
"So we now only need this line here now"
DIST=MIN(DIST,XL,XR);
IF(DIST<0) [
OUTPUT LEAFIS,NX,NY,NZ; (/'negative dist: ',4I3);
]





ELSE[ "beyond outer edges of leaf bank"
" IF (PLT_$BLMLC = 1) [
" OUTPUT; ('BY HERE');
" WRITE(73,252) XYL2,XYL1,Z(NP),LEAFIS,NX,NY,NZ,
"    'X';
" ]
  IF(XYL1 <= SURPARA1_$BLMLC(1,1)*(Z(NP)-ZFOCUS_$BLMLC(1)))[
      TEMP1=SURPARA1_$BLMLC(1,1);                                           
      TEMP1=ABS((TEMP1*(Z(NP)-ZFOCUS_$BLMLC(1))-XYL1)/
                 SQRT(1+TEMP1**2));
    ]                                                                         
  ELSEIF(XYL1 >= SURPARA1_$BLMLC(TOT_LEAF_$BLMLC,6)*                      
                   (Z(NP)-ZFOCUS_$BLMLC(1)))[                               
      TEMP1=SURPARA1_$BLMLC(TOT_LEAF_$BLMLC,8);                           
      TEMP1=ABS((TEMP1*(Z(NP)-ZFOCUS_$BLMLC(1))-XYL1)/
                 SQRT(1+TEMP1**2));    






















   COUNT,  
   IRL,        "T>local region number (absolute), required by HOWNEAR macro
   I, J,        "T>loop control
   REGION_$BLMLC,     "T>region number within CM (relative)
   NEWREGION_$BLMLC,     "T>region number within CM (relative)
   NX,NY,NZ,        "T> Subindices for region
   OUTOFCMFLAG,     "T> Flag to denote particle out of CM
   OUTOFMLCFLAG,    "T> Flag to denote particle out of MLC 
   LEAFIS,          "T> Leaf number
   LHS,RHS,     "T> Macro variables to find + and - closest boundary index 
   ZLHS,ZRHS,
   YLHS,YRHS,LEAF_CHWITH,LEAF_DE, "for leaf boundary indicees
   IDIR,        "T> direction sign, used in call to where_am_i
   XREG_MIN, XREG_MAX,
   YREG_MIN, YREG_MAX,
   ZREG_MIN, ZREG_MAX, "Indicees of end boundary regions"
   YREG_STRT,
   LEAF_TOP, LEAF_MIDDLE, LEAF_BOTTOM;
DOUBLE PRECISION
   DIST,      "T>Distance to z boundary along current particle trajectory   
   UVL(2),    "T>temporary variable
   TRYY1,TRYY2,
   XoN,XoP,    "T> Negative and Positive leaf centers (rounded leaf)
   Zo,         "T> z position of rounded leaf tip
   XP,XN,YP,YN,ZP,ZN,    "T>+ and - distances in x,y, z directions
   XDIST,YDIST,ZDIST,    "T> x,y, Z distances to nearest boundaries 
   DIST1,DIST2,DIST3,    "T> Variables to control particle propagation
   STEP2,                "T>  "
   TLHS,TRHS,            "T> temporary macro variables like lhs,rhs
   DISCRIMINANT,         "T> Variable for rounded leaf
   TEMP,TEMP1, TEMP2, TEMP3, TEMP4, TEMP5, HOLE,
   STEP_UNIT,
   XYL(2),     "T> rearranged x and y coordinates
   XYFL(2),
   Z_LEAF_BOTTOM,
   Z_LEAF_TOP,
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   XL, XR,
   ZFL,




IF (LEAFIS > 0) [
IF (LEAFTYPE_$BLMLC(LEAFIS)=1) [
IF (NY=1) [
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ZRHS=3;
]
























































































































































































































































































































































































































ZDIST = MAX(ZP, ZN);
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];    
IF((UVL(1)-SURPARA1_$BLMLC(LEAF_DE,YRHS)*W(NP))~= 0 ) [
YP = (SURPARA1_$BLMLC(LEAF_DE,YRHS)*(ZFL-ZFOCUS_$BLMLC(1))-XYFL(1));





IF((UVL(1) - SURPARA1_$BLMLC(LEAF_CHWITH,YLHS)*W(NP))~ = 0 ) [
YN = (SURPARA1_$BLMLC(LEAF_CHWITH,YLHS)*(ZFL-ZFOCUS_$BLMLC(1))-XYFL(1));










] "Left in from dynvmlc but is this correct?"






























ELSEIF ((NZ>LEAF_TOP) & (NZ<=LEAF_MIDDLE)) [
IF (NX=1) [
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] "end of focused leaf end"
XP=XR;
XN=XL;








IF( YDIST>=0.0 ) [
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TEMP=MIN(TEMP,YDIST);
]











OUTPUT NX,NY,NZ,LEAFIS; "should not happen"
('neg dist nx = ',I3,' NY= ',I3,' NZ= ',I3,' LEAF= ',I3);
OUTPUT XDIST,YDIST,ZDIST;















"End of BLMLC_cm.mortran (Rev 1.4)"
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 *  $Id: BLMLC_macros.mortran,v 1.3 2005/11/10 05:19:11 bwalters Exp $
 *
 *****************************************************************************/
"Macros for use in the BLMLC Component Module "
----------------------------------------------------------------------






" See BLMLC_CM for more details "
"Tony Millin, 2008 "
"--------------------------------------------------------------------"
"     BLMLC miscellaneous replacement macros                    "
"--------------------------------------------------------------------"
"                                                                    "
REPLACE {$MAX_N_$BLMLC} WITH {{REDUCE $MAXIMUM_N_$BLMLC}};
"       ==========="
REPLACE {$MAXIMUM_N_$BLMLC} WITH {3}; 
"       ==================="
" THE MAX # OF the leaves TO BE ALLOWED IN THIS MODULE"
REPLACE {$MAXLEAF} WITH {160}
;
"---------------------------------------------------------------------"




"V>ICM_$BLMLC        = index of CM, set as ICM in INPUT_$BLMLC,not reset
"V>IRSTART_$BLMLC    = first region number for this CM
"V>IREND_$BLMLC      = last region number for this CM
"V>N_$BLMLC          = number of regions in CM
"V>TITLE_$BLMLC      = title of CM
"V>ZMIN_$BLMLC       = Front of BLMLC
"V>ZMAX_$BLMLC       = back of BLMLC
"V>ZTHICK_$BLMLC     = Thickness of leaves
"V>ZFRONT_$BLMLC     = Upstream Z boundary of this CM
"V>NGROUP_$BLMLC     = the number of groups of leaves where the leaves
"V>                         in each group have the same width
"V>NUM_LEAF_$BLMLC(I)= the number of leaves in group I
"V>LEAFWIDTH_$BLMLC(I)= the width of each leaf in group I at ZMIN_$BLMLC 
"V>                          excluding the tongue 
"V>TOT_LEAF_$BLMLC   = the total number of leaves in the MLC 
"V>ORIENT_$BLMLC     = the index to indicate the leave direction
"V>                      0: default, leaf orientation in y
"V>                      1:                           in x
"V>START_$BLMLC      = the start position wrt the CAX of the lowermost
"V>                         leaf ie leaf 1 tongue as projected to ZMIN_$BLMLC
"V>HOLEPOS_$BLMLC(I) = distance from leaf tip to start of driving screw hole 
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"V>                      for each leaf in group I
"V>LEAFGAP_$BLMLC    = the width of the interleaf air gap at ZMIN_$BLMLC
"V>ENDTYPE_$BLMLC    = the leaf end geomery ( 0 = rounded, 1 = focused )
"V>LEAFRADIUS_$BLMLC = the radius of the leaf end if ENDTYPE_$BLMLC = 0
"V>ZREG_$BLMLC(TOT_LEAF_$BLMLC,8) = the z boundaries of the 7 sub-regions in 
"V>                                     z direction
"V>YREG_$BLMLC(TOT_LEAF_$BLMLC,7)  
"V>                   = the boundaries along the perpendicular direction
"V>                     to the leaf orientation of sub-regions
"V>SUBINDEX_$BLMLC   = an index number to represent which region the  
"V>          belongs in based on sub-dividing each leaf into regions.
"V>ZFOCUS_$BLMLC(2) = the two focus point coordinates: 1. for leave side
"V>                                                  2. for leave end.
"V>SURPARA1_$BLMLC($MAXLEAF,8)  the parameters to describe the leaf side
"V>                               surface i.e. tangent along that side.
"V>LEAFA_$BLMLC(TOT_LEAF_$BLMLC) = coordinates of A side leaves at 
"V>                     ZMIN_$BLMLC if ENDTYPE_$BLMLC = 1 or at
"V>                     rounded leaf tip @ ZMIN_$BLMLC+(ZTHICK_$BLMLC)/2
"V>LEAFB_$BLMLC(TOT_LEAF_$BLMLC) = coordinates of B side leaves at
"V>                     ZMIN_$BLMLC if ENDTYPE_$BLMLC = 1 or at
"V>                     rounded leaf tip @ ZMIN_$BLMLC+(ZTHICK_$BLMLC)/2.
"V>SURPARA2_B_$BLMLC($MAXLEAF)the parameters to describe the leaf end
"V>                               surface i.e. tangent along that end.
"V>SURPARA2_A_$BLMLC($MAXLEAF)the parameters to describe the leaf end
"V>                               surface i.e. tangent along that end.
"V>IR_$BLMLC          local region number
"V>LEAFTYPE_$BLMLC(I) Leaf type of leaf I: 1=FULL leaf 
"V>                                          2=TARGET leaf
"V>                                          3=ISOCENTER leaf
"V>LEAFWIDTH_$BLMLC(LEAFTYPE) = width of leaf of type LEAFTYPE excl. tongue
"V>WTONGUE_$BLMLC(LEAFTYPE) = width of tongue for LEAFTYPE leaves
"V>WGROOVE_$BLMLC(LEAFTYPE) = width of groove for LEAFTYPE leaves
"V>WTIP_$BLMLC(LEAFTYPE) = width of leaf tip for LEAFTYPE leaves
"V>WRAILTOP_$BLMLC(LEAFTYPE) = width of upper support rail for LEAFTYPE
"V>WRAILBOT_$BLMLC(LEAFTYPE) = width of lower support rail for LEAFTYPE
"V>ZTIP_$BLMLC(LEAFTYPE) = Z where leaf tip starts/ends for LEAFTYPE
"V>ZLEAF_$BLMLC(LEAFTYPE) = Z where leaf starts/ends for LEAFTYPE
"V>ZTONGUE_$BLMLC(LEAFTYPE) = Z where tongue starts/ends for LEAFTYPE
"V>ZGROOVE_$BLMLC(LEAFTYPE) = Z where groove starts/ends for LEAFTYPE
"V>ZHOLETOP_$BLMLC(LEAFTYPE) = Z of top of driving screw hole for LEAFTYPE
"V>ZHOLEBOT_$BLMLC(LEAFTYPE) = Z of bottom of driving screw hole
"V>HOLEPOS_FULL/TAR/ISO_$BLMLC = Distance of hole from leaf tip for leaf
"V>                                type specified.  Later stored in 
"V>                                HOLEPOS_$BLMLC(I) for each leaf.
"V>ZRAILTOP_$BLMLC(LEAFTYPE) = Z of upper support rail for LEAFTYPE
"V>ZRAILBOT_$BLMLC(LEAFTYPE) = Z of lower support rail for LEAFTYPE 
"V>MIN_PLANE_$BLMLC  min. plane perp. to leaf direction.  For particles
"V>                    in leaves with position < MIN_PLANE_$BLMLC,
"V>                    air gaps and driving screw holes will be ignored when 
"V>                    doing range rejection (IGNOREGAPS_$BLMLC=1)
"V>MAX_PLANE_$BLMLC  max. plane perp. to leaf direction.  For particles
"V>                    in leaves with position > MAX_PLANE_$BLMLC,
"V>                    air gaps and driving screw holes will be ignored when 
"V>                    doing range rejection (IGNOREGAPS_$BLMLC=1)
"V>IGNOREGAPS_$BLMLC Set to 1 to ignore air gaps and driving screw holes 
"I>                    when doing range rejection
"V>                    for particles in the leaves and beyond the most open
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      ZMIN_$BLMLC,
      ZMAX_$BLMLC,
      ZTHICK_$BLMLC,
      ZFRONT_$BLMLC,
      ZFOCUS_$BLMLC,
      THETA_TOP_$BLMLC,
      THETA_BOTTOM_$BLMLC,
      SURPARA2_B_$BLMLC,
      SURPARA2_A_$BLMLC,
      START_$BLMLC,
      HOLEPOS_$BLMLC,
      LEAFGAP_$BLMLC,
      LEAFRADIUS_$BLMLC,
      LEAFA_$BLMLC,
      LEAFB_$BLMLC,
      SURPARA1_$BLMLC,
      ZREG_$BLMLC,
      YREG_$BLMLC,MIN_PLANE_$BLMLC,MAX_PLANE_$BLMLC,
      LEAFWIDTH_$BLMLC,WTONGUE_$BLMLC,WGROOVE_$BLMLC,
      WTIP_$BLMLC,WRAILTOP_$BLMLC,WRAILBOT_$BLMLC,
      ZTIP_$BLMLC,ZLEAF_$BLMLC,
      ZTONGUE_$BLMLC,ZGROOVE_$BLMLC,ZHOLETOP_$BLMLC,
      ZHOLEBOT_$BLMLC,
      HOLEPOS_FULL_$BLMLC,HOLEPOS_TAR_$BLMLC,HOLEPOS_ISO_$BLMLC,
      ZRAILTOP_$BLMLC,ZRAILBOT_$BLMLC, 
      ICM_$BLMLC,IRSTART_$BLMLC,IREND_$BLMLC,N_$BLMLC,N_GAP_$BLMLC,
      IR_$BLMLC,NUM_LEAF_$BLMLC, ORIENT_$BLMLC,ENDTYPE_$BLMLC,
      SUBINDEX_$BLMLC,NGROUP_$BLMLC,TOT_LEAF_$BLMLC,
      LEAFTYPE_$BLMLC,IGNOREGAPS_$BLMLC,
      TITLE_$BLMLC,
      PLT_$BLMLC;
   DOUBLE PRECISION 
      EPS,
      ZMIN_$BLMLC,
      ZMAX_$BLMLC,
      ZTHICK_$BLMLC,
      ZFRONT_$BLMLC,
      ZFOCUS_$BLMLC(2),
      THETA_TOP_$BLMLC,
      THETA_BOTTOM_$BLMLC,
      SURPARA2_B_$BLMLC($MAXLEAF),
      SURPARA2_A_$BLMLC($MAXLEAF),
      START_$BLMLC,
      HOLEPOS_$BLMLC($MAXLEAF),
      LEAFGAP_$BLMLC,
      LEAFRADIUS_$BLMLC,
      LEAFA_$BLMLC($MAXLEAF),
      LEAFB_$BLMLC($MAXLEAF),
      SURPARA1_$BLMLC($MAXLEAF,8),
      ZREG_$BLMLC($MAXLEAF,17),
      YREG_$BLMLC($MAXLEAF,8),MIN_PLANE_$BLMLC,MAX_PLANE_$BLMLC; 
  $REAL
      LEAFWIDTH_$BLMLC(3),WTONGUE_$BLMLC(3),WGROOVE_$BLMLC(3),
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      WTIP_$BLMLC(3),WRAILTOP_$BLMLC(3),WRAILBOT_$BLMLC(3),
      ZTIP_$BLMLC(3),ZLEAF_$BLMLC(3),
      ZTONGUE_$BLMLC(3),ZGROOVE_$BLMLC(3),ZHOLETOP_$BLMLC(3),
      ZHOLEBOT_$BLMLC(3),
      HOLEPOS_FULL_$BLMLC,HOLEPOS_TAR_$BLMLC,HOLEPOS_ISO_$BLMLC,
      ZRAILTOP_$BLMLC(3),ZRAILBOT_$BLMLC(3);
  INTEGER
      ICM_$BLMLC,IRSTART_$BLMLC,IREND_$BLMLC,N_$BLMLC,N_GAP_$BLMLC,
      IR_$BLMLC,NUM_LEAF_$BLMLC($MAXLEAF), ORIENT_$BLMLC,ENDTYPE_$BLMLC,
      SUBINDEX_$BLMLC($MAXLEAF,5,7,15),NGROUP_$BLMLC,TOT_LEAF_$BLMLC,
      LEAFTYPE_$BLMLC($MAXLEAF),IGNOREGAPS_$BLMLC,PLT_$BLMLC;
  CHARACTER*1 TITLE_$BLMLC(60);
}




" this macro is used to determine the regon #"
"{p1}: the return region value, local region"
"{p2}: the step dist which is used to calc. the particle final position"
REPLACE {$BLMLC_FIND(#,#);} WITH {;
    XYFL(1)=XYL(1)+{P2}*UVL(1);
    XYFL(2)=XYL(2)+{P2}*UVL(2);
    ZFL=Z(NP)+{P2}*W(NP);
IF((W(NP)>0. & ZFL>=ZMAX_$BLMLC) | (W(NP)<0. & ZFL<=ZFRONT_$BLMLC)) [
OUTOFCMFLAG=1;
]
"put in = signs to get this to exit stepping loop in HOWFAR" 
IF(N_GAP_$BLMLC=1 & ZFL<=ZMIN_$BLMLC & ZFL>=ZFRONT_$BLMLC) [
 {P1}=4; 
]
ELSE ["inside leaf bank"
LEAFIS=0;
DO I = 1,TOT_LEAF_$BLMLC [ "Determine which leaf we are in"
TEMP1=SURPARA1_$BLMLC(I,1)*(ZFL-ZFOCUS_$BLMLC(1));
TEMP2=SURPARA1_$BLMLC(I,8)*(ZFL-ZFOCUS_$BLMLC(1));







"  IF(LEAFIS=0) ["
IF((XYFL(1) < TEMP1) | (XYFL(1) > TEMP2) ) [ 
{P1}=1;
OUTOFMLCFLAG=1;
] "assume going into air, set"
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ELSE[
DO I = 1,15 [ "Determine Z region" 





























"So we know NY but are we on the next leaf along?"
IF ((NY = 6) & (LEAFIS < 26)) [
IF (LEAFTYPE_$BLMLC(LEAFIS)=1) [
IF ((NZ=3)|(NZ=7)|(NZ=11)) [
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]
ELSEIF ((NY =7) & (LEAFIS <26)) [
IF (LEAFTYPE_$BLMLC(LEAFIS)=1) [
IF ((NZ~=5) & (NZ~=9) & (NZ~=13)) [


















IF ((NZ~=3) & (NZ~=7) & (NZ~=11)) [


















"Now determine X region index"




"   TEMP3=LEAFB_$BLMLC(LEAFIS)-HOLE;
"  TEMP4=LEAFA_$BLMLC(LEAFIS)+HOLE; 
TEMP3=TEMP1-HOLE;
TEMP4=TEMP2-HOLE; 
"By now we know which z region we are in so use this to calculate"
"which X region we are in. Also calculate XL and XR for dist calc"




IF ((XYFL(2)>TEMP1 & XYFL(2)<TEMP2) | (XYFL(2)=TEMP1 & UVL(2)>=0.0) |
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    (XYFL(2)=TEMP2 & UVL(2)<0.0)) [
NX=1;
]
ELSEIF ((XYFL(2)<TEMP1 & XYFL(2)>TEMP3) | (XYFL(2)=TEMP1 & UVL(2)>=0.0) |
  (XYFL(2)=TEMP3 & UVL(2)>=0.0)) [
NX=3;
]
ELSEIF ((XYFL(2)<TEMP3) | (XYFL(2)=TEMP3 & UVL(2)<0.0))[
NX=2;
]
ELSEIF((XYFL(2)>TEMP2 & XYFL(2)<TEMP4) | (XYFL(2)=TEMP2 & UVL(2)>=0.0) |
    (XYFL(2)=TEMP4 & UVL(2)<0.0)) [
NX=4;
]




ELSEIF ((NZ>5) & (NZ<=10)) [" In middle region of leaf"
IF ((XYFL(2)>TEMP1 & XYFL(2)<TEMP2) | (XYFL(2)=TEMP1 & UVL(2)>=0.0) |
   (XYFL(2)=TEMP2 & UVL(2)<0.0)) [
NX=1;
]
ELSEIF ((XYFL(2)<TEMP1 & XYFL(2)>TEMP3) | (XYFL(2)=TEMP1 & UVL(2)>=0.0) |
(XYFL(2)=TEMP3 & UVL(2)>=0.0)) [
NX=3;
]
ELSEIF ((XYFL(2)<TEMP3) | (XYFL(2)=TEMP3 & UVL(2)<0.0)) [
NX=2;
]
ELSEIF((XYFL(2)>TEMP2 & XYFL(2)<TEMP4) | (XYFL(2)=TEMP2 & UVL(2)>=0.0) |
(XYFL(2)=TEMP4 & UVL(2)<0.0)) [
NX=4;
]








IF ((XYFL(2)>TEMP1 & XYFL(2)<TEMP2) | (XYFL(2)=TEMP1 & UVL(2)>=0.0) |
  (XYFL(2)=TEMP2 & UVL(2)<0.0)) [
NX=1;
]
ELSEIF ((XYFL(2)<TEMP1 & XYFL(2)>TEMP3) | (XYFL(2)=TEMP1 & UVL(2)>=0.0) |
   (XYFL(2)=TEMP3 & UVL(2)>=0.0)) [
NX=3;
]
ELSEIF ((XYFL(2)<TEMP3) | (XYFL(2)=TEMP3 & UVL(2)<0.0)) [
NX=2;
]
ELSEIF((XYFL(2)>TEMP2 & XYFL(2)<TEMP4) | (XYFL(2)=TEMP2 & UVL(2)>=0.0) |
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" NEXT COMES HOWNEAR MACRO"
"========================="




"End of BLMLC_macros.mortran (Rev 1.3)"
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